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Abstract 
Carbon-hydrogen bonds are typically not viewed as a reactive site, rather they 
are commonly the backbone of the molecule to which functional groups are 
attached. We believed that we could find a method of reacting directly at C-H 
bonds via a hydride transfer to provide a simple, atom efficient method of 
constructing carbon-carbon bonds, providing a new target site for small molecule 
synthesis. Our initial targets for C-H activation were benzylic ethers. This was to 
be achieved with the use of Lewis acid catalysts to promote hydride transfer. It 
was initially thought that this transformation could be achieved through a 
modification of the Oppenauer oxidation, which had previously shown a small 
degree of conversion (8%) within the group.  
The yield was improved to 24%, but no further progress was made despite inquiry 
into a wide range of conditions and substrates. These results led us to consider 
a method of intramolecular C-H activation which would be achieved via a 1,5-
hydride shift. This reaction has seen use previously with electron withdrawn 
alkenes, but only a very limited number of nitroalkenes had been observed 
performing this transformation, using a protic solvent. We have developed a 
method of Lewis acid catalysis to convert nitrostyrene substrates. 
The nitrostyrene acts as a hydride acceptor to form a nitronate anion, which then 
attacks the newly generated cation to form a six-membered ring. A novel route 
into the synthesis of substituted tetrahydroquinolines has been achieved via a 
nitro-Mannich cyclisation, something only previously performed with n-BuLi 
mediated deprotonation of nitroalkanes or the use of an external hydride source 
to generate the required nitronate. Our reaction has the potential to be incredibly 
atom efficient, with no gain or loss of mass from the starting material to product, 
requiring only the use of a catalyst. 
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Abbreviation Meaning 
Ac Acetyl 
acac Acetylacetone 
AIBN Azobisisobutyronitrile 
aq Aqueous 
BINAP 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl 
Bn Benzyl 
Boc t-Butyloxycarbonyl 
Bpin Bis(pinacolato)diboron 
bpy 2,2'-Bipyridine 
Bu Butyl 
CDC Cross-Dehydrogenative Coupling 
CN Cyano 
cod 1,5-Cyclooctadiene 
coe Cyclooctene 
Cp Cyclopentadiene 
d Days 
dr Diastereomeric ratio 
DBU 1,8-Diazabicyclo(5.4.0)undec-7-ene 
DCE Dichloroethane 
DDQ 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone 
DIBAL-H Diisobutylaluminium hydride 
DIPEA N,N-Diisopropylethylamine 
DMA Dimethylacetamide 
2,2-DMB 2,2-Dimethylbutane 
DME 1,2-Dimethoxyethane 
DMF Dimethylformamide 
DMP Dess-Martin Periodinane 
DMSO Dimethylsulfoxide 
dtbbpy 4,4′-Di-tert-butyl-2,2′-dipyridyl 
E Entgegen 
ee Enantiomeric excess 
EPR Electron paramagnetic resonance 
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Eq Equivalents 
Et Ethyl 
EWG Electron withdrawing group 
h Hour 
Hex Hexyl 
HFIP 1,1,1,3,3,3-hexafluoroisopropanol 
HPLC High-performance liquid chromatography 
hv Light 
IBX 2-Iodoxybenzoic acid 
OiPr Isopropoxide 
IPA Isopropyl alcohol 
iPr Isopropyl 
LCMS Liquid chromatography–mass spectrometry 
m Minutes 
mbar Millibar 
Me Methyl 
MeCN Acetonitrile 
MS Molecular Sieve 
NaBARF Sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate 
NMP N-Methyl-2-pyrrolidone 
NMR Nuclear Magnetic Resonance 
OTf Triflate 
Ph Phenyl 
PhMe Toluene 
PIDA (Diacetoxyiodo)benzene 
PIFA [Bis(trifluoroacetoxy)iodo]benzene 
PLE Pig Liver Esterase 
PMB Para-methoxybenzene 
ppy 2-phenylpyridine 
Pr Propyl 
PTAD (1-adamantyl)-(N-phthalimido)acetato 
PyBOX Pyridine-linked bis(oxazoline) 
rac Racemic 
rt Room Temperature 
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S-DOSP S-N-(p-Dodecylphenyl)sulfonylprolinate 
S-PTTL N-phthaloyl-(S)-tert-leucinate 
SET Single electron transfer 
TBHP t-butyl hydrogen peroxide 
TEMPO (2,2,6,6-Tetramethylpiperidin-1-yl)oxyl  
TFA Trifluoroacetic acid 
THF Tetrahydrofuran 
THIQ Tetrahydroisoquinoline 
THQ Tetrahydroquinoline 
TLC Thin Layer Chromatography 
TMB Trimethoxybenzene 
TMEDA Tetramethylethylenediamine 
TMS Trimethylsilyl 
tol-BINAP 2,2′-bis(di-p-tolylphosphino)-1,1′-binaphthyl 
TRIP 3,3′-Bis(2,4,6-triisopropylphenyl)-1,1′-binaphthyl-2,2′-diyl 
hydrogenphosphate 
UV-CFL Ultraviolet Compact Fluorescent Light 
XPhos 2-Dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl 
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1. Introduction 
The field of drug discovery requires constant innovation, both in terms of moieties 
investigated and the processes by which they are made. The most important 
reactions are those which form carbon-carbon bonds, thereby allowing major 
structural changes to the molecule in question. An important class of carbon-
carbon bond forming reactions is those which occur through C-H activation.  
Traditionally, the C-H bond has been viewed as reasonably chemically inert, with 
transformation reactions preferentially being achieved through functional group 
interconversions. This is despite the long history of C-H activation, the very first 
example of this reaction, although it was not known at the time, was published in 
1894, when Fenton published a method of achieving the oxidation of tartaric acid 
in the presence of iron.1  
Certain processes are now used extensively in academia, namely cross-coupling 
reactions which have revolutionised areas such as natural product synthesis 
where it allows major late stage functionalisation.2,3 Although C-H 
functionalisation occurs across a truly vast range of substrates, by far the most 
investigated type of C-H functionalisation is the transition metal catalysed cross-
coupling of aryl substrates, with palladium catalysts being all but ubiquitous.4–11 
Indeed, direct C-H bond activation and functionalisation is one of the most active 
research fields in organic chemistry.12 This recent interest is perhaps unsurprising 
considering the current drive towards providing synthetic methodology of greater 
atom efficiency and sustainability.13 
The functionalisation of non-aryl C-H bonds is comparatively less well 
investigated. In the sections that follow, current methods for the functionalisation 
of C-H bonds adjacent to amines and ethers will be discussed in general terms. 
This will be followed by further discussions of cross-dehydrogenative couplings 
adjacent to both amines and ethers and finally, the state of the art in the field of 
the 1,5-hydride shift. 
1.1 C-H Functionalisation Adjacent to Amines 
The main methods of C-H functionalisation adjacent to amines can be divided 
into several categories which have been investigated in depth, the deprotonative 
cross-coupling, radical formation, metal insertion and carbenoid insertion based 
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approaches.14 Other key transformations are the cross-dehydrogenative cross 
coupling and the 1,5-hydride shift, which will be covered in detail in sections 1.3.1 
and 1.4.1 respectively. 
1.1.1 Deprotonative Cross-Coupling Adjacent to Amines 
The first reported approach to α-amine C-H functionalisation was deprotonative 
cross-coupling or α-lithiation.15,16 This was the first of many publications which 
functionalised the α-position of N-protected heterocycles such as 1.16 The most 
common activating/directing group in these reactions was the Boc group and a 
range of electrophiles were successfully inserted (Scheme 1). The authors 
observed that these reactions lead to the trans- product when the 2-position is 
alkylated.17 However when 2-methylpyrollidines were used in place of 2-
methylpiperidines, the trans/cis selectivity was reduced significantly, with a ratio 
of 2:1 observed.17 The authors proposed that the selectivity observed with 6-
membered rings such as 1 was through ring interconversion. Equatorially 
substituted piperidines are less stable than the axially substituted analogues.17 
The 2-methyl piperidine analogue 1 would therefore sit in conformation 4 and 
undergo the substitution to form 2 (Scheme 1). This steric bias is not present to 
the same extent in 2-methyl pyrrolidines and as a result the diastereoselectivity 
was decreased. 
Scheme 1: Example of deprotonative cross coupling to form 217 
More remarkably, Beak et al. discovered that the presence of (-)-sparteine 9 to 
chelate to the lithium cation in place of TMEDA led to the formation of a chiral 
organolithium complex 10. This complex 10 selectively removes the pro-S 
hydrogen from 7, leading to the formation of a single anionic enantiomer which 
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retains its chirality upon reaction with an electrophile to give ees which were 
generally >90% (Scheme 2).18 
 
Scheme 2: Enantioselective α-lithiation and electrophilic substution18 
Subsequent studies suggested that the abstraction of the pro-S proton is 
determined kinetically with the resulting intermediate being stable through dipole 
stabilisation to -50 °C with stereochemistry being retained during electrophilic 
attack.19 This enantioselective deprotonation was repeated with 2-methyl 
pyrrolidines such as 11a and these yielded trans- 2,5-substituted compounds 12 
with excellent drs and ees in contrast to the use of TMEDA (discussed above) 
(Scheme 3).18,19 The scope of protected amine has since been increased.20–23 
However, (+)-sparteine is not readily available and success in preparing other 
ligands which promote these reactions in a similar manner was generally 
limited.24,25 
 
Scheme 3: Enantioselective alkylation of 1119 
There is, however, one notable success in this area which is ligand 13b, 
developed by O’Brien et al. in 2004.26 Through the use of computational 
modelling, a range of target (±)-sparteine analogues which would form a similar 
cage upon chelation to lithium were identified. A pair of these ligands, 13a and 
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13b were found to provide chelation as per (±)-sparteine without a major 
decrease in reactivity as had previously been observed with other (±)-sparteine 
analogues. These new compounds had the advantage of both (-) and (+) 
analogues being relatively straightforward to synthesise. Crucially, their new 
ligand 13, which replaces ring D with a simple methyl group, acts analogously to 
(+)-sparteine, allowing chemists for the first time to access enantiomers which 
were inaccessible through the use of (-)-sparteine 9. An example of this was 8b, 
which was prepared in a 90% ee and an 84% yield (Scheme 4).26 
 
Scheme 4: The first successful synthesis of 11b with a (+)-sparteine 
analogue26 
Another breakthrough in the utility of these reactions came in 2004, when Dieter 
et al. discovered that it was possible to transmetallate the generated 
organolithium with copper salts.27 The copper salts (e.g. 14) were able to 
successfully react with a much wider range of electrophiles, including 
iodoalkenes and iodoalkynes.27  This was, however, at a cost to the 
enantioselectivity, which was reduced, compared to the direct use of simple 
electrophiles such as the alkyl halides and TMSCl used in the reactions discussed 
above. A possible explanation for this could be the cuprate being inherently less 
configurationally stable.27 An example of this broadened scope is the styrene 
functionalised pyrrolidine 16 (Scheme 5). Transmetalation with zinc species has 
since been performed, allowing aryl cross-coupling to occur in the presence of a 
palladium catalyst.28 
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Scheme 5: Example of broadened scope from transmetallation27 
A further example of transmetallation came in 2008, when the Coldham group 
reported the arylation of piperidinyl species.29 Here again a zinc species was used 
for transmetallation, which was followed with a Negishi-type coupling. Whilst 
enantioselectivity could not be achieved for the majority of substrates, in contrast 
to pyrrolidinyl substrates, 17 was obtained as a single diastereomer (Scheme 
6).29 
 
Scheme 6: α-Lithiation and subsequent transmetallation/arylation29 
This was followed by work to develop an enantioselective process of 
functionalising N-Boc piperidines.30 The best enantioselectivity was found to be 
attained with the (+)-sparteine derivative 13b developed by O’Brien  (Scheme 
7).26,30 Here ees were not achieved to the same extent as with pyrrolidines, 
instead ranging between 14-74%. Yields were likewise slightly reduced 
compared to when TMEDA was used (Schemes 1 and 6, above). 
 
Scheme 7: Enantioselective synthesis of 930 
In 2005, Xiao et al. published an alternate method of α-lithiation which selectively 
alkylated the 2-position of nitrogen heterocycles.31 This difference was due to the 
presence of a phenyl group in the 2- position rather than an alkyl group, which 
effectively converts the 2-position into a benzylic C-H. This selectivity was used 
to synthesise the NK1 agonist 22 (Scheme 8). This reaction failed to proceed in 
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the presence of (-)sparteine in place of TMEDA and as a result both 
diastereomers 22a and 22b were formed. 
Scheme 8: Synthesis of NK1 agonists through deprotonative cross 
coupling 
Coldham et al. went on to develop a method of preparing 1,1-disubstituted 
tetrahydroisoquinolines in 2014 (Scheme 9).32 This method was used to prepare, 
amongst other compounds, a precursor 24 to (+)-FR115427, a noncompetitive 
antagonist of the NDMA receptor (Scheme 9).32 Once 24 was prepared it was 
subjected to a simple Boc deprotection to give the desired compound in a 91% 
yield.32 
 
Scheme 9: Preparation of a key intermediate to (+)-FR11542732 
Finally, the Coldham group have also turned the α-lithiation reactions upon which 
they have worked towards total synthesis.33 Using this methodology they have 
successfully prepared two natural products, 26 and 29 (Scheme 10).33 The 
authors made use of the selectivity seen with N-Boc tetrahydroisoquinolines 
towards the deprotonation of the benzyl position to prepare 26 in a 90% yield 
(Scheme 10, A).  The use of dibromoalkane led to the subsequent successful 
synthesis of (±)-11-methylharmicine 29 (Scheme 10, B) 
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Scheme 10: Total syntheses of 26 and 29 via α-lithiation33 
1.1.2 Radical Mediated C-H Functionalisation Adjacent to Amines 
The first series of conditions to perform radical mediated C-H functionalisation 
adjacent to amines were developed through the 1990s. These early methods 
overcame the difficulties of generating the desired radical intermediate for α-C-H 
functionalisation through the use of 1,5-hydrogen transfers in a manner 
analogous to the 1,5-hydride shift, which will be discussed in greater detail in 
section 1.4.1, below.34–37 Here, functional groups which more readily form radical 
species, for example, halides which will homolytically cleave, are the initial site 
for radical formation. The first example of this came in 1990, when Snieckus et 
al. reported that compounds such as 33 could access α-amino radicals to form 
new 5- and 6-membered rings in the presence of tethered radical acceptors 
(Scheme 11).34 The authors also reported that the methodology could be applied 
to non-tethered radical acceptors. 
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Scheme 11: The first radical mediated C-H functionalisation adjacent to an 
amine34 
Undheim et al. applied this methodology to 2-iodobenzyl protected 
heterocycles.35 The radical cleavage of the iodine which led to radical formation 
also results in a readily cleavable benzyl protecting group on the amine following 
functionalisation (Scheme 12). This methodology was found to work with both 
diethylamine and a range of heterocycles including morpholine and azepane.35 
 
Scheme 12: Example radical mediated functionalisation to leave Bn 
protecting group35 
The scope of electrophile was extended over the next decade with the 
fundamental method of radical formation essentially unchanged until, in 2005, 
Yoshimitsu published a route to direct α-C-H formation (Scheme 13).38 Here the 
authors proposed that Et3B and oxygen react to form an ethyl radical, which 
serves to abstract a hydrogen from 37. The subsequent radical 39 has two 
plausible methods of reacting with the electrophile to form 38 and regenerate the 
ethyl radical.38 In path a, the radical 39 reacts with aldehyde 40 to form the oxy 
radical 41. This radical then reacts with Et3B to release an ethyl radical and 
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generate 43 which forms 38 upon workup. In path b, Et3B coordinates to aldehyde 
40 before reacting with the initially formed radical 39. This forms intermediate 43 
directly which gives the desired product 38 upon workup. 
 
Scheme 13: First direct α-C-H radical formation/functionalisation and 
proposed mechanism38 
However, the real breakthrough in this area has been with photoinduced radical 
formation and subsequently photoredox catalyst SET-based methodology. An 
early example of photoinduced radical formation was seen in 1989 where 
homolytic cleavage of TMS groups led to a novel method of pyrrolidine synthesis 
(Scheme 14).39 This was achieved in the presence of dicyanonaphthalene which 
acts as an electron acceptor from the starting material 44 (Scheme 14). Notably, 
this reaction proceeded with an alkynyl radical acceptor to form an alkenyl-
substituted heterocycle which would not form if the reaction proceeded via an 
iminium pathway.40 
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Scheme 14: An early dicyanonaphthalenea mediated radical coupling 
adjacent to an amine39 
Through the development of alternate sensitisers/electron acceptors, the scope 
of products which could be formed from radical formation adjacent to an amine 
was extended. A good example of the importance of the sensitiser is a study 
published in 1999 by Bertrand et al. whereby through sensitiser choice the 
authors were able to more than double their yield.41 Using 4,4'-
dimethoxybenzophenone 50, nine analogues were prepared in good yields, 
though electron deficient alkenes were required as the coupling partner (Scheme 
15). Unlike earlier reactions, the α-amino radical is generated directly by the 
sensitizer (Scheme 15), this radical then reacting as above, albeit with an 
external radical acceptor. The Bertrand group subsequently applied this 
methodology to the synthesis of Necine bases.42  
                                            
a Authors do not state the substitution pattern of dicyanonaphthalene 
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Scheme 15: Radical coupling with 4,4'-dimethoxybenzophenone 5041 
Harakat reported, in 2006, that the addition of thiocarbonyl compounds leads to 
decreased reaction times and allows the reaction of less active species of 
amine.43 It was proposed that this is achieved through the thiocarbonyl reversibly 
trapping radical intermediates following their initial generation to form “persistent 
radicals”.43 However, the addition of a thiocarbonyl species in many cases led to 
a loss of diastereoselectivity (A vs B, Scheme 16). 
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Scheme 16: Effect of thiocarbonyl 57 on radical coupling43 
A key development in this field was the use of iridium and ruthenium-based 
photocatalysts, the first clear example of which was the MacMillan group’s 
“accelerated serendipity strategy” which led to the discovery of a method of 
generating a radical adjacent to an amine.40 When a tertiary amine was subjected 
to an iridium catalyst in the presence of 1,4-DCB 59, a novel coupling was seen 
(Scheme 17). The authors proposed that the excited iridium catalyst undergoes 
a SET to form a 1,4-DCB radical anion and then abstracts an electron from the 
amine species, in this case 58, to form a radical cation. The radical cation and 
anion subsequently undergo a radical-radical coupling to form 60 following the 
loss of –CN.40 
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Scheme 17: Photochemically induced radical coupling adjacent to an 
amine40 
This methodology was developed further by the Reiser group who performed 
conjugate addition between N-aryltetrahydroisoquinoline 70 and Michael 
acceptors with both Ru(bpy)3Cl2 and [Ir(ppy)2(dtb-bpy)]PF6 in the presence of 
blue light.44 This methodology allowed the synthesis of 5,6-dihydroindolo[2,1-
a]tetrahydroisoquinoline 71 in a 25% overall yield across two steps (Scheme 18, 
A).  However, the authors report that the intramolecular reaction pathway is 
unclear, with the proposed mechanism for the intermolecular reaction (Scheme 
18, B) not being compatible with the aromatisation of the indole portion of 71.44 
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Scheme 18: Two step synthesis of 71 via α-amino radical coupling and 
proposed mechanism for 7244 
Concurrently, Miyake et al. developed a similar method of α-amino radical 
coupling, though with a wider range of amines than tetrahydroisoquinolines.45 
Here Michael acceptors such as diethyl ethylidenemalonate were reacted in the 
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presence of an iridium catalyst (Scheme 19). Over 25 analogues were prepared 
under general conditions, showing the wide applicability of these photoinduced 
α-amino radical couplings.45 
 
Scheme 19: The scope of Ir catalysed α-amino radical coupling45 
Noble et al. published a photoredox α-vinylation of N-arylamines and α-amino 
acids.46 Here a SET occurs between the N-arylamine 58 and the iridium 
photocatalyst to generate a radical cation which is deprotonated to give the 
neutral radical 66. This α-amino radical attacks vinyl sulfone 82 which 
desulfonates to form the desired allylic amine 84 (Scheme 20). Finally, the 
sulfonyl radical 85 is reduced to the anion via a second SET and regenerates the 
Ir(iii) species. 
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Scheme 20: Photoredox catalytic cycle to form 8446 
Finally, the Sunden group have recently published a new method of α-aminoalkyl 
radical addition to maleimides, which was achieved through the generation of an 
electron donor/acceptor (EDA) complex (Scheme 21).47 Using UV-CFL in 
dioxane at rt, 25 analogues were prepared. The authors submit that the reaction 
is driven by the photochemical activity of the EDA complex 87. Once excited, this 
EDA complex undergoes an SET and subsequent proton transfer to generate 
species 89 and 90. Once 90 has undergone oxidation to regenerate maleimide 
92, a radical coupling 93 occurs which, upon a further SET-oxidation, gives the 
product 94 (Scheme 21). 
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Scheme 21: Mechanism for α-aminoalkyl radical addition to maleimides47 
Whilst there are examples of photoredox chemistry being used to generate 
α-amino radicals to react directly, as discussed above, in the majority of reactions 
in which these α-amino radicals are generated they are oxidised a second time 
to form an iminium ion which is then reacted with a nucleophile in a manner akin 
to the CDC reactions explored in detail below. A vast array of reactions have been 
accessed through this photoredox mediated iminium formation, particularly by the 
MacMillan and Rueping groups, which will not be discussed in depth.48–54  
1.1.3 C-H functionalisation through α-C-H metal insertion 
Whilst the insertion of transition metals into sp3 C-H bonds is inherently difficult, 
there are several examples of this having been performed successfully. An early 
example was published by the Sames group whereby an iridium catalyst inserts 
into the α-amino C-H bond of the pyrrolidine derivative 95 and coordinates to the 
tethered alkene.55 This tethering leads to C-C bond formation and eventual 
alkene reformation to give the bicyclic compound 96 (Scheme 22).55  
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Scheme 22: Early α-amino C-H insertion/functionalisation55 
An alternate, ruthenium-based,  method of metal catalysed C-H insertion was 
developed by the Yi group.56 Both the N-H and α-C-H were activated, converting 
a secondary amine 102 into the corresponding alkylated imine 107 (Scheme 23). 
The proposed mechanism involves C-H activation, β-hydride elimination and 
secondary C-H activation into the resulting imine 105 before the final reductive 
elimination to form 107 (Scheme 23).56 The authors reported that these 
conditions, with a THF solvent, were suitable for a range of amines and alkenes 
with yields between 29-84%. 
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Scheme 23: Ruthenium catalysed α-amine C-H functionalisation56 
Several other methods of converting secondary and tertiary amines into 
functionalised imines and enamines have since been developed along similar 
lines.57,58 When moving from a rhodium to ruthenium catalyst, Murai et al. 
discovered that the conditions which had previously led to functionalised imines 
instead formed a di-α-alkylated product (Scheme 24).59 Scope was limited to 2-
aminopyridines and other nitrogen containing heterocycles. Accordingly, the 
authors proposed that the aryl nitrogen was acting to coordinate to the ruthenium 
to enable α-C-H metal insertion and the subsequent reaction steps.59 Curiously, 
other known directing groups were not found to enable the reaction in an 
analogous manner. 
 
Scheme 24: Example of the Murai group’s α-amino alkylation of 
arylamines59 
Shibata et al. published a selective method of C-H functionalisation using iridium 
to alkenylate in the α-amine position.60 The authors report that biaryl scaffolds 
were essential to see conversion and that rac-BINAP performed best of the biaryl 
scaffolds surveyed. Compounds such as 112 were prepared in moderate to good 
yields, with diphenylacetylene as the highest yielding alkyne scaffold 111 
(Scheme 25).60 
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Scheme 25: Alkenylation through C-H insertion of iridium60 
The Shibata group extended their methodology to provide a method of 
enantioselective functionalisation through the use of S-BINAP.61 Whilst ruthenium 
had previously been used to alkylate the α-amino position, it was only with iridium 
and S-tolBINAP (Scheme 26) that enantioselectivity was observed.59,61,62 
 
Scheme 26: Enantioselective alkylation to form 11561 
Notably, these insertions are no longer limited to the formation of C-C bonds. In 
2012, the Sawamura group reported a novel method of borylation adjacent to 
amines (Scheme 27).63  This functionalisation was achieved with the immobilised 
silica-TRIP ligand and Rh2(OMe)2(cod)4 and a Bpin dimer. The reaction was 
found to perform well with amides and N-arylamines with a preference shown for 
cyclic over aliphatic amines and –CH3 over -CH2 carbons as a site for attack.63 
An example of the general procedure with aliphatic amide 116 is shown, though 
16 analogues were prepared and several successfully underwent a subsequent 
Suzuki coupling, allowing access to a large number of previously inaccessible 
coupled products.63 
Scheme 27: α-Amino borylation and subsequent Suzuki coupling63 
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1.1.4 Metal Mediated Carbenoid Insertion to an Amino α-C-H 
The research into carbenoid insertion adjacent to amines has been a relatively 
under-investigated area in C-H functionalisation compared with the 
corresponding carbenoid insertions in ethereal and alkyl substrates. In 1999 the 
Davies group developed a new method of α-amino C-H activation, carbenoid 
insertion.64 This carbenoid insertion was found to be highly regio- and 
diastereoselective when Boc-protected cyclic amines were used with a Rh2(S-
DOSP)4 catalyst. Unsubstituted substrates such as N-Boc pyrrolidine 7 saw 
substitution in the 2- position with high diastereo- and enantioselectivity (Scheme 
28, reaction A). However, when moving to N-Boc piperidine, monosubstitution 
was again observed, albeit with much lower diastereo- and enantioselectivity, 
however, no explanation in the difference of reactivity was suggested by the 
authors.64 In order to access similar enantioselectivity, the unsaturated analogue 
121 was used and subsequently hydrogenated to deliver 123 (Scheme 28, 
reaction B). 
 
Scheme 28: Alternate reactivity of pyrrolidines and piperidines64 
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 This work was followed by a study into the reactivity of 2-substituted cyclic 
amines.65 This study also expanded on the effect of temperature and ring size on 
diastereoselectivity, with drs of >95:5 seen in 5-, 7- and 8- membered rings, and 
ees of 88-94%. By contrast, despite a similarly high ee (89%), the dr in the 6-
membered ring was 64:36.65 The presence of a group in the 2-position was found 
to lead to the anti- product being formed (Scheme 29). 
Scheme 29: Kinetic resolution of 125 through asymmetric carbenoid 
insertion65 
This methodology was used to develop a new synthesis of Ritalin.64,66 A mixture 
of N-Boc piperidine and carbenoid precursor 119 were reacted with 
Rh2(S-biDOSP)2 with a TFA to remove the Boc group to give Ritalin in a 52% 
yield with an ee of 86% (Scheme 30). 
 
Scheme 30: Synthesis of Ritalin via carbenoid insertion 
Whilst this earlier work required the presence of a cyclic amine, aliphatic α-amino 
carbenoid insertion methods have now been developed. In 2012, McMills et al. 
published a rhodium catalysed carbenoid insertion which led to two products 130 
and 131 being formed, only the lower yielding of which was desired (Scheme 
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31).67 The major product was instead formed through the cyclopropanation 
reaction of the double bond present in the starting material 128. The minor 
product 131 resulted from the desired regioselective carbenoid insertion. This 
minor product was subsequently cyclised through cross-metathesis with a 
Grubbs (II) catalyst to provide a new route to nitrogen containing heterocycles.67 
This methodology was found to form 6-8 membered rings successfully with n = 
1-3; n=4 saw successful carbenoid insertion but failed to cyclise. In all analogues 
the equivalents to 130 and 131 maintained their 2:1 ratio.67  
Scheme 31: Carbenoid insertion as a route to new N-heterocycles67 
The Maguire group have since developed a technique for carbenoid insertion 
which does not rely on the use of expensive rhodium catalysts. Instead, the 
cheaper, more environmentally benign copper was used to insert a sulfonyl 
carbenoid.68 The authors had previously used their catalyst system to perform 
carbenoid insertions in a range of non-nitrogen containing substrates and were 
able to apply the same methodology successfully (Scheme 32).68–73 The 
predominant product for these cyclisations was the anti-sulfonyl substituted 
pyrrolidine (>75% of yield), with the syn- product (<15% of yield) and 
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corresponding β-lactam (2-16% of yield) also formed. However, the tertiary amine 
was limited to substitution with alkyl chains and the sulfonyl R- group was limited 
to alkyl, aryl and alkylaryl substituents, though within this group yields for 134 
were between 40-70% with ees between 51-70%.68 Less bulky ligands than 137 
increased overall yields but at the expense of reduced enantioselectivity. 
Scheme 32: Copper catalysed carbenoid insertion68 
 
1.2 C-H Functionalisation Adjacent to Oxygen 
1.2.1 Radical Mediated C-H Functionalisation Adjacent to Ethers 
In comparison to C-H functionalisation adjacent to amines, as described in 
section 1.1, C-H activation adjacent to ethers has received very little attention. 
This is despite the first C-H activations adjacent to ethers being published by 
LaZerte et al. in 1955, achieved through a radical reaction.74 Polyfluoroalkenes 
such as perfluorocyclobut-1-ene were converted to radicals with gamma-ray 
radiation which then reacted with THF in situ to form products such as 139 in 
yields between 95-22% (Scheme 33).74 
 
Scheme 33: First reported functionalisation of C-H adjacent to ethers74 
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Muramatsu et al. continued the work of LaZerte et al. with two papers furthering 
their methodology in the mid-1960s.75,76 However, until the 1990s when Fuchs et 
al. reported radical addition/elimination of ethers with alkynyl triflones (Scheme 
34) there was little else published.12,77 Fuchs et al. followed this alkynylation with 
alkenylation which proceeded in an analogous manner, albeit with a mix of E/Z 
isomers formed.78 These reactions generated a range of functionalised ethers in 
moderate to excellent yields following the reaction of cyclic ethers with alkynyl or 
alkenyl triflones in the presence of AIBN or hv with the proposed mechanism of 
Scheme 34. 
 
Scheme 34: Radical alkynylation of ethers77 
This was followed by Hirano et al. again functionalising THF with electrophilic 
alkenes in the presence of N-hydroxyphthalimide 145, Co(OAc)2 and molecular 
oxygen (Scheme 35). Unlike with polyfluoroalkenes, above, the THF did not 
functionally add across the alkene. Instead, oxygen was added on the opposite 
end of the alkene to the ether to form both secondary alcohols 146 and ketones 
147. The proposed mechanism involved an N-hydroxyphthalimide 145 O radical 
and Co(OAc)2 combining to abstract an H· radical from THF which reacts with 
alkene 144 to provide a second alkyl radical. This radical reacts with the oxygen 
and the resulting peroxide collapses to either form the alcohol 146 or ketone 147. 
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Scheme 35: THF functionalisation with electrophilic alkenes79 
Further functionalisation of THF was achieved by Yoshimitsu et al, who first 
performed the α-hydroxyalkylation of THF with aldehydes via radical C−H 
abstraction (Scheme 36). This was achieved through the use of triethylborane 
and t-butyl hydroperoxide which caused rapid conversion to the desired product .  
 
Scheme 36: Radical mediated α-hydroxyalkylation of THF80 
Crucially, this reaction was applied to the synthesis of (−)-Muricatacin, which was 
achieved through the functionalisation of THF.81 This marked the first time that 
C-H functionalisation adjacent to ethers was used in the total synthesis of a 
natural product, albeit a simple one. The key transformation used the same 
conditions as in Scheme 36 with tridecanal as the aldehyde (Scheme 37).81 The 
undesired diastereomer was converted through Mitsunobu reaction. The anti 
diastereomer was taken and resolved using PLE before undergoing oxidation and 
deprotection to give the desired product 152. 
 
Scheme 37: Radical mediated α-hydroxyalkylation of THF applied to total 
synthesis81 
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This was followed in 2004 with the discovery by Tomioka et al. of an alternate 
product 153 which was attainable through the use of Me2Zn in lieu of 
triethylborane.82 It was proposed that following radical formation, when Me2Zn 
was used, molecular oxygen reacted with THF first rather than the aldehyde 153 
leading to the observed reactivity (Scheme 38).83 
 
Scheme 38: Formation of product 154 and proposed mechanism83 
The decreased reaction speed when using Me2Zn was applied as a method of 
chemoselectivity.82 Tomioka et al. found that, if THF, p-methoxyaniline 159 and 
benzaldehyde were mixed together, the previously described alcohol 161 was 
formed as the major product in the presence of triethylborane. However, if Me2Zn 
was used, amine 160 was instead isolated (Scheme 39). 
 
Scheme 39: Product differentiation through choice of Lewis acid82 
Around the same time, Porta et al. developed a novel three component coupling 
using Ti and TBHP (Scheme 40).84 Here a phenyl radical is generated from 
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phenyldiazonium cation. The phenyl radical then abstracts a hydrogen from THF 
to form a nucleophilic radical which reacts with the C-atom of the methylene 
iminium salt, forming functionalised tetrahydrofurans 167 or 168 following a final 
SET reduction. 
 
Scheme 40: Formation of functionalised tetrahydrofurans84 
Finally, in 2012, Sølvhøj et al. developed a method of radical coupling between 
THF and bromostyrenes such as 169 with dimethyl zinc acting as an initiator 
(Scheme 41).85 The substrate scope was extended to cover a range of ethers 
and tertiary amines and could tolerate substitution on the styrene aromatic ring.85 
 
Scheme 41: Dimethylzinc catalysed radical coupling adjacent to an ether85 
1.2.2 Metal Mediated Carbenoid Insertion to an Ethereal α-C-H 
Carbenoid insertion into C-H bonds adjacent to ethers has developed into a 
powerful method of C-H activation, used both in the formation of new aliphatic 
and 5-membered cyclic compounds. 
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This use of carbenoid insertion to form a 5-membered ring was first developed 
as a useful reaction in 1989, whereby Adams et al. used rhodium acetate to form 
cyclic esters such as 174 (Scheme 42).86 Once the diazo-ketone 173 was 
prepared from the corresponding acid, it was cyclised with the rhodium diacetate 
catalyst to form the cyclised product 174 in a 58% yield. 
 
Scheme 42: An early example of carbenoid insertion adjacent to an ether86 
This initial study by Adams et al. was followed with a model study into the 
stereoelectronic effects of the above-mentioned reaction (Scheme 42).86,87 This 
study was performed exclusively with cyclic substrates in order to avoid steric 
and conformational effects which the authors believed could predominate with 
acyclic structures.87 Cyclohexane based scaffolds were prepared then the further 
cyclisation was catalysed with Rh2(OAc)4 or Rh2(Cap)4 (Scheme 43). 
Unsurprisingly, it was found that electron-donating groups adjacent to the 
reaction site led to increased reactivity, with conversion to 177 preferred to 176 
when R1 is a better electron donating group than R2. This is a result of the δ+ 
charge generated at the R1/R2 C-H position during carbene insertion, which is 
more effectively stabilised by electron donating groups and as such reacts more 
readily. 
 
Scheme 43: General reaction conditions for investigations into 
stereoelectronic effects in carbenoid insertion adjacent to ethers87 
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Since these initial results, the scope of catalysts and asymmetric conditions has 
increased massively, with several groups working to develop new protocols over 
the past 20 years, rhodium does, however, remain the catalytic metal of choice.  
A key ligand in the enantioselective insertion of carbenoids is S-DOSP, which 
was first prepared by the Davies group in 1997.88 This ligand was found, in 
subsequent publications, to enable enantioselective C-H activation in 
cyclohexadienes, cycloheptatrienes, Boc-protected amines and allyl silyl-
ethers.64,89–91 
This scope was extended at the turn of the millennium when Davies et al. 
published a method of enantioselectively preparing substituted 
dihydrobenzofurans such as 179 (Scheme 44).92 This was achieved through the 
use of Rh2(S-DOSP)4 to catalyse the intramolecular insertion of the aryl 
diazoacetate derived carbenoid into the methine C-H bond adjacent to the phenyl 
oxygen. However, whilst the example shown (Scheme 44) had an excellent yield 
and ee, overall the extent of asymmetric induction was highly dependent on the 
site of C-H activation and the catalyst, with little scope for general conditions.92 
 
Scheme 44: dihydrobenzofuran formation via carbenoid insertion92 
In 2002, this work was followed by a publication from Hashimoto et al, which 
improved upon the results of Davies through the use of an Rh2(S-PTTL) catalyst 
(Scheme 45).93 Whilst yields were similar to those of Davies et al. (Scheme 44, 
above), crucially, these high yields and ees were maintained with a 
monosubstituted α-C-H adjacent to the ether (Scheme 45).93 
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Scheme 45: Alternate catalyst in the formation of dihydrobenzofurans93 
The Davies group had likewise been developing new chiral rhodium catalysts for 
carbenoid insertion, which culminated in Rh2(S-PTAD)4, a catalyst which, in 
addition to providing decent yields and high dr/ees, could be recycled and reused 
with a limited loss of stereoselectivity (Scheme 46).94  This ability to reuse the 
catalyst is of increasing importance with the current focus on decreasing the 
environmental impact of more traditional organic syntheses. 
 
Scheme 46: A third method of preparing dihydrobenzofurans94 
Whilst all of the carbenoid insertions discussed above have relied on the use of 
rhodium catalysts and the presence of a diazo group, in 2009 a novel method of 
cyclisation via carbene insertion was reported which was free of both rhodium 
and diazo compuounds95 This was achieved via a MW assisted high temperature 
Brook rearrangement to form a siloxycarbene which subsequently inserted into 
the neighbouring C-H bond adjacent to an oxygen (Scheme 47). Shen et al. 
discovered that the choice of solvent was essential, with o‐dichlorobenzene 
leading to the formation of the dihydrobenzofuran product 183, whereas when 
DMSO was used, the dihydrobenzofuran 183 underwent a subsequent loss of 
silanol to give 184 (Scheme 47).  
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Scheme 47: MW assisted formation of 183 and 18495 
Table 1: Solvent dependent change in product 
Solvent Product Yield (%) 
o‐dichlorobenzene 183 92 (72:28 cis:trans) 
DMSO 184 80 
 
With robust protocols in place for the intramolecular reaction of carbenoids with 
tethered C-H bonds adjacent to ethers, many groups turned their attention to the 
corresponding intermolecular reaction. Whilst the reaction was known, the 
development of enantioselective protocols had lagged behind the advances seen 
with intramolecular insertion.  
The Davies group published an early example of an enantioselective carbenoid 
insertion into an acetal C-H.96 Here Rh2(S-DOSP)4 was used to catalyse the 
insertion of 119 into 186 to give the products 187 and 188 in a 76% yield with a 
ratio of 71:29 187 to 188 (as determined by 1H NMR) (Scheme 49). However, 
these conditions had issues with regioselectivity for the C-H insertion on the 
acetal with any substituents on the acetal aryl group (Scheme 49) limiting the 
utility of the reaction. When the acetal aryl group had a MeO group, a ring 
expansion was also seen. Reducing the temperature led to greater selectivity 
towards 192 at the cost of significantly poorer yields. 
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Scheme 48: Carbenoid insertion into acetal C-H96 
When a TBDMS ether was used as the site of C-H insertion, improved drs and 
yields were observed when using the same S-DOSP ligands.97 These drs and 
yields increased further when S-PTTL ligands were applied (Scheme 49), 
reaching a 95% yield with a dr of 19:1 and a 98% ee. Unsurprisingly, the overall 
yield of 195 was improved versus 187 as there were no competing insertion sites. 
 
Scheme 49: Carbenoid insertion to functionalise TBDMS ethers97 
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Compared to intramolecular carbenoid insertion, there is a wider choice of metal 
catalysts available when pursuing an intermolecular insertion. Pérez et al. 
published, in 2002, a method of inserting ethyl diazoacetate 196 into, amongst 
other non-ethereal substrates, THF (Scheme 50).98 This was achieved in a 95% 
yield through the use of TpxCu 197 as catalyst. Through tuning the R groups of 
the Tpx ligand the authors were able to observe yields approaching those 
reported with the much more expensive rhodium catalysts used elsewhere.98 
 
Scheme 50: TpxCu 197 catalysed carbenoid insertion into THF98 
Heterogenous copper catalysis has also been developed for carbenoid insertion 
into ethereal C-H bonds. Fraile et al. reported the use of immobilised box-Cu 
complexes supported on laponite in 2007.99 The use of the laponite support led 
to both increased ees and allowed washing and reuse of the catalyst. Here yields 
were less impressive, ranging from 20 to 85% with up to 88% ee and drs of 56:44 
to 78:22 syn:anti dependent on the box ligand used (Scheme 51).99 
 
Scheme 51: Heterogeneously catalysed C-H functionalisation to form 
19999 
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1.2.3 C-H Activation Adjacent to Alcohols 
In addition to the above, there have been limited examples of C-H activation 
adjacent to alcohols which, depending on the mechanism, may likewise provide 
insight towards novel methods of C-H activation adjacent to ethers. The most 
common method of performing this transformation is via transfer hydrogenative 
coupling, which is analogous to cross-dehydrogenative coupling as will be 
discussed in greater detail in Section 1.3.2, page 53 whereby the alcohol is 
oxidised to form an aldehyde which subsequently reacts. 
1.2.4 α-Oxygen C-H Activation Through Transition Metal Insertion 
Alternatively, cross-coupling conditions have been developed whereby alcohols 
and alkenes are reacted via C-H insertion. The first example of this reaction was 
observed as a side product by Shi et al. in 2005.100 Here the use of Wilkinson’s 
catalyst and BF3.OEt2 as co-promoter in tandem led to the formation of secondary 
and tertiary alcohols such as 200 from alkenes and primary or secondary alcohols 
respectively (Scheme 52).  
 
Scheme 52: The first reported TM catalysed insertion of an alkene into an 
alcohol C-H bond100 
A series of deuterium labelling experiments and experiments with radical 
scavengers were performed by the authors. A statistical distribution of deuterium 
was observed and the reaction was completely inhibited in the presence of these 
radical scavengers. Shi et al. therefore proposed a radical mechanism to explain 
the formation of 205 (Scheme 53).100 
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Scheme 53: Proposed mechanism for the formation of 205100 
Further experimentation by the authors led to improved rhodium-catalysed 
reaction conditions as well as the development of two new protocols, which were 
based on the use of palladium with BF3OEt2 and FeCl3 (Scheme 54). The 
palladium catalysed reaction suffered from the same limitations as with rhodium, 
that the use of non-aryl alkenes and non-aliphatic alcohols led to sharply 
decreasing yields.101 When FeCl3 was used, Shi et al. reported that the reactions 
proceed with high efficiency and without the need of an additive or co-promoter 
as with rhodium and palladium.102 
Scheme 54: Alcohol-alkene cross-coupling with palladium (L) and iron (R) 
catalysts101,102 
1.2.5 Catalyst Free C-H Activation Adjacent to Alcohols 
Finally, Harada et al. have developed a method of performing a catalyst-free 
coupling between an alkene and alcohol as a method of direct C-H 
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functionalisation.103 However, due to the extreme conditions required (Scheme 
55), whilst interesting, there is little practical application to this reaction. 
 
Scheme 55: Catalyst free synthesis of 213103 
Two key areas of C-H functionalisation adjacent to oxygen which have not been 
discussed in this section are the cross-dehydrogenative coupling reaction and the 
1,5-hydride shift. Due to the importance of these reactions to the research 
presented herein, cross-dehydrogenative coupling and the 1,5-hydride shift are 
discussed in greater detail in separate sections 1.3.2 and 1.4.2 respectively, 
below. 
1.3 Cross-Dehydrogenative Coupling 
Following from the general introduction of C-H functionalisation adjacent to two 
important heteroatoms, oxygen and nitrogen, attention will now be turned to two 
specific examples of C-H functionalisation. The first to be covered is the Cross-
Dehydrogenative Coupling (CDC) reaction, which has found use adjacent to both 
ethers and amines. The basic process for the reaction features the removal of 
hydrogen across two molecules to form a carbon-carbon bond. In practice 
molecular hydrogen itself is rarely formed, with the hydrogen sequestered 
elsewhere in the reaction mixture (Scheme 56). There is the possibility of this 
reaction occurring catalytically, which would be particularly useful in the modern 
green conscious world. 
 
Scheme 56: CDC reaction  
1.3.1 Cross-Dehydrogenative Coupling Adjacent to Amines 
In general terms, in order to effect a cross-dehydrogenative coupling adjacent to 
an amine, the amine must first be oxidised to form an iminium ion which 
subsequently undergoes nucleophilic attack. An early example of this came in 
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1999 when low-temperature electrolysis was used to generate iminium ions as a 
“cation pool” to subsequently react.104 As noted by the authors, a key requirement 
for successful cross-dehydrogenative coupling was the ability of the nucleophile 
and iminium ion to react before degradation occured.104 Despite this, the 
functionalisation of an amine α-C-H with cyano groups was first described in 
1969.105 This reaction was achieved through the use of electrochemistry and was 
followed in 1977 with an improved method.106  
A key early example of chemical oxidation to form an imine for cross-
dehydrogenative coupling was published in 1988.107 Chen et al. had developed 
a method of generating bicycle 216 from 1-piperidine-propanol 214 using ClO2 as 
a stoichiometric oxidant (Scheme 57). 
 
Scheme 57: A key early chemically induced α-amino cross-
dehydrogenative coupling107 
It wasn’t until 2003 that an intermolecular cross-dehydrogenative coupling 
adjacent to an amine was achieved, when Murahashi et al. developed a method 
of coupling a cyano group to compounds such as 73 (Scheme 58).108 Here the 
oxygen and peroxide both act as oxidants in competing mechanisms to form 
α-cyanoamine adducts, which are useful precursors to both 1,2-diamines and 
amino acids.108,109  
 
Scheme 58: Synthesis of a functionalised tetrahydroisoquinoline through 
a CDC reaction108 
This was followed, in 2004, by Li et al. who developed a method of alkynylating 
N,N-dimethyanilines 218 under neat conditions (Scheme 59).110 This reaction 
was found to proceed with both Cu(I) and Cu(II) species, with CuBr providing the 
highest yields. The same conditions were applied to N,N,dimethylbenzylamine 
and the alkynylation preferentially occurred on the methyl groups, with none of 
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the product which would result from addition to the benzyl C-H being isolated.110 
However, when tetrahydroquinolines were used, cross coupling occurred at the 
benzylic position rather than the homobenzylic position.  
 
Scheme 59: Alkynylation of N,N-dimethylanilines 218110 
Table 2: Range of substituents for alkynylation of N,N-dimethylanilines 
Ar R Yield (%) 
Ph Ph 74 
Ph 4-MeOPh 82 
Ph 4-MePh 74 
Ph 4-BrPh 74 
Ph 4-PhPh 60 
Ph 2-Py 36 
Ph CH2OH 40 
Ph CH2O2CEt 58 
Ph CO2CH3 25 
Ph Bu 12 
4-MePh Ph 73 
2-MePh Ph 53 
4-BrPh Ph 69 
 
A development of the reaction saw the addition of PyBOx as a chiral ligand.111 Its 
use led to modest to good ees (Scheme 60), which the authors viewed as 
supporting a mechanism whereby the copper binds to the iminium ion prior to 
attack by the alkyne.110,111 In 2008, Li (C-J) et al. extended the scope of the 
alkynylation reaction published by Li (Z) et al. to cover glycine derivatives, 
although again the nucleophile scope was restricted to aryl alkynes.112  
                                                                                                            Oliver Ware 
49 
 
 
Scheme 60: Synthesis of enantioenriched substituted 
tetrahydroquinolines111 
Elsewhere, progress had been made with nucleophile scope. The reaction of 
tetrahydroquinolines with electron rich aromatic rings such as indoline was first 
published in 2005, whereby the coupling occurred via a Friedel-Crafts style 
mechanism.113 With indole substrates C3 alkylation predominates and with 
naphthols, Betti bases such as 223 were prepared (Scheme 61).113 However, 
when naphthols are used, a degree of homocoupling to form BINOL derivatives 
was observed.113  
  
Scheme 61: Synthesis of Betti base derivative 223113 
These same indole and naphthol nucleophiles can be cross-dehydrogenatively 
coupled with dimethylanilines such as 224 in a manner analogous to alkynyl aryls 
as shown above (Scheme 59).114 Around the same time, Itami et al. developed 
an iron catalysed cross-dehydrogenative coupling with a scope which extended 
beyond indoles to cover monocycles such as thiophene and furan.115 Unlike the 
examples above, the CDC did not proceed with CuBr as the catalyst. Instead,  
FeCl3/bipy provided the best conversion, with pyridine N-oxide acting as a 
stoichiometric oxidant (Scheme 62).115 
 
Scheme 62: Iron catalysed arylation adjacent to an amine115 
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It is also possible to cross-dehydrogenatively couple N-methyl amides and 
heteroaromatics.116 Tsuchimoto et al. developed a zirconium triflate method in 
the presence of oxygen (Scheme 63). The authors surveyed a range of Lewis 
acids including scandium and indium triflate which showed catalytic activity, albeit 
to a lesser extent than zirconium.116 In the proposed mechanism, the amide 227 
is oxidised by the oxygen via radical cation intermediates. The heteroaromatic 
nucleophile then undergoes electrophilic aromatic substitution to couple to the N-
acyliminium cation. The authors report that the presence of TEMPO as a radical 
scavenger inhibits the reaction, which supports their proposed mechanism. 
 
Scheme 63: Zirconium triflate catalysed coupling of amide 227 with 
electron rich heteroaromatic 228116 
Cross-dehydrogenative coupling adjacent to amines has also been observed with 
nitronate and enolate nucleophiles. An early example of a nitronate nucleophile 
was published by the ever-present Li group.117 Here a range of 
tetrahydroisoquinolines such as 73 were functionalised via a nitro-Mannich type 
reaction (Scheme 64). Here nitromethane was used both as reagent and solvent 
with tBuOOH and CuBr present. 
 
Scheme 64: Nitro-Mannich type CDC117 
Li et al. extended their nucleophile scope to include malonates first under neat 
and then aqueous conditions with an analogous mechanism to nitroalkenes, 
shown below with dimethylmalonate 232 (Scheme 65).117–119 This reaction was 
also found to work with malonitrile, albeit poorly.118 The authors proposed that the 
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copper catalyst is involved in the generation of both reactive species 233 and 
236. 
 
Scheme 65: Extended nucleophile scope for Li et al’s CuBr based CDC 
conditions and proposed mechanism118 
Some progress has been made regarding asymmetric CDC reactions adjacent to 
amines, which started with a study published by Klussmann et al. combining 
L-proline and VO(acac)2 to obtain modest enantioselectivity (Scheme 66).120 The 
authors note that enantiopure 237 obtained by prep TLC was observed to slowly 
racemise, which the authors propose may explain the poor ees they obtained. 
Despite this, the conditions developed by Klussmann still provided the first route 
into using ketone nucleophiles in CDC reactions. 
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Scheme 66: Cross-dehydrogenative coupling with moderate selectivity120 
Enantioselective control in a CDC reaction was achieved by Chi et al. in 2012 
through the use of CuBr2 and a Jørgenson-Hayashi diphenyl prolinol catalyst 238 
(Scheme 67).121 This reaction was found to proceed well with aldehydes, 
however, moving to ketones led to low enantioselectivity and the use of N,N-
dimethylaniline or N-aryl pyrrolidine gave low enantioselectivities or yields.121 
 
Scheme 67: Enantioselective synthesis of 239121 
Finally, the Stephenson group have also developed a method of coupling 
nitroalkanes and tetrahydroisoquinolines through the use of photocatalysis to 
perform a SET initiated process (Scheme 68).48 Notably, this reaction proceeds 
in the absence of oxygen, suggesting that the nitroalkane can act as an electron 
acceptor and light acts to initiate the SET process leading to coupling.48  
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Scheme 68: Visible light/Ir catalysed nitro-Mannich type CDC48 
1.3.2 Cross-Dehydrogenative Coupling Adjacent to Ethers 
As discussed above in section 1.3.1, in the past decade cross-dehydrogenative 
coupling (CDC) reactions on the amine α-carbon have been widely explored as 
a method of C-C bond formation. The application of this methodology to oxygen 
in the ether functional group is an attractive prospect as at present the vast 
majority of carbon-carbon bond forming reactions proceed via functional group 
manipulation. In comparison, C-H functionalisation can be far more atom 
efficient.109 A CDC reaction adjacent to an ether would proceed similarly to 
Scheme 68, with the aim of functionalising at the benzylic position, again with the 
loss of H2 and an oxidant required (Scheme 69). 
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Scheme 69: CDC reaction adjacent to an either 
Far less work has been published on the functionalisation of ethers compared to 
equivalent amines. The first published benzylic C-H activation adjacent to an 
ether was published in 1993 by Xu et al.122 Here DDQ was used to generate an 
oxocarbenium cation from a range of isochroman derivatives which were then 
attacked by the alcohol present (Scheme 70). 
 
Scheme 70: First published isochroman CDC reaction122 
This work was followed up by the same group in 1994, where DDQ was again 
used to achieve glycosidation at the desired site.123 Whilst no chiral catalyst or 
auxiliaries were used, when isochroman had a substituent in the 3-position, only 
the anti products were observed (Scheme 71). 
 
Scheme 71: Glycosidation of isochroman derivative 250 with DDQ123 
Nothing further was published in this field until 1999, when Katritzky et al. 
published a novel method of synthesising α-(Benzotriazol-1-yl)alkyl ethers 
directly via C-H activation using only boron or titanium Lewis acids.124 However, 
the authors state that there was not enough data to suggest a mechanism; there 
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was no clear oxidant and barring isochroman only symmetrical ethers were used 
(Scheme 72). 
Scheme 72: Synthesis of α-(Benzotriazol-1-yl)alkyl ethers124 
DDQ was used as a terminal oxidant by Li et al. in 2006 with a copper/indium 
catalyst pair (Scheme 73).125 However, their approach was limited to the use of 
malonates as nucleophiles and it required indium as a Lewis acid, both of which 
restrict its utility. 
 
Scheme 73: DDQ mediated CDC on isochroman 255 
A second paper was published in 2006 by Li et al. showing a metal-free approach 
to benzylic ether functionalisation.126 Whilst minor conversion was seen using 
solely DDQ in solvent, in order to obtain high conversion the reactions were 
required to be neat (Scheme 74).126 
 
Scheme 74: DDQ mediated CDC without metal catalyst 
In 2010, Floreancig et al. reported a DDQ mediated C-H functionalisation 
adjacent to a non-benzylic ether (Scheme 75).127  The procedure used DDQ as 
an organocatalyst, however, 6 equivalents of MnO2 were required for the reaction 
to proceed. Despite the broad scope shown, the high quantity of metal present 
imposes a limit on the usefulness of the reaction beyond an academic setting. 
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Scheme 75: MnO2 and DDQ mediated cyclisation via C-H functionalisation 
Non-DDQ oxidants have found use in the functionalisation of benzylic ethers. Liu 
et al. published a procedure in 2014 which used a trityl cation as an oxidant.128 
This reaction was notable in its broad substrate scope, something that has 
traditionally been difficult to achieve within this field (Scheme 76). 
 
Scheme 76: Trityl cation mediated C-H functionalisation 
A potential method of ether functionalisation could be via the modification of 
amine CDC reactions such as those of Murahashi (Scheme 77).129  However, α-
oxidation of ethers seems to be harder to achieve than with amines, as the 
number of reported reactions of the latter far outstrips the former. A possible 
rationale for the increased difficulty could lie in the difference in electronegativity 
between oxygen and nitrogen leading to the oxocarbenium ion being less stable 
and hence harder to form. 
 
Scheme 77: Introduction of CN moiety adjacent to amine using CDC 
Another potential target for improved C-H functionalisation could be isochromene 
265, which only one group have investigated as a substrate for C-H activation.130 
In this case DDQ was used as the primary oxidant with lithium perchlorate also 
present as a means to break up a proposed isochromene-DDQ dimer. The 
reactions were performed at between -35 and 0 °C in MeCN with the nucleophile 
component being either allyl silanes/stannanes or aryl potassium trifluoroborates 
giving yields between 46-92% (Scheme 78). Crucially these reactions proceeded 
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much faster than corresponding ones with isochroman, potentially due to the 
more stable aromatic oxocarbenium ion 267 formed.130 
 
Scheme 78: Functionalisation of isochromene130 
 
1.4 The 1,5-Hydride Shift 
1.4.1 The 1,5-Hydride Shift in Amino Substrates 
Despite first being reported by Pinnow in 1885, the 1,5-hydride shift languished 
in relative obscurity for most of the following century, with the main body of work 
in this area coming from Meth-Cohn, who published two major reviews in 1972 
and 1996.131–133 These reviews are mainly notable for coining the term tert-amino 
effect as a way of describing these hydride shifts when they occur adjacent to an 
amine, though they have since been reported adjacent to other heteroatoms, and, 
in some cases, without the presence of a heteroatom at all.132–135 Interest in these 
reactions has steadily increased in the past 15-20 years, especially in the last 10, 
thanks, in part to the same driving forces that have moved research towards all 
types of C-H activation, the desire for atom-efficient “green” chemistry.13,136  
A key example of the 1,5-hydride shift occurring with amine substrates came in 
1984 when Reinhoudt et al. published a novel method of preparing substituted 
tetrahydroquinolines such as 269 (Scheme 79).137 Here the aniline derivative 268 
was heated in nBuOH for 2 h to form tetrahydroquinoline 269 in a 67% yield.137 
Reinhoudt observed that the 1,5-hydride shift benefits from the presence of a 6-
membered ring in the backbone of the molecule, as this provides a closer 
framework to the required spatial orientation for the shift to occur.137 
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Scheme 79: Novel method of tetrahydroquinoline formation through a 
1,5-hydride shift137 
In the 1990s interest in 1,5-hydride shifts started to increase, with Heathcock et 
al. discovering, during their work on daphniphylline alkaloids, a new 
transformation (Scheme 80).138,139 Iminium ion 270 underwent an attack by the 
pendent alkene to form the carbocation 271. This cation acted as the hydride 
acceptor for a 1,5-hydride shift to form a second iminium ion 272 that 
subsequently hydrolysed. 
 
Scheme 80: Unexpected 1,5-hydride shift139 
A good early example of the modern 1,5-hydride shift, using Bronsted acids, 
came in 2008 from Barluenga et al. using alkynyl Fischer carbene complexes.140 
Here an iminium ion was generated via a 1,5-hydride shift to the alkyne 273 to 
form an allene 274 which subsequently underwent cyclisation (Scheme 81).140 
Whilst a 91% yield was obtained in 1.5 h at 90 °C there were issues with 
selectivity, the reaction giving 275 and 276 in a ratio of 3:1 respectively.140 
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Scheme 81: Competition between hydride shift sites140 
This catalyst free hydride shift has also been used in the synthesis of potential 
antibiotic targets such as (-)-PNU-286607 279, with it forming the final step in the 
route published by Ruble et al.141 This offers a clear example of the advantages 
these generally high yielding reactions can provide, though here it is referred to 
as the tert-amino effect rather than a 1,5-hydride shift.141 The reaction is 
performed in tandem with the incorporation of barbituric acid 278 which the 
authors believe to be the limiting step. Regardless, this incorporation/cyclisation 
reaction has given yields of 74% (Scheme 82).141 
 
Scheme 82: Synthesis of 279 via a 1,5-hydride shift terminal step141 
In 2009 both the Seidel142 and Akiyama143 groups published methods of 
producing tetrahydroquinazolines with the use of heat and an acid catalyst 
(Scheme 83). In both cases the reaction proceeded via the formation of an imine 
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from a 2-aminobenzaldehyde derivative 280 which subsequently underwent a 
1,5-hydride shift and cyclisation following imine protonation142,143 
 
Scheme 83: 1,5-hydride shift mediated quinazoline synthesis143 
As shown by the reactions above, and as is clear by Meth-Cohn’s reviews, 
1,5-hydride shift conditions tended to be performed with Bronsted acids or under 
thermal conditions.132,133,144 
Seidel et al. investigated, in 2009, the use of Lewis acids to effect these 
transformations.145 The authors screened a wide range of Lewis acids and 
discovered that Sc(OTf)3 and Gd(OTf)3 could lead to the formation of 
tetrahydroquinolines similar to those prepared by Reinhoudt. No reaction was 
observed with the dicyano- substrate Reinhoudt themselves cyclised (Schemes 
79 and 84).137,145 Instead, dicarbonyl substrates were required, though both 
ketones and esters were tolerated, suggesting chelation. Similar yields were seen 
with Sc(OTf)3 and Gd(OTf)3 but the latter catalyst led to reduced reaction times. 
 
Scheme 84: Formation of 286 through Lewis acid catalysis145 
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Seidel et al. also investigated the possibility of performing these reactions 
enantioselectively, the only research in this direction to date.145 The best result 
obtained was with the magnesium (II) complex 287, which gave the desired 
compound in a 74% yield with an ee of 30% (Scheme 85). The enantioenriched 
material 286 was found to racemise in the presence of Gd(OTf)3. 
 
Scheme 85: The first enantioselective 1,5-hydride shift in amino 
substrates145 
The use of more common metals as catalysts was described in 2012. Yuan et al. 
used iron (III) chloride to form spirooxindole 289 in a high yield and excellent dr 
(Scheme 86). 
 
Scheme 86: Yuan et al’s synthesis of spirooxindolines146 
An interesting use of the 1,5-hydride shift was described in 2012  by Jurberg et 
al.147 The authors found that 2-carbonylanilines such as 290, when in the 
presence of Sc(OTf)3 in DCE, were found to form N,O-acetals such as 291. These 
acetals were not isolated and were instead reacted with Grignard reagents to 
functionalise adjacent to the amine with the carbonyl reduced to an alcohol 
(Scheme 87).147 
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Scheme 87: The use of a 1,5-hydride shift to functionalise amines with a 
Grignard reagent147 
Zhang et al. described, in 2012, another interesting method of applying the 1,5-
hydride shift (Scheme 88) through the use of a carbophilic Lewis acid to first 
enact a cyclisation to form a furanyl derivative 297 which then induced a 1,5-
hydride shift by virtue of an incipent C+ to give 295. However, in the presence of 
an oxophilic Lewis acid, the 1,5-hydride shift and cyclisation proceeded before 
any furanyl derivative could form.145,148 This route gives the highly functionalised 
tetrahydrofuran 294 via intermediate 296. 
Scheme 88: Alternate heterocycles through choice of Lewis acid148 
A method of using a 1,5-hydride shift for ring expansion was discovered by Zhang 
et al, again in 2012.149 According to the mechanism as proposed, the 1,4-
diiminoazetidine 299 was treated with LiN(SiMe3)2 to provide the 
dihydropyrimidinesulfonamide 300 in a 99% yield, with 28 further substrates 
prepared (Scheme 89). After an initial sigmatropic rearrangement of 301 to form 
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302, a 1,5-hydride shift occurs to give 303 which subsequently rearranges in a 
ring-closure reaction to give 300.  
 
Scheme 89: 1,5-hydride shift catalysed ring opening149 
1.4.2 The 1,5-Hydride Shift in Ethereal Substrates 
Non-amine 1,5-hydride shifts are, by comparison, a much less studied area. An 
early example of a 1,5-hydride shift adjacent to an oxygen came in 1993 when 
Kataoka et al. discovered that it was possible to functionalise alkenes such as 
308 tethered to an O,Se acetal in the presence of SnCl4 to form a hydroxyketone 
such as 309 (Scheme 92).153  
 
Scheme 90: Hydroxyketone formation via a 1,5-hydride shift153 
The mechanism, as proposed by Kataoka, first proceeds by the formation of 306 
following the SnCl4-mediated cleavage of the acetal (Scheme 91).153 This is 
followed by a Prins cyclisation and subsequent hydride shift before hydrolysis 
occurs on workup to give 305. 
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Scheme 91: Mechanism for hydroxyketone formation153 
The first major papers in this area in the modern era came from Sames et al. in 
2005 when the authors reported a novel method of forming bicyclic ether 
spirocycles, which was followed with a second more complete publication of 
increasing scope (Scheme 92).135,154 This is further notable as the 1,5-hydride 
shift was performed with an ether moiety rather than with amines as had 
predominantly been published previously. As with Atkinson (see above) the 
hydride shift was found only to occur with a 1,5- arrangement, attempts at 1,4- 
and 1,6-hydride shifts with analogous substrates failed.135 This highlights the 
importance of the relative arrangements of the reacting portions of the molecule 
in space.135  
 
Scheme 92: Sames et al. first 1,5-hydride shift mediated cyclisation135 
This reaction was performed via a 1,5-hydride shift to form an intermediate which 
contained both an enolate and an oxocarbenium ion 311 (Scheme 93). The 
oxocarbenium ion then underwent rapid nucleophilic attack from the tethered 
enolate to give the spirocycle 310 at room temperature with a Lewis acid catalyst. 
 
Scheme 93: Mechanism for 1,5-hydride shift mediated cyclisation135 
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Further studies by both Sames and Akiyama suggested some general reactivity 
rules for ethereal substrates.155,156 Sames et al. did so by developing a novel 
method of preparing dihydrobenzopyrans from salicylaldehyde derived ethers.155 
By generating an oxonium ion adjacent to an aromatic ring the authors were able 
to achieve 91% yield with full consumption of starting material within 24 h at 80 °C 
(Scheme 94).155 Here Sc(OTf)3 proved to be uniquely effective as a catalyst, with 
many lanthanide triflates showing no or low yields. The authors found that esters 
perform better than ketones as whilst diketones cyclised, a significant amount of 
side product was formed that wasn’t seen with esters. The authors also observed 
that ring substitution is preferred in the para- position relative to the ethereal 
oxygen and that electron donating groups in the aromatic ring increase the 
reaction rate.155 
 
Scheme 94: Dihydrobenzopyran synthesis via 1,5-hydride transfer155 
Concurrently, Akiyama et al. found that the presence of a bulky group ortho- to 
the hydride source greatly improved the reaction rate.156 This improvement 
occurred to the extent that it was possible to form substituted chroman 315 in a 
97% yield with a 0.5 mol% catalyst loading (Scheme 95). It was proposed that 
the presence of the bulky ortho- group forced 314 to sit in the desired 
conformation for the 1,5-hydride shift.156 
 
Scheme 95: Effect of an ortho- substituent on 1,5-hydride shifts156 
The carbonyl-substituted alkene hydride acceptors shown above have been 
found to perform better when the carbonyl is an ester or aldehyde.157  McQuaid 
et al. published a new method of performing 1,5-hydride shifts with ketones which 
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proceeded much more swiftly and without the formation of side products due to 
the protection of the ketones as acetals, leading to the formation of an 
oxocarbenium ion (Scheme 96).157  
 
Scheme 96: Improved 1,5-hydride shift with acetals157 
Later in 2009 Sames et al. published a method of forming 5-membered rings with 
a platinum catalysed hydride shift to an alkyne. This generated a reactive cation 
that then underwent nucleophilic attack from the platinated alkene to form a ring 
(Scheme 97).158 This reaction was found to successfully convert both amino and 
ethereal substrates. 
  
Scheme 97: Sames et al. platinum catalysed cyclisation158 
Since then, several papers have been published using the formation of α,β-
unsaturated iminium ions as a means to promote the hydride shift. These 
reactions proceed similarly to that shown above (Scheme 93), with the iminium 
ion replacing the enone as a hydride acceptor. In 2012 Tu et al. first demonstrated 
iminium ion activation to form spiroethers similar to those in Sames’ 2005 paper 
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but leading to a product that was enantioenriched.159 Here the weakly 
coordinating Cl- counterion increases the electrophilicity of the generated iminium 
ion, promoting the hydride shift (Scheme 98). 
  
Scheme 98: Enantioenriched cyclisation via hydride shift154  
1.4.3 The 1,5-Hydride Shift in Substrates Without an Adjacent Heteroatom  
The first non-heteroatom adjacent example of a 1,5-hydride shift was published 
in 1969 by Atkinson.150 Atkinson discovered that if enone 326 was heated in in 
BF3.OEt2, cyclised product 327 was formed in a 77% yield as a single 
diastereomer (Scheme 99). 
 
Scheme 99: First example of a non-amine based 1,5-hydride shift150 
This initial result was shown to be an intramolecular process through a deuterium 
labelling experiment where a mixture of D labelled and standard starting materials 
were reacted as per Scheme 99, and no mono-deuterated products were 
obtained.150 Also notable was a further study by Atkinson which both broadened 
the range of catalysts which could be used to effect this transformation and 
showed that a 1,4-hydride shift would not occur under the same conditions.151 
However, despite this early result, the work of Atkinson suffered, as did tert-amino 
effect induced cyclisations, from forcing reaction conditions. Atkinson’s reactions 
required either a 1:1 mix of BF3.OEt2 and benzene as solvent/catalyst or 96% 
H2SO4 as solvent for products to be obverved.150,152 The aforementioned H2SO4 
reaction saw substituted aldehydes such as 328 converted into tetrahydropyrans 
such as 329.  
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Scheme 100: Formation of tetrahydropyran 307152 
Another early example of a 1,5-hydride shift occurring without the presence of an 
adjacent heteroatom came in 1999, when Wölfling et al. described the synthesis 
of aliphatic rings with BF3.OEt2 as a catalyst before its adoption by Sames et al. 
for 1,5-hydride shifts adjacent to ethers (Scheme 101).160 
 
Scheme 101: Synthesis of bridged steroid alkaloids via 1,5-hydride shift160 
Following Sames et al. publication of Sc(OTf)3 catalysed 1,5-hydride shifts in 
2005, this same methodology was applied to substrates without an adjacent 
heteroatom.135,161 In 2009 Fillion et al. used Sc(OTf)3 methodology as a means 
of preparing complex tetracycles with Meldrum’s acid.161 Here 40 mol% was used 
to effect the initial 1,5-hydride shift at room temperature in 36 h, followed by 3 h 
at 100 °C for the subsequent decarboxylation and Friedel-Crafts acylation with a 
52% yield of 333.161 This publication was notable as with Meldrum’s acid and 
Sc(OTf)3 the authors managed to functionalise a benzylic carbon at rt (Scheme 
102).161 
 
Scheme 102: Tetracycle synthesis via 1,5-hydride shift161 
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This was followed in 2011 by Akiyama et al, who published a method of forming 
6 membered aliphatic rings with Sc(OTf)3 via a 1,5-hydride transfer and 
cyclisation via a tertiary carbocation (Scheme 103).162 This was performed in 
dichloromethane at reflux for 24 h, giving yields of 93-97%.162 This was achieved 
without a heteroatom adjacent to the hydride donor or electron donating 
substituents on the aromatic ring. 
 
Scheme 103: 1,5-hydride shift to form aliphatic ring 
In 2012 the authors applied this methodology to the formal synthesis of (±)-
tetrahydropalmatine 338, forming 337 via imine formation and a subsequent 1,5-
hydride shift (Scheme 104).163 This compound is a key intermediate in the 
synthetic route to (±)-tetrahydropalmatine 338 published by Enders et al. in 
2005.163,164 
 
Scheme 104: Formal synthesis of (±)-tetrahydropalmatine via a 1,5-hydride 
shift163,164 
In 2012 the Sames and Akiyama groups both published separate methods of 
forming new nitrogen containing heterocycles via a 1,5-hydride shift with the 
formation of an imine in situ.163,165 The amine formed by the hydride shift then 
attacks the new cation 342 to form a 6 membered ring (Scheme 105). 
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Impressively, in the case of Sames, this transformation involved a hydride donor 
without an adjacent heteroatom. 
  
Scheme 105: Sames’ nitrogen heterocycle formation165 
In addition to the varied 1,5-hydride shifts discussed above, there have been a 
small number of successful 1,4-hydride shifts. An early example of a 1,4-hydride 
shift came in 1968, when Gwynn et al. published a novel oxidation of endo-6-
bromomethyl-exo-2-norbornanol 343.166 In addition to the desired elimination 
product 345, the ketone 344 was formed in a 3:1 ratio (Scheme 106). The authors 
proposed that this was the result of an unexpected 1,4-hydride shift leading to 
elimination of Br- and the oxidation of the alcohol group to a ketone.166 
 
Scheme 106: An unexpected 1,4-hydride shift166 
A similar process involving a 1,4-hydride shift has also been observed in the 
rearrangement of sterically congested homoallyl alcohol 347 to the corresponding 
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alkyl ketone 350 in a 1:1 mixture of AcOH/H2SO4.167 Rather than relying on the 
elimination of a bromide, instead the authors propose a mechanism wherein the 
alkene is protonated and the generated cation acts as the hydride acceptor 
(Scheme 107). The authors also report that, due to steric hindrance, no 
corresponding 1,3-hydride shift can occur.167 
 
Scheme 107: 2-step rearrangement involving a 1,4-hydride shift167 
Alajarin et al. developed, in 2011, a method of C-H functionalisation via a 1,4-
hydride shift which used the hydride acceptors used elsewhere in 1,5-hydride 
shifts.145,168 The authors discovered that 1,3-dioxolanes, 1,3-dithiolanes or 1,3-
dithianes were required as a hydride source, rather than the wider range of 
donors seen in 1,5-hydride shifts.168 A wide range of Lewis acids were screened, 
with Sc(OTf)3 providing the desired products in yields between 30-58%, with the 
acetal cleaving in situ following cyclisation (Scheme 108).168 The authors 
discovered that when BF3.OEt2 and AlCl3 were used as the catalyst, 354 was 
formed instead, the acetal having cleaved to provide the aryl aldehyde. 
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Scheme 108: 1,4-hydride shift to form 353168 
Table 3: Results of condition screen to form 353 
351 R R1 Catalyst (eq) Temp (°C) 353 Yield (%) 
351a CO2Et H AlCl3 25  
351a CO2Et H BF3.OEt2 80  
351a CO2Et H Sc(OTf)3 25  
351a CO2Et H Sc(OTf)3 50  
351a CO2Et H Sc(OTf)3 60  
351a CO2Et H Sc(OTf)3 80 353a (30) 
351a CO2Et H Sc(OTf)3 80 353a (58) 
351a CO2Et H Sc(OTf)3 80 353a (55) 
351b CO2Me H Sc(OTf)3 80 353b (54) 
351c CO2Et OMe Sc(OTf)3 80 353c (41) 
351d CO2Me OMe Sc(OTf)3 80 353d (35) 
Finally, Mori, whose work with Akiyama on the 1,5-hydride shift work has been 
discussed in detail in section 1.4, page 59 onwards, has also published one 
successful 1,4-hydride shift reaction (Scheme 109).169 The authors discovered 
that, contrary to their 1,5-hydride shift reactions, the presence of bulky groups on 
the amine adjacent to the hydride donor saw a decrease in reaction time and 
increase in yield.169 This difference was rationalised as the steric clash between 
the bulky amine substituents and the hydride acceptor preventing the nucleophile 
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attack of the hydride acceptor by the amine, ensuring the desired 1,4-hydride shift 
occurred.169  
 
Scheme 109: General reaction Scheme for formation of 356169 
As is apparent from the above discussion, the hydride acceptor in a 1,5-hydride 
shift needs to be suitably electron withdrawn for reactions to proceed. Generally, 
where a vinyl aldehyde will readily act as a hydride acceptor, a less electrophilic 
vinyl ester would require a second electron withdrawing group in order to react, 
such as a second ester or a nitro group.154,170 This also goes some way to 
explaining the decreased reactivity seen with vinyl ketones compared to the 
corresponding aldehyde, with the highest yielding reactions requiring the 
generation of an oxocarbenium or iminium ion.157 These reactive iminium anions 
have also found use in asymmetric syntheses, with the iminium formed through 
reaction with the chiral auxiliary being more reactive than the starting aldehyde, 
for example (Scheme 100).159 
Despite the wide range of synthetic methods as described in the sections above, 
when we commenced our investigations a 1,5-hydride shift had been used to 
form a nitronate to allow a nitro-Mannich cyclisation to occur on just one 
occasion.171 This reaction was published in 2007 by Jordis et al, where the 
cyclisation occurred in refluxing nBuOH for 80 hours with a combined yield of 
358a and 358b of 25% with a ratio of 12:1 (Scheme 110).171  
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Scheme 110: Literature cyclisation via 1,5-hydride shift then nitro-
Mannich171 
A second 1,5-hydride shift with a nitro- group present was published in 2016 by 
Briones et al.170 The authors observed that Mg(OTf)2 catalysed the formation of 
bicycle 360 (Scheme 111) as a key intermediate in a route towards 
tetrahydroquinoline-3-spirohydantoin derivatives via the synthesis of spirocycles.  
 
Scheme 111: Literature route featuring Lewis acid catalysis170 
The use of the nitro-Mannich reaction to perform a cyclisation following the 
internal generation of a nitronate was therefore an area ripe for further 
exploration. 
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2. Results and Discussion 
2.1 Previous Work in the Group 
The cross-dehydrogenative coupling of ethers as a method of C-H activation 
adjacent to ethers had previously been investigated by an exchange student 
within the group who had focused on choices of Lewis acids when working with 
benzoquinone as an oxidant. He had first prepared 1-(2,4,6-
trimethoxyphenyl)isochroman 362 in order to obtain clean NMR data with which 
to compare conversion during methodological investigation (Scheme 112).172  
 
Scheme 112: Literature synthesis of 362 to give 1H NMR data172 
Once 1H NMR data was obtained for 362 attention was turned to screening of 
reaction conditions to effect the formation of 362 via an Oppenauer oxidation. 
Both solvent and Lewis acid were investigated with benzoquinone in use as an 
oxidising agent (Scheme 113, table 4). The conversion was measured by the 
relative intensities of the 1H NMR peaks of isochroman 255 and the desired 
product 362. 
 
Scheme 113: General Scheme for reaction screening 
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Table 4: Conditions screened previously within the group 
Solvent 
Lewis 
Acid(s) 
Catalyst Load 
(mol%) 
Temperature 
(°C) 
Conversion 
(%) 
Toluene InCl3 10 110 0 
Toluene ZrCl4 20 110 6 
Toluene CuBr2 25 110 8 
Toluene ZrCp2Cl2 25 110 2 
Toluene CeCl3.7H2O 25 110 6 
Toluene IrCl3.H2O 5 110 6 
Toluene CuBr2 10 50 6 
Toluene CuCl 10 50 5 
Toluene BF3.OEt2 30 50 0 
Toluene FeBr3 20 50 2 
Toluene None n/a 50 0 
Toluene Ti(iOPr)4 10 80 0 
Toluene NiCl2.6H2O 10 80 0 
Toluene AgNO3 20 80 0 
Toluene RuCl3.H2O 10 80 6 
Toluene ZnBr2 10 80 1 
MeCN CuBr2/ZnBr2 10 60 8 
 
2.2 Proposed Research 
It was clear from the results achieved previously within the group that a great deal 
of improvement would be required in order to develop a synthetically useful 
reaction. Due to this lack of success two routes into C-H activation were pursued. 
We proposed the use of hypervalent iodine compounds, both iodine (III) species 
such as (diacetoxyiodo)benzene (PIDA) 363 and iodosobenzene 364 based on 
their ability to oxidise alcohols to carbonyls.173 Our scope also included iodine (V) 
species such as Dess-Martin periodinane (DMP) which has also found much use 
in alcohol oxidation 365 (A), Scheme 114).174 By analogy, we proposed that 
should DMP oxidise an ether 369, the generated oxonium ion 371 would then be 
susceptible to nucleophilic attack (B) Scheme 114) 
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Scheme 114: DMP oxidation of alcohol and potential application to ethers 
Alongside this work with hypervalent iodine oxidants, we planned to continue the 
investigation into the oxidation of ethers via the proposed Oppenauer oxidation. 
It was thought that the choice of oxidant could be key and would be a good 
starting point for improving reactivity. We proposed to find an initial method of 
oxidation adjacent to ethers which could then be extended to cover a wide range 
of substrates and nucleophiles (Figure 1). 
 
Figure 1: A selection of substrates and nucleophiles 
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2.3 The Functionalisation of C-H Bonds Adjacent to Ethers 
2.3.1 Hypervalent Iodine 
The first conditions attempted used PIDA and was based on the reaction 
conditions from a Liu et al. paper which used a trityl cation as an oxidant to 
functionalise via a CDC (Scheme 115).128  This showed no conversion as was 
reported by the Liu group for their substrates.128 
 
Scheme 115: Attempted functionalisation with PIDA oxidant 
The reaction was then repeated, using DMP 372 in lieu of PIDA 363. The 
reactions were performed under an inert atmosphere, but with standard 
dichloromethane.175 The initial attempt was a modification of the PIDA conditions 
used by Liu et al. (Scheme 115) with the use of DMP and a slight increase in the 
ratio of 1,3,5-TMB to isochroman 255. This saw a conversion to product 362 of 
1%, due to the appearance of a signal at δ 6.69 (d, J = 7.7 Hz, 1H) in CDCl3 of 
the product 362 compared to δ 4.79 (s, 2H) of isochroman 255. Both peaks 
appeared as single resonances in their respective regions of the spectrum. Whilst 
conversion was poor, this result implied that DMP 372 could be used to 
functionalise isochroman 255. 
Reaction optimisation was attempted with DMP 372 as the oxidant for oxonium 
ion formation (Table 5). However, as conversion couldn’t be increased above 2%, 
the use of DMP 272 as an oxidant with 1,3,5-TMB 361 as the nucleophile was 
abandoned. 
Both triethylamine and pyridine were trialled as a basic additive as the desired 
oxidation with DMP produces two equivalents of acetic acid (Scheme 114). It was 
proposed that the use of basic conditions could quench this acetic acid produced 
by DMP 372 reduction. However, in both cases no conversion was seen. 
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Table 5: DMP and 1,3,5-trimethoxybenzene screening conditions 
Solvent Additive Temperature Time (h) % Conversion 
Dichloromethane None Room Temp 24 1 
Dichloromethane None Room Temp 72 2 
Dichloromethane NEt3 Room Temp 24 0 
Dichloromethane Pyridine Room Temp 24 0 
MeCN None Room Temp 24 1 
MeCN None 75 °C 24 2 
Dichloromethane None 40 °C 72 1* 
*This reaction saw another unknown product forming in a slightly larger, but still 
minor, quantity. 
Despite the limited success of DMP 372 when using 1,3,5-TMB as a nucleophile, 
several other nucleophiles were trialled in an attempt to improve functionalisation. 
If increased conversion was observed it would have suggested that the lack of 
conversion with 1,3,5-TMB was due to the nucleophile itself rather than DMP 372. 
Initially diethyl malonate was used without a base to increase the nucleophilicity 
of diethyl malonate. This was due to the previous reactions with a basic additive 
seeing a complete lack of conversion (table 5, entries 3 and 4). No conversion 
was seen here either (Scheme 116). 
 
Scheme 116: Attempted DMP oxidation with diethyl malonate nucleophile 
The DMP 372 mediated reaction was attempted again using acetic acid as a 
possible nucleophile, in this case with 5 equivalents. Whilst a stoichiometric 
amount of DMP 372 was used only trace amounts of 255 were present in crude 
1H NMRs despite poor conversion. However, no conversion to 374 was seen after 
6 days (Scheme 117). 
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Scheme 117: Attempted DMP oxidation with acetic acid nucleophile 
At this point, the use of DMP 372 as a reagent for C-H functionalisation was 
abandoned due to the inability to improve conversion beyond 2%. A harsher 
reagent, iodosobenzene 364, was synthesised from (diacetoxyiodo)benzene 363 
with the use of a strong base. The resulting product is a highly insoluble heat and 
shock sensitive material when fully dry and as such was kept slightly wet. As it is 
insoluble, it was not possible to obtain a 1H NMR spectrum. The IR obtained 
matches that of Woggon et al., but this is not a sensible method of determining 
purity.176 Plattner et al., from whom the synthetic route was obtained, stated that 
their product was determined to be 99.5% purity by iodometric titration, however, 
as both the product and starting material are I(III) species, a method of 
differentiating via iodometric titration was not apparent to us.177 The synthesised 
material was not used in screening reactions as we could not be certain of its 
identity and it proved to be insoluble in every solvent in which dissolution was 
attempted. 
 
Scheme 118: Synthesis of iodosobenzene 364177 
It was at this point that a paper by Kita et al. was found utilising 
[bis(trifluoroacetoxy)iodo]benzene (PIFA) 375 to mediate a radical based cross 
coupling reaction (Scheme 119).178 The initial reaction intermediate after single 
electron transfer resembles that of the iridium mediated PMB deprotection as 
postulated by Tucker et al. (Scheme 119)179 Though Kita et al. believe their 
reaction to be a cross coupling via radical cation, they provide no clear 
mechanism for this actual process, instead providing a basic Scheme (Scheme 
119).178 
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Scheme 119: PIFA mediated radical cross coupling178 
By analogy, a possible functionalisation of isochroman 255 with PIFA 375 was 
considered as the radical cation 378 generated appears to be similar to that 381 
formed prior to oxocarbenium ion 382 generation in iridium catalysed PMB 
deprotection (Scheme 120).179 No conversion to the desired product or any other 
was observed. The PIFA 375 used was later seen to be partially degraded by 1H 
NMR and the BF3.OEt2 discoloured, a usual sign of degradation.  
 
Scheme 120: Attempted PIFA mediated functionalisation  
As this reaction failed to form the desired product, a control experiment was 
planned to ensure PIFA 375 could perform the desired oxidation. Using a 
substrate from the original PMB deprotection paper (Scheme 121) PIFA was 
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used, instead of an iridium photocatalyst, as the oxidant. This attempted 
deprotection was successful, seeing almost complete conversion to p-
anisaldehyde 148 and L-menthol 387 as predicted after 3 hours.  
A plausible mechanism for this (Scheme 121) could be via the same radical 
cation reactive intermediate 384 as proposed in the Tucker and Kita papers.178,179 
This intermediate could then undergo a hydrogen abstraction conceivably 
involving PIFA’s initial degradation product to form iodobenzene and 
trifluoroacetic acid to give the desired oxonium ion 385. This could be hydrolysed 
into p-anisaldehyde 148 and L-menthol 387. 
Scheme 121: Potential mechanism for PMB cleavage with PIFA 
This successful use of PIFA 375 as a method of PMB removal suggested that it 
might form the oxocarbenium ion intermediate 386. Potentially this could be 
intercepted by a nucleophile other than water. Therefore simple PMB ethers were 
prepared with which to attempt functionalisation. Methylation of p-methoxybenzyl 
alcohol 388 by deprotonation and treatment with iodomethane in THF was 
performed. The analogous ethyl ether, p-methoxy(ethoxymethyl)benzene 390, 
was prepared from p-methoxybenzyl bromide and ethanol in THF, albeit with a 
much lower yield of 23% due to the ethanol being used as supplied with no 
additional precautions against likely adventitious water. 
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Scheme 122: Synthesis of p-methoxy(methoxymethyl)benzene 389 
The first reaction attempted was with 390 and diethyl malonate, and was 
monitored via TLC. Diethyl malonate was chosen as a nucleophile, as the Kita et 
al. paper showed coupling between aromatics and for an initial reaction we 
wanted to avoid this further complication by using a non-aromatic nucleophile.178 
From TLC it was apparent that within three hours of the reaction commencing p-
anisaldehyde 148 was present, but there was no evidence of any functionalised 
product (Scheme 123). The simplest explanation was that the oxonium ion was 
formed but was not reacting with the desired nucleophile and was instead 
hydrolysed either during workup or reaction. 
 
Scheme 123: Attempted functionalisation of p-
methoxy(ethoxymethyl)benzene 390 with PIFA 
In a second attempt, 1,3,5-TMB was used as a nucleophile because it had 
previously given conversion when diethyl malonate had not (Table 5, Scheme 
116). As before, p-anisaldehyde 148 appeared within three hours and ceased to 
appear after 24 h. However, the desired product was not formed, instead the 1H 
NMR suggested one of three plausible structures (Scheme 124). 
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Scheme 124: Attempted functionalisation of p-
methoxy(methoxymethyl)benzene 389 with PIFA 
The structure was determined by a combination of 1H NMR and LCMS which 
gave a mass peak of 289.20, corresponding to structure 394+H+ (Scheme 124). 
The formation of this product was not compatible with our initial mechanism 
(Scheme 121). A plausible mechanism to account for the formation of 394 would 
most probably involve BF3.OEt2 acting as a Lewis acid to eliminate the methoxy 
group at the benzyl position. The resultant quinone-methine like intermediate 397 
could then undergo nucleophilic attack from 1,3,5-TMB (Scheme 125). 
Scheme 125: Alternate mechanism to account for 394 
This reaction pathway can also be used to account for the formation of p-
anisaldehyde if water were to act as the nucleophile to form PMB alcohol 388 
which would then be oxidised by PIFA 375 in an analogous method to PIDA 
oxidation of alcohols (Scheme 114). Therefore the L-menthol deprotection 
observed previously was not proof of the radical mechanism.  
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In order to probe the mechanism of this reaction a range of conditions were 
attempted. Firstly, in order to test if the reaction was in fact BF3.OEt2 mediated, 
with PIFA 375 acting only to oxidise the resulting PMB alcohol 388 (Scheme 
126), p-methoxy(methoxymethyl)benzene 389 was reacted with BF3.OEt2 only. 
This was considered as other hypervalent iodine compounds such as IBX, DMP 
363 and PIDA 372 have all found use as oxidants.173,175,180–182 If this hypothesis 
was correct, the resulting products would be methanol, which would evaporate, 
and PMB alcohol 388, which would be observed. However, the p-
methoxy(methoxymethyl)benzene 389 degraded into a complex mixture by TLC 
both pre- and post-aqueous workup. This complex mixture could not be 
separated, giving no conclusive answer. 
Scheme 126: Alternate mechanism for p-anisaldehyde formation 
In order to see if PIFA 375 could act as an oxidant for any PMB alcohol formed 
during reaction, the two were reacted together under the standard conditions for 
the PIFA/BF3.OEt2 reaction, but without the BF3.OEt2 present. This gave a 
complex mixture of products that could not be separated via column 
chromatography but which crucially lacked a diagnostic aldehyde peak. 
When PMB alcohol 394 was reacted with both PIFA 375 and BF3.OEt2 under the 
standard conditions as discussed above, full conversion was seen to p-
anisaldehyde 148 by NMR, with no starting material remaining. This showed that 
a benzyl alcohol, if formed, could be oxidised to the aldehyde that had been 
observed in previous reactions. However, this formation could be accounted for 
by both proposed reaction pathways (Schemes 121 and 125), with the latter 
seeming more likely.  
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TEMPO is generally known to act both as a radical inhibitor and initiator 
dependent on reaction. TEMPO was therefore added as an additive to the 
reaction mixture in order to see if it affected the reaction or trapped some form of 
radical intermediate (Scheme 127). This gave the same product 394 as before, 
along with a trace of 1,3,5-trimethoxybenzene dimer 398. This could be formed 
via a PIFA 375 mediated radical cross coupling as shown by Kita et al. (Scheme 
127).178 The mechanism shown in Scheme 125 seemed more likely due to the 
same product being obtained despite the presence of TEMPO. 
 
Scheme 127: PIFA mediated reaction with TEMPO 
In order to probe whether the selection of which alcohol to oxidise was purely 
steric or had an electronic bias, it was decided to prepare 1-((benzyloxy)methyl)-
4-methoxybenzene 399. Benzyl alcohol 400 and PMB chloride were reacted with 
NaH in THF to give 399 in a 79% yield. Treatment of 399 with the conditions used 
as standard previously (Scheme 128) gave a mixture of only the benzyl alcohol 
400 and p-anisaldehyde 148, suggesting an electronic bias for PIFA oxidation. 
This would help explain why menthol wasn’t oxidised (Scheme 121). 
 
Scheme 128: PIFA deprotection of 1-((benzyloxy)methyl)-4-
methoxybenzene 399 
The evidence obtained mostly suggested that the Lewis acid mediated route was 
the mechanism of deprotection and not that of the desired radical based route. 
This is due to the failure to synthesise the desired product 392 and instead seeing 
the formation of 394, which could not be explained satisfactorily with a radical 
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mechanism. With this in mind, attention was turned away from hypervalent iodine 
as an oxidant and back to more traditional hydride acceptors such as quinones. 
2.3.2 Isochroman and Isochromene 
2.3.2.1 Isochroman 
Previous work within the group found that the best conversion of isochroman 255 
to 362 used benzoquinone as an oxidant with a 5 mol% loading of each of CuBr2 
and ZnBr2 with 8% conversion seen after 24 h. In an attempt to improve this, 
other oxidants were screened under identical conditions to those used previously 
within the group (Schemes 113 and 129). These were heated in sealed tubes 
under nitrogen, aliquots were taken at 24 h. The acetonitrile was then removed 
via rotary evaporation and the metal salts removed via filtration with CDCl3. 
Conversion was again obtained comparing δ 6.69 (1H, d, J = 7.7 Hz, ArCH(Ar)O) 
in CDCl3 of the product 362 to δ 4.79 (s, 2H) of isochroman 255 due to both peaks 
appearing as single resonances in their respective regions of the spectrum.  
 
Scheme 129: General functionalisation procedure and trialled oxidants 
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Table 6: Comparison of various hydride acceptors 
Oxidant Temperature (°C) % Conversion after 24 h 
401 70 8 
402 70 <5 
403 60 12 
404 70 Trace 
405 70 Trace 
 
From the initial experiments DDQ 403 seemed to be the best choice of oxidant 
for further trials, outperforming all others, albeit with a low 12% conversion. Whilst 
we had initially proposed the oxidation occurring via an Oppenauer oxidation-like 
mechanism, the improvement shown by DDQ could potentially have been 
achieved via a SET mechanism (Scheme 130). 
 
Scheme 130: Potential SET mechanism for the oxidation of isochroman 
A very similar mechanism was proposed by Zhang et al. in 2009 in their 
functionalisation of isochroman with simple ketones.126 However, as both 
mechanisms would generate the same oxonium ion 408 it was not considered 
important to investigate further the mechanism at this point in time. If the 
distinction between routes were to be viewed as relevant to the reaction, 
monitoring via EPR could be performed. There was no change in performance 
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when the reaction with DDQ as oxidant was repeated with the addition of TEMPO 
as a radical scavenger. With DDQ as the best performing oxidant under the initial 
reaction conditions, a range of modifications were trialled in an attempt to 
increase conversion via screening of Lewis acids, solvents, and temperature, with 
conversion measured by 1H NMR after 24 h. 
Table 7: Brief reaction optimisation with MeCN and solvent screen 
Solvent Temperature (°C) Lewis Acid % Conversion 
MeCN 80 CuBr2 9 
MeCN 80 ZnBr2 7 
MeCN 80 CuCl 9 
MeCN 150* CuBr2, ZnBr2 5 
MeCN 80 CuBr2, ZnBr2 10 
Toluene 90 CuBr2, ZnBr2 24 
Toluene 110 CuBr2, ZnBr2 12 
DMSO 110 CuBr2, ZnBr2 0 
Benzonitrile 110 CuBr2, ZnBr2 Trace 
DMF 110 CuBr2, ZnBr2 6 
Xylenes 110 CuBr2, ZnBr2 Trace 
Chlorobenzene 110 CuBr2, ZnBr2 0 
Neat 80 CuBr2, ZnBr2 0 
*Reaction performed via microwave irradiation for 2 h 
Toluene with a mixture of 5 mol% CuBr2 and 5 mol% ZnBr2 at 90 °C (entry 6) was 
found to give the best conversion at 24%. However, this was still far lower than 
desired and the reaction was capricious. As such, the decision was made to turn 
to the synthesis of isochromene to prepare a more active hydride donor. 
2.3.2.2 Isochromene Synthesis 
As limited progress had been made with isochroman 255, attention was turned 
instead to isochromene 265. The generation of the oxonium ion 267 should be 
more favourable compared to that of isochroman 411 due to hydride abstraction 
leading to an aromatic intermediate for isochromene 267, (Scheme 131).130 It 
was thought that the low conversion previously seen in Scheme 129 could be 
due to difficulty in hydride abstraction rather than the nucleophile failing to react 
with a generated oxonium ion, assuming lower activation energy to reach the 
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more stable intermediate. Related work has similarly shown an increase in 
reactivity for isochromene relative to isochroman (Scheme 78).130  
 
Scheme 131: Reactive intermediates for isochroman 255 and isochromene 
265 
A synthetic route to isochromene is known in the literature (Scheme 132) and 
was followed directly.183  
 
Scheme 132: Literature route to isochromene183 
The first step for this route was a simple Fischer esterification of homophthalic 
acid 412 and ethanol to give diethyl homophthalate 413 as a yellow oil.183 Toluene 
was required as a solvent as homophthalic acid is insoluble in ethanol. This 
proceeded in generally good yields of up to 93% (lit 84%, Scheme 133).183 
  
Scheme 133: Synthesis of diethyl homophthalate 413 
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Following this, a cyclisation was attempted using DIBAL-H, with the proposed 
mechanism in Scheme 134. The unusual selectivity is believed to come from the 
relative ease of collapse of the benzylic aluminium hemiacetal compared to that 
further from the aromatic ring, as a more stable aldehyde is formed which is then 
reduced in the presence of the tetrahedral intermediate. 
Scheme 134: Proposed mechanism for 3-hydroxyisochroman formation 
This procedure was low yielding with yields of 40-45% (lit 68%)183,184 and tended 
to proceed with difficulty with large amounts of over-reduction leading to the diol 
product being observed. The over-reduction was generally mitigated through the 
use of a cannula rather than syringe to add the DIBAL-H slowly, keeping the 
temperature at -78 °C for the duration of the reaction. The yield was vastly 
improved when the reaction scale was increased to 5 g (Scheme 135). 
 
Scheme 135: DIBAL-H mediated cyclisation to form 3-hydroxyisochroman 
414184 
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The dehydration reaction conditions reported were very brief.183 The neat mixture 
of 414 and KHSO4 was heated at 1 atm for 4 h (Scheme 136). The desired 
product 265 was visible in the crude 1H NMR as the major product, with no 
starting material remaining, however, when purification via Kugelrohr vacuum 
distillation was attempted, only degradation products were obtained. Likewise, 
purification via column chromatography could not separate isochromene from 
another unknown impurity, rendering it too impure to be used as a methodological 
starting material. 
 
Scheme 136: Dehydration to form isochromene 
At this point an alternate method of isochromene synthesis was discovered 
following a literature search.185 Here isochromene was formed via a cyclisation 
of 2-ethynyl benzyl alcohol 418 (Scheme 137) 185 A synthetic route to 418 was 
then planned from 2-bromobenzaldehyde 415. A paper following this route to 418 
was then found and followed directly (Scheme 137).186 
Scheme 137: Synthetic route to isochromene via 2-ethynyl benzyl alcohol 
418185,186 
The Sonogashira reaction of 2-bromobenzaldehyde 415 and TMS acetylene 
gave 2-[(trimethylsilyl)ethynyl]benzaldehyde 416 in a 62% yield (lit. 90%) as a 
yellow liquid.186 Removal of the TMS group with KF gave a poor yield of 417 
(38%) with a mixture of byproducts, including a dimer byproduct 419, which was 
isolated in a 2% yield. This dimer byproduct 419 could be formed by the 
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intermolecular addition of the alkynyl anion to the aldehyde to form a propargyl 
alcohol. 
 
Scheme 138: TMS deprotection and side product formation 
Due to the formation of the dimer product 419 and generally low yields, the order 
of the TMS deprotection and aldehyde reduction were reversed. The reduction of 
2-[(trimethylsilyl)ethynyl]benzaldehyde 416 to the alcohol 420 was achieved with 
NaBH4 in ethanol. Following workup the crude 1H NMR contained only the desired 
product and 2-ethynylbenzyl alcohol in a 2:1 ratio and so was carried directly to 
the TMS deprotection. Treatment with K2CO3 in MeOH (Scheme 139) gave the 
desired product 418 in 74% over two steps. 
Scheme 139: Alternate route to 2-ethynylbenzyl alcohol 418 
The prepared 2-ethynylbenzyl alcohol 418 was reacted with 10 mol% 
CpRuCl(PPh3)2 in nbutylamine at 90 °C for 6 h. Within this time the starting 
material was consumed and the crude 1H NMR showed the peaks indicative of 
isochromene 265. However, there were many impurities present and due to the 
small scale of the reaction (13 mg) no purification was attempted.  
 
Scheme 140: Ruthenium catalysed cyclisation185 
As this route requires a greater number of reactions than that using homophthalic 
acid, using materials of greater expense, with no clear advantage in terms of 
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yield, it was abandoned as a method of preparing isochromene 265. Attention 
was therefore returned to the dehydration based isochromene preparation. An 
acetylation of 3-hydroxyisochroman was performed with acetic anhydride and 
pyridine with a 45% yield in order to provide a better leaving group. 
 
Scheme 141: Acetylation of 3-hydroxyisochroman 414 
Dehydration was first attempted using DBU in THF at room temperature. This 
saw no conversion after 24 h so the reaction was repeated at 50 °C but this saw 
no improvement in conversion. 
 
Scheme 142: Dehydration of 3-acetoxyisochroman with DBU 
Following a search of the literature, a palladium catalysed elimination to form an 
alkene was found using palladium acetate and calcium carbonate in toluene.187 
This failed to provide any conversion even after 3 days of reflux despite the 
literature seeing full conversion after 2 h. 
 
Scheme 143: Palladium catalysed isochromene formation 
There had been difficulties obtaining a mass spec for 3-acetoxyisochromene 421 
as it appeared to be degrading during the mass spec process. However, the 
major mass peak matched that of isochromene, suggesting that a 
decarboxylation was occurring at some point prior to data collection. With this in 
mind the controlled decarboxylation of 421 was attempted at 160 °C on a 2 mmol 
scale in an inert atmosphere. This did give isochromene as desired, but with an 
isolated yield of 3%, limiting its utility. 
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Scheme 144: Pyrolysis of 3-acetoxyisochroman 421 
At this point we returned to the original route as this seemed to be the most 
promising of making isochromene, providing a method of purification could be 
found. This was discovered via the quick distillation of the starting material 414 
through a short air column (Vigreux) under vacuum.188 It was important to use a 
Bunsen burner rather than an oil bath in order to ensure the air column was hot 
enough for distillation. This gave the desired product as a yellow oil in 80% yield 
(Scheme 145). With pure isochromene obtained, cross-dehydrogenative 
couplings could be investigated. 
 
Scheme 145: Synthesis of isochromene from 3-hydroxyisochroman 
2.3.2.3 Oxidant Screening 
As isochromene 265 could be more amenable to oxidation than isochroman 255, 
the initial conditions for CDC with benzoquinone were attempted (Schemes 113 
and 146). No conversion to 422 was observed under these reaction conditions. 
It was thought this could be due to isochromene 265 less readily undergoing 
hydride abstraction than isochroman 255. 
 
Scheme 146: Initial attempted isochromene functionalisation 
A range of nucleophiles (diethyl malonate, furan, phenol, allyl-TMS) were then 
screened with benzoquinone. However, no conversion was seen with any of the 
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screened nucleophiles, the reactions returning only starting material. The 
stronger oxidant DDQ was trialled as oxidant in place of benzoquinone with 1,3,5-
TMB 361 as the nucleophile and conditions otherwise remaining the same. This 
showed full consumption of isochromene 265 within 5 minutes by TLC, degrading 
to a complex mixture over 24 h (Scheme 147).  
 
Scheme 147: Attempted isochromene functionalisation with DDQ 
This degradation continued to be observed with decreasing temperatures until -
10 °C at which point a product was formed after 24 h. Isolation by column 
chromatography gave 423 in a 16% yield (Scheme 148). Presumably, this could 
be formed by protonation then electrophilic substitution into the enol ether double 
bond. There was also a large amount of degradation and some 
trimethoxybenzene dimer was also isolated in trace amounts. 
 
Scheme 148: Unexpected product 423 from DDQ oxidation at -10 °C 
Finally, in order to examine 1,3,5-TMB as a nucleophile, a literature procedure 
was attempted both with the allyl-tin nucleophile used in the literature procedure 
and 1,3,5-TMB.130 The desired product, 1-allyl isochromene 266 was isolated as 
per the literature in a 17% yield (lit. 79%), with large amounts of degradation 
observed by 1H NMR.130 When the reaction was repeated with 1,3,5-TMB as the 
nucleophile only degradation products were observed.  At this point it was 
decided to move away from isochromene 265 functionalisation with DDQ 403 as 
our conditions did not see conversion to the desired product. Attention was turned 
to other methods of oxidation that do not rely on DDQ. 
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Scheme 149: Formation of 1-allyl isochromene 
The functionalisation of the amine α-CH has been achieved using LED-sourced 
blue light to form polyhalogenated carbocations as the oxidant (Scheme 150, 
reaction A).53 We speculated whether the generated CCl3 radical could act in a 
similar manner with isochromene 165 or isochroman 255 to form the analogous 
oxonium cation. Isochroman 255 was used as a substrate rather than 2-phenyl-
1,2,3,4-tetrahydroisoquinoline 73 with either dimethylmalonate or 1,3,5-TMB, the 
conditions otherwise remaining constant (Scheme 150, reaction B). 
Isochromene 265 was also used as a substrate for oxidation without a 
nucleophile, with the reaction monitored by 1H NMR for the formation of 
chloroform (Scheme 150, reaction C).  
In reaction B no conversion was seen, with only starting material observed by 1H 
NMR and TLC. Isochromene 265 failed to show degradation when subjected to 
blue light in the reaction mixture, which would have shown its oxidation as 
discussed previously (Scheme 147). The literature procedure showed full 
conversion to the desired product after 24 h with aniline. This suggested that the 
desired CCl3 radical was forming as required by the proposed mechanism for 
hydrogen abstraction. However, the absence of chloroform in the monitoring 1H 
NMRs of the isochroman reactions suggest that the CCl3 radical was not 
abstracting hydrogen from isochroman or isochromene. 
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Scheme 150: Attempted polyhalogenated carbocation mediated 
functionalisation 
Several months after these light-mediated reactions were attempted Huo et al. 
published a paper using CBr4 as a catalytic oxidant to functionalise isochroman 
in air at 100 °C as shown (Scheme 151).189 This suggests that polyhalogenated 
carbons can find use as a method of generating an oxonium ion. However, there 
does not seem to be any particular use for this as a method of isochromene 
oxidation due to the high temperature required and the observed instability of the 
oxidised isochromene at even room temperature, as discussed above (Schemes 
147 and 150). 
  
Scheme 151: Literature CDC with CBr4 and oxygen 
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2.3.3 Conclusions 
This chapter has focussed on attempts to functionalise the C-H bond adjacent to 
an ethereal oxygen. Ultimately, although the functionalisation of isochroman saw 
an improved conversion rate of 24%, up from the 8% previously reported within 
the group, no further progress was achieved. Due to a lack of success and the 
saturated nature of the field, the decision was made to investigate the 
functionalisation of C-H bonds intramolecularly via a 1,5-hydride shift. It was 
decided that this would give a greater chance of success and could use some 
more mature chemistry from within the group, namely the nitro-Mannich reaction.  
2.4 The Functionalisation of C-H Bonds via a 1,5-Hydride Shift 
2.4.1 Proposed Research 
Since the 1,5-hydride shift is a fairly well studied method of forming carbon-
carbon bonds via the in situ generation of a tethered cation and anion we 
proposed the use of a tethered nitroalkene as the hydride acceptor to generate a 
nitronate and an iminium ion that could then rapidly ring close via a 6-endo-trig 
cyclisation.190,191 One example of this occurring was reported in the literature by 
Rabong et al., albeit in a very low yield with long reaction times, with 
stereochemistry assigned by NMR (Scheme 152).171 
 
Scheme 152: Literature precedent for 1,5-hydride shift/nitro-Mannich 
cyclisation 
We proposed to improve upon these conditions through a screening of Lewis and 
Brønsted acids as well as solvents. In addition, as Rabong et al. only report this 
transformation for 357 and for the piperidinyl derivative, in the latter case only by 
TLC, we were further seeking to improve the scope of this reaction beyond a 
single substrate. During the course of our studies into the scope of the 1,5-hydride 
shift mediated cyclisation we developed, Kim et al. published an analogous 
Sc(OTf)3 catalysed cyclisation.192 The authors reported yields between 62-99% 
albeit with a more limited substrate scope than was eventually achieved. 
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2.4.2 Synthesis of Starting Materials for Synthetic Development 
The first nitroalkene 425 that we planned was expected to provide a simple 
example of an intramolecular nitro-Mannich reaction as shown in Scheme 153. 
It was proposed that 425 could be prepared from tetrahydroisoquinoline (THIQ) 
428 in two steps. First the secondary amine of THIQ 428 could be reacted with 
homoallyl bromide 429, with the resulting compound being nitrated directly as 
had previously been achieved with non-amine containing substrates.193 
 
Scheme 153: Ring formation via a 1,5-hydride shift followed by nitro-
Mannich cyclisation 
As a result, the first synthetic target was 430, (Scheme 154). The first reaction 
attempted towards this was an amination of 429 to give 430 with K2CO3 to act as 
a proton scavenger following SN2 attack of homoallyl bromide to form an 
ammonium ion. This gave full conversion by 1H NMR after 72 h (Scheme 154) in 
a reaction based upon the analogous procedure with allyl bromide to form 2-allyl-
1,2,3,4-tetrahydroisoquinoline 430.194  
 
Scheme 154: Initial synthesis of 2-(but-3-en-1-yl)-1,2,3,4-THIQ 
A modification of this reaction with catalytic quantities of KI was used to shorten 
the reaction time to 18 h through a Finkelstein reaction.195 This modified reaction 
proceeded well, giving an 81% yield of 430 as a brown oil that was judged >95% 
pure by 1H NMR following removal of baseline impurities with a silica plug.  
A method of directly preparing nitroalkenes from alkenes was developed by Maity 
et al.193 Here an NO2 radical adds to an alkene to generate a carbon centred 
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radical 431.193 TEMPO is then reduced via hydrogen abstraction to regenerate 
the alkene, exclusively giving the E isomer (Scheme 155).   
Scheme 155: Literature nitration of alkene with AgNO2/TEMPO193 
The nitration conditions developed by Maity were applied to 430 (Scheme 156). 
However, this nitration did not proceed as desired, causing degradation into a 
mixture of products with no clear formation of the desired nitroalkene. This could 
be due to the amine in 430 chelating to the AgNO2 or TEMPO oxidising 430. 
There are no literature examples of this reaction being performed successfully on 
amine containing substrates.193 
  
Scheme 156: Synthetic route to nitro-Mannich precursor 
A new route for nitroalkene synthesis using a modified Henry reaction with 
nitromethane was considered. One possible route to the aldehyde required could 
be from 430 via ozonolysis (Scheme 157). 
 
Scheme 157: Alternate route to desired nitroalkene 425196 
Ozonolysis of 430 was attempted, giving 433 in trace quantities (10 mg, 2%) with 
impurities present and all starting materials consumed. The product was not 
successfully isolated, instead coeluting with a mixture of complex degradation 
products when purification was attempted via column chromatography (EtOAc) 
(Scheme 158). 
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Scheme 158: Ozonolysis of 430 
As traditional ozonolysis failed, a Lemieux-Johnson oxidation, an alternate 
“chemical ozonolysis”, was attempted with osmium tetroxide and sodium 
periodate (Scheme 159). This was performed with a mixtutre of dioxane and 
water as the solvent but 1H NMR showed mostly starting material and 
degradation products after 1.5 h, with no aldehyde peaks present, the starting 
material being recovered in an 84% yield. 
 
Scheme 159: Lemieux-Johnson oxidation of 430 
A second “chemical ozonolysis” with ruthenium chloride and sodium periodate 
was attempted.197 This gave amide 434 as a brown oil (41%) rather than the 
desired aldehyde (Scheme 160). A subsequent search of the literature showed 
ruthenium oxide has been used as a method of oxidising amines to amides.198 
The ruthenium oxide generated in situ from the reaction of ruthenium chloride 
and sodium periodate (Scheme 160) selectively oxidised the benzylic amine of 
434 over cleaving the alkene. 
 
Scheme 160: Formation of 434 with RuCl3 catalysis 
Oxidation of a precursor alcohol 436 was considered as a route to the aldehyde 
433. We thought the alcohol 436 could come from the hydroboration of 435. 
Alkene 435 was prepared by reaction of allyl bromide and 428 in a 43% yield (lit. 
53%) (Scheme 161).194 Hydroboration with 9-BBN was attempted with 435, 
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though, after base peroxide workup the crude 1H NMR showed <5% conversion 
with 95% of 435 remaining. 
Scheme 161: Initial route to 436 
At this point a search through the chemical literature found a procedure to prepare 
214 directly from cyclic secondary amines and 3-chloro-1-propanol. This was 
performed on piperidine 437. It was not possible to move 214 from the baseline 
on silica so the product was used impure for an oxidation with Dess-Martin 
Periodinane. This crude material did not oxidise to give an aldehyde but it was 
not clear from the crude 1H NMR what had happened, with a complex mixture of 
products observed (Scheme 162).  
 
Scheme 162: Synthesis of 214 and attempted Dess-Martin oxidation 
Conjugate addition of amines to acrolein 439 to generate species such as 440 
has literature precedent, however β-amino aldehydes generated in this manner 
are unstable and prone to polymerisation when isolation is attempted.199 The use 
of benzylic amines causes the reaction to fail.199 Nevertheless the reaction of 
pyrrolidine 102 and acrolein 439 was attempted with catalytic quantities of DBU 
with both THF, the literature solvent for the reaction of pyrrolidine 102 and 
acrolein, and MeNO2 as a solvent (Scheme 163). After 15 min at -15 °C an aliquot 
was taken and submitted for 1H NMR. With THF as a solvent multiple aldehyde 
peaks were present in the crude 1H NMR but the 13C NMR showed a range of 
products and did not match the literature peaks for 440.199 However, it is possible 
that the product polymerised in the NMR tube prior to 13C NMR collection and no 
1H NMR data are reported.199 The use of MeNO2 as solvent led to degradation 
immediately upon the addition of acrolein; as such this did not seem to provide a 
promising route towards the synthesis of nitroalkenes in situ. 
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Scheme 163: Attempted conjugate addition of acrolein 439 to pyrrolidine 
102199 
As the desired aldehyde 440 could not be prepared successfully via conjugate 
addition or from alkene 430, attention was turned to the protected aldehyde 442. 
This was prepared from 428 and 441 in a 67% yield after 48 h (Scheme 164). 
 
Scheme 164: Preparation of protected aldehyde 442 
With 442 prepared, a range of deprotections were screened. First a procedure 
using 0.2 eq iodine in acetone was attempted (Scheme 165).200 This returned 
starting material only even after 72 h (lit. 45 min).200 The tertiary amine present in 
442 may be the cause of the lack of reaction as there are no amine containing 
compounds deprotected in this manner in the published literature.200 
 
Scheme 165: Iodine mediated deprotection 
A deprotection with HCl was then attempted at a range of molarities (table 8). At 
12 M full consumption of the starting material was observed, however the crude 
1H NMR showed a ratio of 1:20 for the aldehyde:aromatic peaks, rather than the 
1:4 expected. The 6 M HCl solution again showed full consumption but the 1H 
NMR showed degradation to a complex mixture. This reaction was performed 
separately to the others with a pre-prepared solution of 6 M HCl rather than one 
prepared from dilution of 12 M HCl immediately prior to reaction so it is possible 
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that this reaction was cross-contaminated. This could be the reason for the 
difference in results but this reaction was left as an anomaly as the obtained ratios 
were not useful. The ratio of aldehyde to aromatics for the 3 M solution was 1:46 
suggesting poor conversion and at 1.5 M the ratio was 1:55. These results 
suggest that HCl will deprotect the acetal as desired but at too strong a molarity 
a mixture of unwanted side products were also formed. 
 
Scheme 166: HCl mediated deprotection 
Table 8: Conversion to aldehyde at a range of HCl concentrations 
HCl Molarity 
Quantity of 442 
(mmol) 
Time (h) 
Ratio aldehyde:aromatic 
peaks 
1.5 0.25 1 1:55 
3 0.25 1 1:46 
6 1 1 n/a 
12 0.25 1 1:20 
 
The direct nitration of alkenes by Maiti et al. has been shown to work with alkenyl 
bromides.193 We therefore proposed to prepare nitroalkene 444 directly and then 
react this with tetrahydroisoquinoline 428 directly to form 425. However, the 
desired nitroalkene 444 may be volatile so a two-step reaction was attempted. 
Homoallyl bromide 443 was subjected to the nitration conditions as discussed 
above for 18 h then 428 was added with K2CO3 and the reaction stirred at 80 °C 
for a further 18 h (Scheme 167). Rather than forming the desired product 425, 
430 was isolated in a 34% yield. It seems likely that the nitration did not proceed 
as desired. 
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Scheme 167: Attempted synthetic route to 425 and isolated product 430 
As the synthesis of amine containing nitroalkene substrates was proving 
challenging, attention was turned to materials which did not contain an amine 
moiety. First 447 was prepared from benzyl bromide 445 and homoallyl alcohol 
446 in a 99% yield (Scheme 168). 
 
Scheme 168: Preparation of alkene 447 
This alkene was then subjected to the nitration conditions of Maiti et al. that 
caused the degradation of the corresponding amino alkene 430.193 This gave the 
desired product in a 5% yield with large amounts of degradation, including the 
formation of benzaldehyde (Scheme 169). This suggested that the reaction 
conditions were oxidising the benzylic ether, leading to the formation of a 
hemiacetal which then cleaved to form benzaldehyde either during the reaction 
or workup. 
 
Scheme 169: nitration of alkene 447 
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A further route to 448 via the aldehyde 451 was followed starting from benzyl 
bromide 445 and 1,3-propane diol 449 (Scheme 170).201 The desired alcohol 450 
was isolated in a 20% yield with respect to benzyl bromide after 18 h at rt. 
 
Scheme 170: Preparation of alcohol 450 
Oxidation of 450 was performed with DMP in DCM at rt (Scheme 171). This gave 
complete conversion by TLC after 3 d and the crude 1H NMR showed mostly 
product with minor impurities. However, the crude product polymerised in air 
during workup before purification was attempted. 
 
Scheme 171: DMP oxidation of 450 to give 451 
The oxidation of 450 was then repeated with the crude material telescoped into 
a Henry reaction.196 This gave trace conversion by 1H NMR following 18 h of 
reflux and 448 could not be isolated (Scheme 172).  
 
Scheme 172: Attempted reaction of 451 to give 448 
In tandem the synthesis of other amine substrates was attempted, first looking to 
prepare 454. This was reported in the only literature example, published by 
Rabong et al, of a 1,5-hydride shift with a nitroalkene moiety.171 Piperidine was 
reacted with 2-fluorobenzaldehyde in DMF to give 453 in a 53% yield (lit 95%)202 
as a yellow oil following purification by column chromatography (Scheme 174).  
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Scheme 174: Preparation of 453 
The prepared aldehyde 453 converted to a nitroalkene via a Henry reaction to 
give nitroalkene 454 in a 40% yield as a red oil (lit. 65%) (Scheme 175).171 This 
gave enough material for an investigation into the 1,5-hydride shift as a route into 
nitro-Mannich cyclisation to proceed. 
  
Scheme 175: Henry reaction of 453 to form 454 
Similarly moderate yields were seen when forming the pyrrolidinyl derivative 357. 
This analogue 357 was prepared in a 35% yield after 3 h, with the initial aldehyde 
290 being formed in a 65% yield (Scheme 176).  
 
Scheme 176: Preparation of 357 
As a result, a range of other reaction conditions were trialled. A two-step Henry 
reaction used within the group previously was followed.203 First the aldehyde 290 
was reacted with an excess of nitromethane in methanol with NaOH (aq) and HCl 
(aq) to give a mixture of the desired nitroalkene and alcohol 455. This was then 
converted to the alkene with mesyl chloride and DIPEA to give 357 in a 7% yield 
following purification via column chromatography (Scheme 177). 
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Scheme 177: Alternate route to 357203 
Secondly a published method for a similar compound was followed using 
ammonium acetate in acetic acid.204 Though this was claimed to form similar 
species in high yield only degradation was observed when the procedure was 
followed using 290 (Scheme 178). 
 
Scheme 178: Attempted alternate formation of 357 
No other conditions attempted gave an improved yield compared to the conditions 
modified from Rabong et al.171 As a result a systematic optimisation of this 
reaction (Scheme 179) was performed (Table 9). A range of temperatures were 
trialled, with 90 °C giving the best conversion by HPLC. The addition of molecular 
sieves reduced the conversion observed and a tweak of the equivalents of KF 
and Me2NH.HCl raised conversion to 72% This saw an increase in isolated yield 
from the 35% originally seen to 60% (Table 9 reaction E).  
 
Scheme 179: General conditions for the formation of 357 
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Table 9: Reaction screening for the formation of 357 
Reaction Temperature (°C) Eq KF Eq Me2NH.HCl Additive Yield* 
A 110 0.25 2 n/a 45% 
B 100 0.25 2 n/a 66% 
C 90 0.25 2 n/a 68% 
D 110 0.25 2 4 Å MS 52% 
E 90 0.19 1.5 n/a 72%† 
*Yield determined by HPLC. †Yield determined to be 70% by crude 1H NMR with an 
internal standard, isolated yield of 60% following column chromatography 
2.4.3 Reaction Screening Towards a Suitable Lewis/Brønsted Acid 
With the route to 357 optimised, a screen of methods to promote a 1,5-hydride 
shift reaction was performed. Initially the sole literature example of a 1,5-hydride 
shift mediated cyclisation with a nitroalkene was repeated (Scheme 180).171 Here 
357 was heated in nBuOH at 118 °C for 90 h, giving 358a in a 5% isolated yield 
(lit. 25%). 
 
Scheme 180: Repeat of the literature cyclisation to form 358a171 
Briones et al. reported, in 2016, a Lewis acid mediated 1,5-hydride shift with a 
nitro-acrylate hydride acceptor.170 This is the only example of a 1,5-hydride shift 
featuring a nitro group following the work by Rabong et al., discussed above. 
Here Mg(OTf)2 was used to catalyse the formation of bicycle 360 as a key 
intermediate in the synthesis of spirocycles as a route towards 
tetrahydroquinoline-3-spirohydantoin derivatives (Scheme 181). The presence of 
the acrylate was essential for the reaction to proceed, with no conversion 
observed in the nitrostyrenyl analogue of 360, as discussed below. 
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Scheme 181: Literature route featuring Lewis acid catalysis170 
The reaction conditions published by Rabong et al. were repeated with toluene in 
place of nBuOH in order to investigate whether the alcohol was acting as a 
Brønsted acid mediating the cyclisation or if it occurred without the need for an 
external reagent (Scheme 182). No reaction was seen, with only degradation 
observed over the course of 80 h. 
 
Scheme 182: Attempted cyclisation with toluene 
The conditions of Briones et al. were applied to 357 (Scheme 183). Here no 
conversion was seen, even when extending the length of reaction from 30 min to 
18 h. 
 
Scheme 183: Attempted Mg(OTf)3 catalysed cyclisation 
This result was notable for its lack of conversion. This suggests that, rather than 
the nitro group of the nitro-acrylate being crucial to the cyclisation, it is the vinyl 
ester-Lewis acid interaction which allows the cyclisation to proceed. This is 
perhaps unsurprising as the use of vinyl esters in 1,5-hydride shift cyclisations is 
well documented.135,145,161 
As neither literature procedure provided a useful cyclisation, a screen was 
performed with common Lewis acid catalysts used for 1,5-hydride shifts. These 
reactions were performed with either (E)-1-(2-(2-nitrovinyl)phenyl)pyrrolidine 357 
or (E)-1-(2-(2-nitrovinyl)phenyl)piperidine) 454. First BF3.OEt2, one of the most 
widely used Lewis acids, was added to a solution of 454 in DCM at room 
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temperature (Scheme 184).135,154,157,160,165,205,206 Upon the addition of BF3.OEt2 
an orange precipitate was formed and the starting material 454 appeared fully 
consumed by TLC. However, following aqueous workup, only starting material 
was recovered, suggesting the BF3.OEt2 was coordinating strongly to 454 to form 
a material insoluble in DCM. As no hydride shift was observed it is likely that 
coordination was to the tertiary amine rather than the nitro group as hoped. 
 
Scheme 184: General Scheme for attempted cyclisation 
Another common Lewis acid catalyst for 1,5-hydride shifts is 
Sc(OTf)3.148,154,157,161–163 (E)-1-(2-(2-nitrovinyl)phenyl)piperidine) 454 was 
dissolved in DCM at room temperature and 5 mol% Sc(OTf)3 was added. Here 
no reaction was observed after 18 h at room temperature, with only starting 
material recovered. No reaction was seen upon heating to reflux or the addition 
of 1 eq of Sc(OTf)3. 
As no degradation was observed, cyclisation of 454 was attempted again with 1 
equivalent of Sc(OTf)3, in a higher boiling solvent DCE, which allowed the 
reaction to be performed at 80 °C, albeit as a heterogenous mixture. This initially 
showed a new material forming by TLC after 18 h, with starting material still 
present. After 36 h the crude 1H NMR was unclear and the majority of the 
recovered material was insoluble, which suggested that polymerisation may have 
occurred. This could be due to the Sc(OTf)3 either not dissolving in DCE or only 
partially dissolving. However, DCM has previously been successfully used as a 
reaction solvent with Sc(OTf)3.135 
Titanium Lewis acids were also trialled. Titanium tetrachloride (5 mol%) was used 
with DCM and stirred at rt. The reaction turned cloudy and a new spot appeared 
on the baseline in addition to the spot corresponding to the starting material when 
the reaction was visualised by TLC but this disappeared if a workup was 
performed prior to running the TLC as with BF3.OEt2 (Scheme 185). It seemed 
likely that TiCl4 was chelating preferentially with the amine in 454 rather than the 
nitro group. 
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Scheme 185: TiCl4 as the Lewis acid catalyst 
Titanium isopropoxide (5 mol%) was used as a Lewis acid to generate a 
comparison to TiCl4 (Scheme 186). After 18 h there was no sign of conversion, 
but after 4 d there was potential conversion by TLC, with a new spot appearing 
that matched that from the cyclisation in nBuOH (Scheme 180). This new product 
was not visible in the crude 1H NMR, suggesting conversion was very poor. 
 
Scheme 186: Ti(iOPr)4 as the Lewis acid catalyst 
SnCl2 was used as a Lewis acid (Scheme 187) as tin species have previously 
been used as Lewis acids for conjugate addition to nitroalkenes.207 This was used 
in 0.5 eq in two experiments for 4 d at rt and 18 h at reflux in nBuOH. In the former 
case starting material was recovered with a minor quantity of degradation and in 
the latter case the starting material polymerised to give an insoluble black 
material. 
 
Scheme 187: Attempted cyclisations with SnCl2 as Lewis acid 
Following a literature search, copper triflate was identified as a promising Lewis 
acid, having previously been used to catalyse conjugate addition to aliphatic and 
aromatic nitroalkenes.208,209 Furthermore, these reactions proceeded in the 
presence of chiral ligands, leading to good to excellent enantioselectivities. 
Copper triflate was therefore used as a Lewis acid, again with 0.5 eq at rt for 4 d. 
As with SnCl2 this gave mostly starting material with a small amount of 
degradation (Scheme 188).   
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Scheme 188:  Attempted cyclisation with Cu(OTf)2 as Lewis acid 
We considered it possible that the nBuOH solvent was ligating to the copper 
species present to the extent that it was preventing the copper triflate from 
effectively catalysing the desired cyclisation. As a result, copper triflate (10 mol%) 
was then screened with (E)-1-(2-(2-nitrovinyl)phenyl)pyrrolidine 357 in MeCN at 
reflux. After 18 h there was apparent conversion by TLC, with a faint product spot 
appearing, but this product could not be isolated due to the small amount of 
material present (Scheme 189). 
 
Scheme 189: Cu(OTf)3 as the Lewis acid catalyst 
As discussed above, gadolinium triflate has been reported as successfully 
catalysing the cyclisation of 360 by Briones et al, though the presence of the vinyl 
ester there proved key.170 Accordingly, gadolinium triflate (10 mol%) was used as 
a Lewis acid in MeCN at reflux (Scheme 190). An isolated yield of 33% was 
obtained as a single diastereomer. This was notable as being the best yield we 
had observed for a Lewis acid catalysed cyclisation of a nitroalkene via a 1,5-
hydride shift and took the isolated yield of 358 above that reported of the thermal 
reaction in the literature.171 
 
Scheme 190: Gd(OTf)3 as Lewis acid catalyst 
With the yields of Lewis acid catalysed cyclisations disappointing, attention was 
turned to the use of Brønsted acid catalysts for 1,5-hydride shift cyclisations. 
Thiourea catalysts have previously seen use in mediating conjugate additions to 
nitroalkenes, including the intermolecular addition of a hydride from a Hantzsch 
ester to form a nitronate.210–212  A non-chiral thiourea catalyst 457 was chosen as 
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the organocatalyst for an attempted cyclisation. The nitroalkene 454 was stirred 
with 5 mol% 457 for 18 h at rt in toluene, with no conversion by TLC (Scheme 
191). The reaction was then heated to reflux for 42 h, several new spots then 
appeared by TLC but the starting material was still the major substrate visible. 
The desired product was not visible by TLC, in line with the lack of conversion 
observed at reflux in toluene without the presence of a catalyst. 
 
Scheme 191: Thiourea catalysed cyclisation attempt 
Subsequent to our studies, Kim et al. published a thiourea catalysed cyclisation 
of nitrostyrenes analogous to our work.213 The authors discovered that thiourea 
459 in toluene effectively catalyses the 1,5-hydride shift with compounds 460, 
giving yields between 35-93% other than the piperidinyl substrate 456, where 
only trace conversion was observed, in line with our own findings (Scheme 192).  
 
  
Scheme 192: Literature thiourea catalysed cyclisation213 
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With no conversion seen by TLC with a catalytic amount of an H-bonding catalyst, 
fluoroalcohol solvents were considered as a potential H-bonding solvent. These 
compounds show greater acidity than the equivalent alcohols which we proposed 
would allow a stronger H-bonding interaction with the oxygens of the nitro group, 
promoting the desired cyclisation. Trifluoroethanol was chosen as solvent 
(Scheme 193). After 9.5 h nitroalkene 357 was fully consumed by TLC, with some 
degradation apparent. Upon workup and purification via column chromatography 
the desired cyclised product 358a was obtained in a 55% isolated yield as a single 
diastereomer. 
 
Scheme 193: Cyclisation of 357 with trifluoroethanol 
Following the increased yield from moving to trifluoroethanol from nBuOH, this 
reaction was repeated with HFIP as solvent. HFIP is also widely used as a solvent 
for polymers based upon its increased ability to solvate through H-bonding.214 
This reaction saw the isolated yield of 358a increase to 90% whilst still generating 
a single diastereomer within 4 hours at 58 °C (Scheme 194). However, the use 
of HFIP in stoichiometric amounts with toluene or DCM as solvent saw no 
conversion, with only starting material recovered. 
 
Scheme 194: HFIP as solvent and Brønsted acid 
2.4.4 Scope of the HFIP Catalysed 1,5-Hydride Shift 
With the success of cyclisation of 357 with HFIP, attention was turned to the 
scope of the reaction. First the reaction was performed with the piperidinyl 
analogue 454 (Scheme 195). The larger 6-membered ring inhibited the reaction, 
leading to a reduced yield of 65% and an increased reaction time for full 
consumption of nitroalkene 454, going from 4 h to 18 h. 
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Scheme 195: The cyclisation of 454 with HFIP 
In addition to amines, an ethereal substrate 465 was prepared from salicyl 
aldehyde 463. It was thought that the adjacent benzyl group could promote 
hydride transfer via the stabilisation of the generated carbocation (Figure 2).  
 
Figure 2: stabilisation of generated positive charge in 465 
This was prepared via using conditions published by Waters et al. to prepare tert-
butyl-dimethyl-[1,4,5,7,8-pentamethoxy-3-(2-nitro-vinyl)-naphthalen-2-yl meth-
oxy]-silane as an intermediate towards the synthesis of purpuromycin.215 First 
salicyl aldehyde 463 was benzylated in ethanol with K2CO3 to act as a proton 
scrubber (Scheme 196). Following purification, aldehyde 464 was used directly 
in a Henry reaction to give the nitroalkene 465. This was formed in acetic acid 
with nitromethane and ammonium acetate (Scheme 196).  
Scheme 196: Henry reaction to form 465 
The nitroalkene 465 was heated in HFIP as with 357 and 454 (Schemes 194 and 
195). Here no reaction was observed, with only starting material recovered after 
18 h (Scheme 197). We believe that the increased electronegativity of the oxygen 
in 465 inhibited the reaction. Crucially, no reduction of the nitroalkene or 
debenzylation was observed, suggesting that no hydride shift was occurring.  
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Scheme 197: Attempted cyclisation with 465 and HFIP 
An amino analogue of 465 was prepared, (E)-N-benzyl-N-methyl-2-(2-
nitrovinyl)aniline 468 to investigate benzyl N-CH in the hydride shift. The amino 
aldehyde 467 was prepared from 2-fluorobenzaldehyde 452 via an SNAr reaction 
as with amino aldehydes 290 and 453. This aldehyde 467 was then transformed 
to the corresponding nitroalkene 468 using the optimised Henry reaction as 
described above (Scheme 198). This gave the nitroalkene 468 in a 28% yield. 
 
Scheme 198: Formation of 468 via Henry reaction 
Once nitroalkene 468 was prepared it was heated in HFIP (Scheme 199). Here, 
as with 464, no conversion was observed.  
 
Scheme 199: Attempted cyclisation of 468 with HFIP 
The increased difficulty of a 1,5-hydride shift from a benzyl group was observed 
by Pastine et al, where an increased quantity of the BF3.OEt2 catalyst (5 to 75 
mol%), time (12 to 45 h) and  temperature (rt to 50 °C) was required to achieve 
cyclisation of 470 compared to the equivalent tetrahydrofuran 328 (Scheme 
200).135 
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Scheme 200: Cyclisation with a cycloalkyl ethereal substrate vs a benzyl 
ethereal substrate135 
Following the lack of success of HFIP with benzylic substrates, (E)-N-benzyl-N-
methyl-2-(2-nitrovinyl)aniline 468 was reacted with Gd(OTf)3 as the best 
performing Lewis acid catalyst (Scheme 201). Conversion was seen to give 469 
as a mixture of diasteromers in a <5% isolated yield. Further investigations into 
the use of gadolinium triflate to catalyse 1,5-hydride shift reactions were therefore 
performed to optimise the yields and extend the scope of substrates beyond 
those with which HFIP allowed successful cyclisation. 
 
Scheme 201: Initial Gd(OTf)3 catalysed cyclisation of 468 
2.4.5 Improvement of Reaction Conditions 
The Gd(OTf)3 catalysed cyclisation conditions had shown minor success with 357 
and 468 (Schemes 190 and 201). As the higher yields obtained when using 
fluorinated alcohols had been discovered shortly after Gd(OTf)3 was first 
screened, no work had been done towards the optimisation of the reaction 
conditions. Attention was first turned towards the choice of solvent for this 
catalyst. A mixture of 357 and 50 mol% Gd(OTf)3 were added to a range of 
solvents (Scheme 202). TIBCO Spotfire® was used to visualise principal 
component analysis (PCA), whereby solvent data from an internal AstraZeneca 
database was arranged by orthogonal “properties”. The axes used to portray the 
solvents in 3D space were not linked to specific properties (e.g. boiling point or 
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dielectric constant) but instead were functions generated from these properties. 
From this 3D visualisation it was possible to divide solvents which should behave 
similarly into octants of “chemical space” and one solvent was picked from each 
octant to screen.  
 
Scheme 202: General conditions for solvent screen 
Each reaction was heated to 60 °C for 12 h with aliquots taken at t = 0, 0.33, 0.67, 
1, 2, 3, 4, 6, 8 and 12 h and monitored by HPLC (table 10). As degradation was 
observed under some conditions the time chosen for comparison was when the 
percentage area of the product peak was at its greatest for each set of conditions. 
Whilst MeCN was used in the initial catalyst screen, it was observed to perform 
poorly as a solvent in these conditions with the product peak accounting for 47% 
of the total peak area. Perhaps surprisingly toluene appeared to perform best, 
with a 94% conversion after 12 h and very little side product formation or 
degradation occurring despite the reaction proceeding more slowly than with 
MeCN and 2MeTHF, for example. 
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Table 10: Solvent screen with Gd(OTf)3 
Solvent Time (h) 
Area of HPLC 
Product Peak 
Observations 
DMF 12 0% - 
Toluene 12 94% Clean conversion 
MeCN 4 47% Major degradation peak 
2MeTHF 3 65% Several degradation peaks 
IPA 4 41% Large range of products 
p-Xylene 12 75% 20% starting material 
1-hexanol 6 46% Large range of products 
NBu
3
 12 0% - 
 
The percentage area for the desired product 358 steadily increased over the 
course of the 12 h of monitoring with toluene as solvent and so a series of 
experiments was performed in order to find the optimal conditions for cyclisation 
with Gd(OTf)3 and toluene (table 11). The concentration of the reaction mixture, 
the temperature of reaction and the catalyst loading were each compared and 
modified to create a reaction map. 
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Table 11: Reaction map for condition optimisation 
Entry 
Concentration 
(g/mL) 
Gd(OTf)
3
 
(mol%) 
Temp 
(°C) 
Time 
(h) 
Area of HPLC Peak 
(% of total area) 
A 0.01 10 50 24 0 
B 0.01 10 100 4 90 
C 0.01 60 50 24 7 
D 0.01 60 100 2 94 
E 0.1 10 50 24 27 
F 0.1 10 100 12 94 
G 0.1 60 50 24 44 
H 0.1 60 100 1 94 
I 0.055 35 75 16 97 
 
Unsurprisingly it was found that a higher catalyst loading, higher reaction 
temperature and a more concentrated reaction mixture led to a faster reaction 
time. It was found that the reaction was greatly temperature dependent, with no 
conversion observed at 50 °C with low catalyst loading. Even at high catalyst 
loading and concentration the product area peak did not get above 44% (table 
11, entry G). It was decided to use the conditions in entry F (table 11) with 357 
in order to obtain an isolated yield of the cyclised product 358a and determine 
the relationship between HPLC area and directly quantifiable yields (Scheme 
203). Entry F was selected as providing the best compromise between catalyst 
loading, reaction time, and yield. This gave the product 358a as the anti 
diastereomer in a 79% yield. 
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Scheme 203: Optimised conditions to form 358a 
Two further lanthanide triflates were then trialled as Lewis acid catalysts with 357, 
using the reaction conditions optimised for Gd(OTf)3 (Scheme 204). A conversion 
of 14% was observed by HPLC with ytterbium triflate and no conversion was 
apparent after 12 h with cerium triflate. 
 
Scheme 204: Cyclisation to form 358a with other Lanthanide triflates 
Lanthanide triflates are known to exist in an equilibrium between the Ln(OTf)3 and 
Ln(OTf)2+ + -OTf species.216 As a result, trace amounts of triflic acid are present. 
Cyclisation with triflic acid in toluene was attempted to determine whether triflic 
acid was capable of catalysing the cyclisation rather than Gd(OTf)3 as we 
believed (Scheme 205). No conversion was observed over the course of 12 
hours, reaffirming that Gd(OTf)3 was indeed responsible for the formation of 
358a. This result was in line with our experience with other Brønsted acid 
catalysts, none of which provided detectable levels of conversion when present 
in catalytic or stoichiometric amounts (see Schemes 191 and 194, above). 
 
Scheme 205: Attempted cyclisation of 357 with triflic acid 
The optimised Gd(OTf)3 conditions were then applied to (E)-N-benzyl-N-methyl-
2-(2-nitrovinyl) aniline 468 (Scheme 206). Here conversion proceeded slowly, 
with very limited conversion observed until the addition of 30 mol% Gd(OTf)3, at 
which point full conversion was reached within 12 h. Upon repetition of this 
reaction with 30 mol% Gd(OTf)3 at the outset, conversion was obtained within 
12 h, giving the desired product in a 67% yield as a mixture of diastereomers (2:1 
anti:syn) (Scheme 206). 
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Scheme 206: Cyclisation to form 469a 
The 1H NMR of the major diastereomer 469a showed a loss of nitroalkene proton 
shifts compared to the starting material 468, with the corresponding peaks shifted 
greatly downfield, in line with the shifts seen with 358, above. The previous benzyl 
CH2 singlet (δ 4.13) was replaced with a pair of multiplets (δ 3.42, 3.01), which 
were assigned as being HA and HB. The multiplet observed at δ 4.84 was seen to 
couple to both benzyl protons and was shown to be attached to the CNO2 carbon 
by 13C-1H correlation, the CNO2 carbon being assigned by analogy to the CNO2 
carbon shift in 358a, this multiplet was therefore assigned as Hc. The final non-
aromatic proton peak present in the 1H NMR was an apparent singlet at δ 5.19 
which was assigned as HD. Unlike the pyrrolidinyl analogue 358a the NCH proton 
in 469a was further shifted than the CHNO2 proton. This was apparent from the 
HSQC spectrum (Figure 3).  
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Figure 3: Coupling between ring protons and C-H coupling for NCH and 
CHNO2 
Despite appearing as a singlet, HD, δ 5.19, (1H, s) showed a small coupling to HA 
δ 3.42 (1H, ddd, J = 16.8, 3.7, 1.4 Hz) as well as to HC δ 4.84 (1H, apparent dd, 
J = 7.8, 3.9 Hz), whereas HC coupled to both HA δ 3.42 (1H, ddd, J = 16.8, 3.7, 
1.4 Hz), and HB δ 3.01 (1H, dd, J = 16.8, 4.4 Hz). The small values of the coupling 
constants suggests that the dihedral angle between HC and HD is around 90°. 
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The NOESY spectrum showed faint coupling between HA and HD which suggests 
that they both sit on the same face, whereas no coupling was seen between HB 
and HD. HD did show strong coupling to the adjacent NCH3 group, reaffirming the 
assignment of this peak. HA and HB have a coupling constant between them of 
16.8 HZ, as would be expected for geminal ring protons.  
HC appears to be a double doublet, however, there are merged peaks and 
comparison to the splitting patterns of HA and HB suggest couplings of 3.7 and 
4.4 HZ respectively. This is in line with a flattened ring system with an unsaturated 
C-C bond, where 3Jax-eq and 3Jeq-eq would be expected to fall between 2-4 HZ 
(Figure 4). In a partially unsaturated 6-membered ring, 3Jax-ax would be expected 
to be in the range of 10-12 HZ. This level of splitting is not observed between 
CHNO2 and the adjacent CH2, we can therefore determine that the CHNO2 proton 
sits equatorially and at an angle that leads to an undetectable level of splitting 
with the adjacent NCH (Figure 4, Quinoline1).  
If we consider these splittings together, the conclusion is that both the nitro- and 
phenyl- groups sit in a more axial position, which can be rationalised as 
minimising the steric interaction between these more bulky groups. This 
assignment was corroborated by computational modelling (table 12, Figure 4), 
which compared the energy of the proposed diaxial anti- product (Quinoline2) to 
that of two cis- conformers (Quinoline1 and Quinoline3). These calculations gave 
the diaxial anti- product suggested by NMR as lower energy than either cis- 
conformer, with the highest energy arrangement calculated to be that of 
Quinoline3, where the Ph group is in an equatorial position. Energies were 
calculated using B3LYP/6-31G* with the relative energies listed in table 12.b 
These values are relative to the lowest energy isomer (Quinoline2). 
Energies are in Hartrees, 1 Hartree = 27.2114 eV. 
 
 
 
 
                                            
b Energies calculated by David Freeman 
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Table 12: Calculated energies of possible conformers 
Isomer Designation Calc Energy 
Relative 
Energy 
(Hartree) 
Relative 
Energy (kJ 
mol-1 
 
Quinoline1 -879.19455451 0.00017632 0.46 
 
Quinoline2 -879.19473083 0 0 
 
Quinoline3 -879.18771543 0.00701540 18.42 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                            Oliver Ware 
128 
 
Quinoline1    Quinoline2 
 
 
 
Quinoline3 
 
Figure 4: Calculated spatial arrangements of 469 
A method of cyclisation which worked with both 357 and 468 had therefore been 
developed that was considerably more efficient than the single literature report.171 
A compound library with which to investigate the scope of the 1,5-hydride shift as 
a route into nitro-Mannich cyclisations was therefore required.  
2.4.6 Preparation of Nitroalkene library 
The preparation of nitroalkenes suitable for cyclisation via the conditions were 
prepared by the route optimised for the synthesis of 357. The decision was made 
to prepare separate groups of nitroalkenes to cover a broad range of potential 
reactivities. Our initial groups fell into 5 categories. Group A (Figure 5) was 
designed to investigate the effect of ring size and the presence of heteroatoms 
within the ring on the reaction. 
                                                                                                            Oliver Ware 
129 
 
 
Figure 5: Group A target compounds 
Compounds 357 and 454 had previously been prepared via an SNAr reaction 
followed by a Henry reaction when preparing substrates with which to screen for 
cyclisation reaction conditions. This route was therefore applied to compounds 
472, 473 and 474. 
The synthesis of 2-(azepan-1-yl)benzaldehyde 477 proceeded smoothly with the 
product isolated in a 62% yield. The optimised Henry reaction conditions were 
applied to 477 to form the desired nitroalkene 472 in a low 12% yield (Scheme 
207). 
Scheme 207: Synthesis of 472 
However, when preparing 2-(perhydroisoquinolin-2-yl)benzaldehyde 478, a dr of 
3:1 trans:cis was observed by HPLC owing to perhydroisoquinoline solely being 
available in this ratio of diastereomers. The desired product 478 was formed in 
an 86% yield after 18 h under the same SNAr conditions as used previously 
(Scheme 208) but it was not possible to separate the diastereomers obtained. 
The mixture of diasteromers 478 were reacted under standard conditions to give 
the nitroalkene 473 (Scheme 208). Here again the same ratio of diastereomers 
was observed in a 47% yield. 
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Scheme 208: Synthesis of 473 
In order to also investigate the effect of additional heterocycles within the cyclic 
amine, the synthesis of three additional compounds was attempted. First 
morpholine was reacted with 2-fluorobenzaldehyde 452 via an SNAr reaction in 
DMF with K2CO3 (Scheme 209). The desired aldehyde 479 was obtained in a 
70% yield. This aldehyde was converted to the corresponding nitroalkene 474 
(Scheme 209). The product was isolated in a 28% yield after 18 h. 
Scheme 209: Synthesis of 474 
Secondly the thio- equivalent 480 of 479 was prepared, again via the SNAr 
reaction with thiomorpholine (Scheme 210).  A lot of degradation was observed 
with 2-thiomorpholinobenzaldehyde 480 obtained in a 13% yield. 
 
Scheme 210: Synthesis of 480 
Due to this low yield, the use of a Buchwald-Hartwig cross-coupling reaction was 
considered. 
The Buchwald-Hartwig reaction was used as an alternate route into preparing 
amino-substituted aryl aldehydes. This reaction was first attempted with 2-
bromobenzaldehyde 481 with pyrrolidine which formed 290 in a 56% yield in 18 h, 
substantially lower than the 87% observed via the SNAr reaction due to 
incomplete conversion via the mechanism shown (Scheme 211). 
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Scheme 211: Buchwald-Hartwig reaction to form 290 and mechanism  
These conditions were applied to 2-bromobenzaldehyde 481 with thiomorpholine 
to form 2-thiomorpholinobenzaldehyde 480 in a much improved 83% yield 
(Scheme 212).  
 
Scheme 212: Alternate route to 480 
The corresponding nitroalkene 475 was prepared via a Henry reaction (Scheme 
213). This formed the desired product in a 13% yield with large amounts of 
degradation observed. 
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Scheme 213: Synthesis of nitroalkene 475 
Additionally, to compare the effect of having a sulfur in the α- or β-position relative 
to the C-H bond broken during cyclisation, 476 was targeted as a substrate to 
compare to the thiomorpholino analogue. Thiazolidine was stirred with 
2-fluorobenzaldehyde 452 in DMF with K2CO3 in attempt to form 485 via an SNAr 
reaction without success (Scheme 214). Here no conversion was seen, instead 
the thiazolidine degraded over time. 
 
Scheme 214: Attempt to form 485 via SNAr 
Another attempt was made to prepare 485 via a Buchwald-Hartwig reaction 
(Scheme 215). Here again no conversion was seen, with a mixture of 
degradation products observed. 
 
Scheme 215:  Attempted Buchwald-Hartwig to form 485 
Group B (Figure 6) compounds were chosen to probe the reactivity around 
benzylamines and other non-cyclic amines. In addition to the previously prepared 
aldehyde 468, the electron rich p-methoxy substituted aldehyde 486 and the 
electron poor p-chloro substituted aldehyde 487 were targeted, along with the 
diethylamine derivative. 
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Figure 6: Group B target compounds 
Aldehyde 490 was prepared under standard conditions, seeing a good yield of 
61% after 18 h. This aldehyde was then subjected to a Henry reaction (Scheme 
216). This gave the desired nitroalkene in a 49% yield. 
 
Scheme 216: Synthesis of 486 via Henry reaction 
The reaction of 2-fluorobenzaldehyde 452 with 1-(4-chlorobenzyl)-N-
methylamine 491, again under standard conditions, gave a poor isolated yield of 
492 of 21% with a large amount of degradation observed (Scheme 217). This 
aldehyde 492 was then reacted with MeNO2 in a Henry reaction (Scheme 217). 
The desired nitroalkene 487 was formed in a 35% yield after 18 h. 
Scheme 217: Preparation of 487 
Diethylamine was reacted with 2-fluorobenzaldehyde 452 in DMF with K2CO3 for 
18 h under a range of conditions (Scheme 218, table 13). First (entry A) the 
standard conditions were used, with only partial conversion to 493 observed, this 
was likely through the loss of diethylamine to the atmosphere due to its low boiling 
point. The reaction was repeated with the temperature lowered to 80 °C with no 
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great increase in conversion (entry B). Doubling the equivalents of diethylamine 
(entry C) likewise saw an increase in conversion to 493 but the reaction did still 
not reach completion. 
  
Scheme 218: General Scheme for the synthesis of 493 
Table 13: Reaction conditions for attempted synthesis of 493 
Entry Temperature (°C) Diethylamine eq. Conversion (%) 
A 120 1.2 15 
B 80 1.2 23 
C 120 2.4 37 
 
At this point dibutylamine was used as a higher boiling replacement for 
diethylamine. This reaction proceeded generally well under standard conditions, 
giving the desired product 494 in a 48% yield after 18 h (Scheme 219). This 
aldehyde 494 was transformed into the corresponding nitroalkene 495. The 
desired compound was formed in a 48% yield. 
Scheme 219: Synthesis of 495 
Group C was designed to investigate the effect of electron density on the 
cyclisation reaction. To this end compounds with a range of modified aromatic 
rings were selected to undergo a 1,5-hydride shift (Figure 7). 
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Figure 7: Group C target compounds 
First the bromo- substituted aldehyde 501 was prepared under standard 
conditions in a 35% yield (Scheme 220). Pyrrolidine was used as the amine for 
the SNAr reaction with 5-bromo-2-fluorobenzaldehyde 501. This aryl aldehyde 
502 was subjected to a Henry reaction (Scheme 220) with the modification of the 
reaction being performed in darkness to prevent debromination. The desired 
product was formed in a 39% yield. 
 
Scheme 220: Synthesis of 496 
Attention was then turned to 2-fluoronicotinaldehyde 503, which was reacted with 
pyrrolidine in DMF with K2CO3 (Scheme 221). The desired product 504 was 
obtained in a 67% yield. The isolated 2-(pyrrolidin-1-yl)nicotinaldehyde 504 was 
transformed into the nitroalkene 497. This product was formed in a 30% yield 
after 18 h. 
 
Scheme 221: Preparation of 497 
All the above amino-aldehydes were prepared via SNAr reactions, which requires 
an electron withdrawn aromatic ring to proceed. The desired electron rich 
substrates therefore required an alternate method of preparation. The SNAr 
reactions were replaced with a Buchwald-Hartwig coupling, as discussed above. 
These conditions were applied to 6-bromoveratraldehyde 505 with pyrrolidine 
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again used as the secondary amine (Scheme 222). This gave the desired product 
506 in a 79% yield. Under the standard Henry reaction conditions nitroalkene 498 
was prepared (Scheme 222). This gave the desired compound 498 in a 62% 
yield after 18 h. 
 
Scheme 222: Synthesis of nitroalkene 498 
The Buchwald-Hartwig reaction conditions were repeated with 6-bromopiperonal 
507 as the aryl bromide with pyrrolidine. The desired product 508 was formed in 
an 86% yield after 18 h. The prepared 6-(pyrrolidin-1-yl)piperonal 508 was 
reacted with MeNO2 in a Henry reaction (Scheme 223). This gave the desired 
compound 499 in an isolated yield of 36% after 18 h. 
 
Scheme 223: Preparation of nitroalkene 499 
The final compound of this group, 3-(pyrrolidin-1-yl)thiophene-2-carbaldehyde 
510, was prepared via a Buchwald-Hartwig cross-coupling between 3-
bromothiophene-2-carbaldehyde 509 and pyrrolidine. The thiophene 510 was 
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converted into the corresponding nitroalkene 500 (Scheme 224). The desired 
product 500 was isolated in a 31% yield after 18 h. 
 
Scheme 224: Synthesis of 500 
Proposed group D combined features of both groups A and B so as to look into 
the effects of a benzylic vs non-benzylic position on cyclisation when using a 5- 
or 6-membered ring amine (Figure 8). 
 
Figure 8: Proposed group D target compounds 
First, 1,2,3,4-tetrahydroisoquinoline (THIQ) was reacted with 2-
fluorobenzaldehyde 452 under the standard SNAr conditions used for preparing 
2-amino aryl aldehydes (Scheme 225). The product 515 was observed by HPLC 
and 1H NMR but it was not possible to isolate 515 via column chromatography or 
automatic column chromatography. 
 
Scheme 225: Attempted synthesis of 515 
It was hoped that synthesis via a Buchwald-Hartwig reaction would solve the 
purification issues, as the side products observed could be different and 
separable. However, when this reaction (Scheme 226) was attempted, the 
desired product 515 was again observed by 1H NMR but could not be isolated 
cleanly. 
                                                                                                            Oliver Ware 
138 
 
 
Scheme 226: Attempted Buchwald-Hartwig cross coupling to form 515 
Tetrahydroquinoline was the next amine to be used as a basis for forming a 
2-amino aryl aldehyde (Scheme 227). Here no conversion was seen when 
reacting via an SNAr reaction in DMF. This is likely due to the amine of 
tetrahydroquinoline being deactivated relative to 1,2,3,4-THIQ as the nitrogen 
lone pair is in in partial conjugation with the adjacent aromatic ring. 
 
Scheme 227: Attempted synthesis of 516 
Due to the purification issues present with 1,2,3,4-THIQ, the decision was made 
not to attempt the synthesis of 516 via a Buchwald-Hartwig reaction as it would 
not be possible to compare the two nitroalkenes 511 and 512. Attention was 
instead turned to the synthesis of the indoline and isoindoline analogues 513 and 
514. 
First the reaction between indoline and 2-fluorobenzaldehyde was trialled under 
the standard SNAr conditions (Scheme 228). Here no conversion was seen and 
only a mixture of starting materials and degradation was observed. 
 
Scheme 228: Attempted reaction to form 517 
When the SNAr reaction was attempted with isoindoline (Scheme 229) again no 
formation of the desired product 518 was observed. Isoindoline instead degraded 
under the reaction conditions required by the SNAr. 
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Scheme 229: Attempted formation of 518 
The preparation of both substrates was subsequently attempted via a Buchwald-
Hartwig cross coupling. When using 2-bromobenzaldehyde 481 and indoline 
(Scheme 230), the desired product 517 was formed in a 65% yield. 
 
Scheme 230: Synthesis of 517 via Buchwald-Hartwig cross-coupling 
The equivalent cross-coupling conditions used with 2-bromobenzaldehyde 481 
and isoindoline did not lead to the desired product 518. Instead, as with the SNAr 
reaction, degradation of the isoindoline was observed and no product was 
isolated (Scheme 231). 
 
Scheme 231: Attempted synthesis of 518 
The isolated 2-(indolin-1-yl)benzaldehyde 517 was reacted with MeNO2 under 
the optimised conditions developed above (Scheme 232). The desired product 
was not formed, instead an alternate product was observed. Based upon the 1H 
NMR it was apparent that a substitution had occurred on an aromatic ring but the 
identity of the substitution was not apparent. 
 
Scheme 232: Attempted synthesis of 513 
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No further investigation of these substrates was performed. The final group of 
compounds prepared were group E (Figure 9), which did not fit clearly into 
groups A to D.  
 
Figure 9: Proposed group E target compounds 
First 2-fluorobenzaldehyde 452 and diallylamine were reacted in DMF with K2CO3 
(Scheme 233). This led to the desired product 522 being formed in only a 9% 
yield with large amounts of degradation of the diallylamine observed. The diallyl 
substrate 522 was subjected to the Henry conditions that had been optimised 
previously. It was not possible to isolate the desired product 519. Instead, only 
degradation was observed. 
Scheme 233: Synthesis of N,N-diallyl-2-(2-nitrovinyl)aniline 519 
An allyl,methyl-amino analogue 523 to 522 was prepared in an equivalent SNAr 
reaction (Scheme 234). Here an improved yield of 27% was obtained. However, 
when the conversion of 523 to the corresponding nitroalkene 520 was attempted, 
the desired product was not obtained (Scheme 234). Instead, only degradation 
was observed with no nitroalkene isolable. 
 
Scheme 234: Attempted synthesis of 520 
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Finally, 2-propoxybenzaldehyde was prepared (Scheme 235). Salicyl aldehyde 
463 was alkylated with bromopropane with KI and K2CO3 under Finkelstein 
conditions. This gave the desired compound 524 in an 89% yield. 
 
Scheme 235: Synthesis of 2-propoxybenzaldehyde 524 
The isolated 2-propoxybenzaldehyde 524 was reacted with MeNO2 in acetic acid 
with ammonium acetate (Scheme 236).217 This gave the desired product in an 
isolated yield of 77%. 
 
Scheme 236: Literature synthesis of 521217 
This then gave us a library of nitroalkenes (Figure 10) with which to probe the 
extent of the reactivity of the Gd(OTf)3 catalysed cyclisation reaction. 
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Figure 10: Nitroalkene library 
2.4.7 Scope of the Gd(OTf)3 Catalysed 1,5-Hydride Shift 
With the alkene library prepared we investigated the scope of the 1,5-hydride shift 
reaction. The standard conditions, developed with nitroalkenes 357 and 468, with 
30 mol% Gd(OTf)3 catalyst in toluene, were used with each of the nitroalkenes 
prepared for the investigation into scope.  
First group A were tested, initially looking at the yield as the ring size changed 
from a 5 to 6 to 7 membered ring. The 5-membered ring 358a (Scheme 237) 
gave the previously recorded yield of 79% as a single diastereomer that matched 
the literature data for the anti diastereomer.171  
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Scheme 237: Synthesis of 358a 
Solely isolating the anti diastereomer 358a was expected. This would allow both 
the nitro and cycloalkyl groups to sit in the equatorial position of the newly formed 
6 membered ring and minimise steric interaction (Figure 11). By contrast, the syn 
diastereomer 525b forces the nitro group into the axial position. 
 
Figure 11: anti- 525a and syn 525b diastereomers of 358 
The piperidinyl, or 6-membered ring nitroalkene 454 was slower, with 10 mol% 
catalyst loading leading to trace conversion by HPLC after 72 h. Increasing to a 
30 mol% catalyst loading saw full consumption of the starting material to form 
456 within 18 h (Scheme 238) in a 57% yield with a 17:1 dr anti:syn.  
 
Scheme 238: Synthesis of 456 
The key peaks for identifying the major diastereomer of 456 were assigned by 1H 
and 13C NMR. There was a loss of nitroalkene peaks compared to the starting 
material 454 and the piperidinyl ring lost symmetry. The key 1H NMR peaks for 
assigning the major diastereomer were HA δ 3.44 (1H, dd, J = 15.5, 7.8 Hz), and 
HB δ 3.16 (1H, dd, J = 15.5, 5.0 Hz), the two benzyl protons, with a coupling 
between them of 15.5 Hz. The CHNO2 peak coupled to each with couplings of 
7.8 and 5.0 Hz respectively and was therefore assigned as HC δ 4.70 (1H, ddd, J 
= 7.7, 6.2, 5.1 Hz). The coupling of 6.2 Hz was therefore between HC and NCH 
(HD) δ 3.54 (1H, ddd, J = 10.8, 6.2, 2.5 Hz). HD’s remaining two couplings are to 
HE and HF, the adjacent protons on the adjacent ring CH2 (Figure 12). 
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Figure 12: Compound 456a with relevant protons labelled 
The coupling between HC and HD is 6.2 Hz, which corresponds to an angle of 
either around 30° or 130°, suggesting a partially eclipsed ring system. The 
saturated ring does not have the same flattening and the coupling between HD 
and HE is 2.5 Hz, which correlated to an eq-ax coupling in a 6-membered ring. The 
coupling of HD and HF is 10.8 Hz, which is typical of an ax-ax interaction, requiring 
HD to sit axial and suggesting that the angle between HD and HC is more likely to 
be around 130° than 30°. The coupling between HC and HA and HB are again 
suggestive of an ax-eq relationship (5.0 Hz) and an ax-ax relationship (7.8 Hz), which 
would put HC in an axial position. We propose that both HC and HD therefore sit 
in an ax-ax relationship with both functional groups equatorial, with the major 
diastereomer therefore the anti- diastereomer (Figure 13). 
We proposed that the difference in reactivity between 357 and 454 was due to 
the differing sterics of the 5- versus 6- membered ring system. We suggest that 
the reactive conformer of (E)-1-(2-(2-nitrovinyl)phenyl)pyrrolidine 357 sits closer 
to the idealised angle of hydride attack into the tethered nitroalkene than is the 
case with (E)-1-(2-(2-nitrovinyl)phenyl)piperidine 454, where the piperidinyl 
protons sit out of plane with the aromatic ring.218 This seems likely especially as 
the α-amino carbon that undergoes hydride abstraction in 357 and 454 has similar 
electronic character.  
 
Figure 13: anti- 526a and syn- 526b diasteromers 
The corresponding azepanyl ring nitroalkene 472, gave an increased yield of 
67%, albeit with a lower dr of 2:1, compared to the piperidinyl nitroalkene 454 
(Scheme 239). We proposed that this was due to the less rigid nature of the 7-
membered ring compared to the 6, which would lead to less difference in energy 
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of the two diastereomeric transition states. This increases the likelihood of the 
conformation required for the hydride transfer being reached. 
 
Scheme 239: Synthesis of 527 
The key peaks for identifying the major diastereomer 527a were assigned by 1H 
and 13C NMR. There was a loss of nitroalkene peaks compared to the starting 
material 472 and the azepanyl ring lost symmetry. The key 1H NMR peaks were 
HA δ 3.21 (1H, dd, J = 17.8, 5.4 Hz) and HB δ 3.54 (1H, d, J = 17.8 Hz), the two 
benzyl protons with a geminal coupling between them of J = 17.8 Hz (Figure 14). 
It was not possible to identify J values for HC δ 4.69 – 4.67 (1H, m), though from 
the benzyl peaks it was apparent that HA and HC had a coupling (5.4 Hz) which 
suggested an eq-ax relationship. The lack of coupling between HB and HC 
suggested an eq-eq relationship in a flattened ring system. HD δ 4.12 (1H, ddd, J = 
7.6, 6.4, 3.1 Hz), the NCH proton, had J values corresponding to both ax-eq and 
eq-eq arrangements. The adjacent ring CH2 protons did not have identifiable 
coupling values, so it was not possible to positively identify the spatial 
arrangement of HD for 527a directly. 
The minor diastereomer 527b had analogous benzyl proton peaks HA’ δ 3.53 (1H, 
dd, J = 16.2, 12.4 Hz) and HB’ δ 3.27 – 3.16 (2H, m, also NCH2). The coupling of 
J = 16.2 Hz was assigned as the geminal coupling between HA’ and HB’. HC’ δ 
4.90 (1H, ddd, J = 12.4, 5.7, 4.3 Hz) therefore had a coupling of J = 12.4 Hz to 
HA’, suggesting an ax-ax relationship between them. The NCH proton HD’ δ 4.08 
(1H, dt, J = 8.5, 4.3 Hz) had a coupling to HC’ of J = 4.3 Hz, suggesting an ax-eq 
relationship. The final coupling for HC’, J = 5.7 Hz, was therefore to HB’, another 
ax-eq spatial relationship, consistent with the other assignments. HC’ therefore sits 
axially and HD’ is equatorial, identifying the minor diastereomer 527b as the syn 
diastereomer. As a result, the major diastereomer 527a is the anti diastereomer. 
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Figure 14: Diastereomers of 527 
The next compound of Group A to be subjected to cyclisation conditions was the 
perhydroisoquinolinyl nitroalkene 473, which was present as a 3:1 mixture of 
diastereomers (Scheme 240). Here a wide range of structural isomers and 
diastereomers were observed by HPLC/LCMS. However, it was not possible to 
isolate any of these isomers in pure enough form to characterise. 
 
Scheme 240: Proposed products from attempted cyclisation of 473 
The attempted rearrangement of (E)-4-(2-(2-nitrovinyl)phenyl)morpholine 474, 
gave no conversion by UHPLC/LCMS (Scheme 241). It was rationalised that this 
was due to decreased reactivity of the 6-membered ring coupled with the electron 
withdrawing oxygen disfavouring any hydride migration β- to it.  
 
Scheme 241: Attempted formation of 530 
Finally in group A, switching to the thiomorpholine analogue 530, conversion was 
observed, albeit in a 9% yield (Scheme 242). We rationalised that this was due 
to the decreased electronegativity of sulfur compared to oxygen. The product 531 
was obtained as a single diastereomer. 
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Scheme 242: Formation of 531 
Group B were subsequently subjected to the developed cyclisation conditions. 
The benzyl- substituted amine 468 had previously been reacted to give the 
desired compound 469 in a 67% yield with a 2:1 dr (Scheme 206, above).  
We proposed that the corresponding p-methoxybenzyl- nitroalkene 486 would 
react more readily under the same conditions than the unsubstituted benzyl 
equivalent, because the p-methoxy group would stabilise the generated positive 
charge (Figure 15). 
 
Figure 15: Resonance of generated positive charge following hydride 
transfer 
The cyclisation of 486 with a Gd(OTf)3 catalyst proceeded as predicted, to give 
the desired product 533 in an 84% yield with a dr of 10:1 (Scheme 243). The 
major product was determined to be the anti-diastereomer.  
  
Scheme 243: Cyclisation to form 533 
The key peaks for identifying the major diastereomer of 533 were assigned 
though the use of 1H and 13C NMR. There was a loss of nitroalkene peaks 
compared to the starting material, in line with the shifts seen elsewhere. The key 
1H peaks for assignment are the two benzyl protons HA and HB, δ 3.77 (1H, ddd, 
J = 11.9, 6.7, 1.1 Hz), and 3.58 (1H, dd, J = 12.0, 3.4 Hz), with a coupling between 
them of 12.0 Hz. The HA coupling of 1.1 Hz is a long range coupling to an aromatic 
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ring proton and the couplings of 6.7 and 3.4 Hz are to HC, the CHNO2 proton δ 
4.90 (1H, td, J = 6.6, 3.4 Hz). Finally, HD δ 4.80 (1H, d, J = 6.6 Hz) was assigned, 
the apparent triplet of HC masking two separate 6.6 Hz couplings to adjacent 
protons (Figure 16). 
 
Figure 16: Key protons for diastereomer assignment of 533a 
The coupling of 6.6 Hz between HA and HC and HC and HD suggests an almost 
eclipsed arrangement for these three protons. The coupling of 3.4 Hz between 
HB and HC would be expected for an angle between the two protons of about 60°. 
We can therefore propose a structure similar to 469, above, with the NO2 and aryl 
groups in a trans- diaxial arrangement, with protons HA, HC and HD sitting 
equatorially. This assignment was supported by the lowest energy conformer as 
predicted using the GAMESS interface, using the HF method and the 3-21G 
Basis Set, which has both bulky groups in the axial position (Figure 17). 
 
Figure 17: Lowest energy conformation of 533a 
We proposed that the p-chloro- analogue 487 would react less readily than the 
non-substituted corresponding nitroalkene 468 as chloro- groups have an 
electron withdrawing effect on an aromatic ring, especially in the o and p 
positions, making said aromatic ring less able to stabilise the generated positive 
charge. Here the starting nitroalkene 486 was consumed in 36 hours (Scheme 
245). However the 1H NMR of the isolated material did not match that of the 
desired compound. A splitting consistent with an additional substitution on the 
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first aromatic ring as well as the desired cyclisation was observed. This new 
substitution did not appear to consist of a group featuring 1H atoms as no 
additional 1H peaks were present. A new 13C NMR peak at δ 115.9 suggested 
that the new product contained a single additional carbon atom and the shift was 
indicative of an –OTf group, however, the corresponding LCMS peak (451.8 m/z) 
was not observed. The identity of the isolated product 534 is therefore unknown 
but could cautiously be assigned as 535. 
 
Scheme 245: Cyclisation of 487 
Finally, dibutyl analogue 495, which has no conformational restriction from a ring 
or bias from separate amine groups, gave the desired compound 536 in a high 
yield of 74% as a single diastereomer (Scheme 246).  
 
Scheme 246: Synthesis of 536 
The two benzyl protons δ 3.52 (1H, d, J = 18.1 Hz), 3.12 (1H, dd, J = 18.1, 5.6 
Hz) have a coupling of 18.1 Hz to each other. One benzyl proton does not appear 
to have a coupling to the CHNO2 proton δ 4.75 (1H, m). This is consistent with a 
90° angle between the protons, suggesting an eq-eq relationship in a flattened ring 
system. The other coupling, 5.6 Hz, is indicative of an angle of about 30°, which 
is consistent with a flattened ring system and an ax-eq relationship. It therefore 
seems likely that the nitro group in 536 sits axially as with 469, above. 
Unfortunately, whilst COSY NMR shows coupling between the CHNO2 and NCH 
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δ 4.04 (1H, m) proton, it was not possible to ascertain J values for their coupling. 
Computational modelling using the GAMESS interface, with the HF method and 
the 3-21G Basis Set, suggested that the anti diastereomer is lower energy 
(Figure 18). The anti diastereomer, when modelled, sits with the NO2 group axial 
in the lowest energy conformation, whereas the syn diastereomer sits with the 
NO2 group equatorial. It may therefore be possible to cautiously assign the single 
diastereomer 536 as the anti diastereomer, though this cannot be claimed with 
any great certainty. 
 
Figure 18: anti- and syn- diastereomers of 536 
The next group of compounds to be screened was Group C. Analogue 496, with 
a 5-bromo substitution, was cyclised under the standard conditions (Scheme 
247). The desired compound was obtained in a 9:1 dr with a decreased yield of 
42% compared to the non-substituted equivalent. Here again the anti diasteromer 
dominated, with the 1H NMR peak for the CHNO2 proton δ 4.42 (1H, ddd, J = 
12.0, 9.7, 4.7 Hz) matching the peak for the non-substituted analogue 358a δ 
4.46 (1H, ddd, J = 11.9, 9.7, 4.8 Hz). The lower yield may possibly be indicative 
of the deactivating effect of the Br atom. 
 
Scheme 247: Synthesis of 537 
The more electron withdrawn (E)-3-(2-nitrovinyl)-2-(pyrrolidin-1-yl)pyridine 497 
was likewise subjected to cyclisation conditions (Scheme 248). Here no 
conversion was observed, only degradation.  
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Scheme 248: Attempted cyclisation of 497 
The reaction was repeated with 1.3 equivalents of Gd(OTf)3 (Scheme 249) in an 
attempt to drive the cyclisation to occur, the additional equivalent of Gd(OTf)3 
added to overcome the potential co-ordination of the Gd(OTf)3 to the pyridine N 
lone pair. Here again mostly degradation was observed. There was a possible 
trace amount of the desired product visible in the crude 1H NMR but it was not 
possible to isolate this material via column chromatography. 
 
Scheme 249: Second attempted cyclisation of 497 
Electron rich aryl systems were likewise reacted to form substituted 
tetrahydroquinolines. First a dimethoxy- substituted nitroalkene 498 was cyclised 
in a 62% yield after 4 h, giving the product as a single diastereomer (Scheme 
250).  
 
Scheme 250: Cyclisation to form 539a 
This analogue gave the same anti diastereomer as the other pyrrolidinyl 
substituted compounds as determined from comparison of their 1H NMRs, with 
the CHNO2 peak for 539a, δ 4.45 (1H, ddd, J = 11.8, 9.8, 4.9 Hz) matching that 
for the unsubstituted analogue 358a. In order to prove this assignment, a crystal 
structure of 539a was obtained (see Figure 19 and Appendix 2). The compound 
being present as both enantiomers which make up the anti diastereomer was 
confirmed. 
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Figure 19: Crystal structure of 539ac
The piperonaldehyde derived analogue 499 was also cyclised (Scheme 251). 
Here the analogous product 540a was isolated in a 72% yield as a single 
diastereomer after 18 h.  
 
Scheme 251: Cyclisation of 499 to form 540a 
We believe the difference in reaction time could be due to the arrangement of the 
lone pair orbitals of the oxygens attached to each aromatic ring. In the case of 
the dimethoxy compound, free rotation of each bond is possible, allowing a 
conformation whereby the lone pair is able to combine with the delocalised 
π-cloud of the aromatic ring and greatly increase the electron density. In contrast, 
the two oxygens of the cyclic compound 499 are much more constrained, so the 
5-membered ring does not allow idealised sp2 hybridisation of the oxygen atoms 
to allow the more favourable p-orbital overlap.  
Two further analogues were prepared in order to investigate the relative effects 
of the decreased reactivity of the morpholino- and thiomorpholino- substrates 541 
and 542 and the increased reactivity achieved with the dimethoxy- compound 
498 (Figure 20). 
                                            
c Crystal structure obtained by Merina Corpinot 
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Figure 20: The two new proposed substrates 
Attention was first turned towards the morpholino- aldehyde 543 (Scheme 252). 
6-bromoveratraldehyde 505 was reacted with morpholine under the previously 
discussed Buchwald-Hartwig conditions. The desired nitroalkene 541 was 
subsequently formed under standard conditions (Scheme 252). This compound 
541 was isolated in a 40% yield. 
  
Scheme 252: Synthesis of nitroalkene 541 
With nitroalkene 541 prepared, cyclisation was attempted (Scheme 253). Here 
no conversion was observed as with the corresponding non-dimethoxy- 
morpholino analogue 474. 
 
Scheme 253: Failed cyclisation of 541 
Attention was therefore turned to the thiomorpholino- analogue in the hope that, 
as with the non-dimethoxy- substrates, cyclisation would be more successful. 
First the required aldehyde 545 was prepared in a poor 13% yield (Scheme 254). 
The aldehyde 545 was converted to the corresponding nitroalkene 542. This 
conversion was performed under the standard conditions discussed above. 
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Scheme 254: Synthesis of nitroalkene 542 
Cyclisation with Gd(OTf)3 was then attempted (Scheme 255). To our surprise no 
conversion was detected, although it was made more difficult due to the small 
scale of the reaction. A similar yield to analogue 531 (9%) would have produced 
under 5 mg of product. 
 
Scheme 255: Attempted cyclisation to form 546 
The final compound of group C, (E)-1-(2-(2-nitrovinyl)thiophen-3-yl)pyrrolidine 
500 was cyclised with Gd(OTf)3 under the optimised conditions discussed above 
(Scheme 256). The desired compound 547 was obtained in a 25% yield as a 
single diastereomer. 
 
Scheme 256: Cyclisation to form 547 
The sole compound 521 of group E was then subjected to standard cyclisation 
conditions with Gd(OTf)3 (Scheme 257). Here no conversion was observed. We 
propose that the increased electronegativity of oxygen versus nitrogen led to a 
decrease in reactivity. 
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Scheme 257: Attempted cyclisation of 521 to form 548 
Finally, we attempted a Zn/HCl reduction, TFA protection of cyclised product 
358a (Scheme 258) as has been used previously within the group.219–221 This 
reaction proceeded in a 46% yield in two steps with full retention of 
diastereoselectivity. 
 
Scheme 258: Reduction and protection of nitro group to form 550 
The 1H NMR of 550 showed a shift downfield of the CHNO2 proton from δ 4.46 to 
δ 4.08, consistent with the conversion of a nitro group to a TFA protected amine. 
A new broad amine proton peak was also present in the 1H NMR δ 6.12 (1H, br). 
The CHNCOCF3 peak δ 4.08 (1H, ddd, J = 11.9, 9.7, 5.1 Hz,) of the product 550, 
retained the coupling pattern seen in the CHNO2 δ 4.46 (1H, ddd, J = 11.9, 9.7, 
4.8 Hz) proton of 358a. We therefore assigned the single diastereomer we 
observed as the anti- diastereomer by analogy to the starting material. 
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2.5 Conclusions and Future Work 
A series of aldehydes were synthesised, initially via SNAr reactions and then via 
Buchwald-Hartwig cross couplings. These aldehydes were then converted into 
nitroalkenes and subjected to a 1,5-hydride shift followed by a nitro-Mannich 
cyclisation. The Henry reaction generally proceeded poorly and further 
optimisation would improve the overall route to novel tetrahydroquinolines 
greatly. 
Ultimately, we were able to cyclise the following compounds in the corresponding 
yields (Figure 21). This gives a decent range of results and gives some insight 
into the reactivity of these conditions. It appears that the ability of the compounds 
to access a reactive conformation is an important factor as to the yield and speed 
of reaction. 
 
Figure 21: Final determined scope of the Gd(OTf)3 catalysed 1,5-hydride 
shift and resulting nitro-Mannich reaction 
The results show the Gd(OTf)3 catalysed 1,5-hydride shift and subsequent nitro-
Mannich cyclisation does have limitations. The reaction proceeds poorly or not at 
all when using electron deficient substrates; the addition of a bromo- substituent 
to the aromatic ring, for example, reduced the yield from 79 to 42% between 358a 
and 537a. To the contrary, electron rich substrates formed the corresponding 
products such as 539a and 540a more quickly, though without a clear trend in 
yield.  
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Providing an improved synthetic route to relevant nitroalkenes was developed, it 
would be interesting to continue the synthesis of further substrates that proved 
difficult. For example, allylamino substrates such as 519 and 520 (Figure 22) for 
comparison with the benzyl substrates 468 and 486 which were successfully 
prepared. This would give a window into the relevance of adjacent unsaturation 
in aromatic versus non-aromatic substrates for the 1,5-hydride shift reaction. 
 
Figure 22: Proposed allyl-nitroalkenes and prepared unsaturated 
equivalents 
Likewise, a thio- analogue of 521 should be prepared and the subsequent 
cyclisation attempted (Scheme 259). This would provide a route to substituted 
thiochromans such as 2-methyl-3-nitrothiochroman 552. A route to the required 
aldehyde to form 551 is known and the Henry reaction used to form the ethereal 
analogue should then be trialled.222  
 
Scheme 259: Proposed cyclisation to form 552 
The use of nitroalkanes other than nitromethane is another area worth 
investigating, though the Henry reactions to form these have traditionally been 
challenging. The clear first choice to investigate would be nitroethane, adding a 
methyl group to the final substituted tetrahydroquinoline 554 (Scheme 260).  
 
Scheme 260: Proposed cyclisation of 553 to form 554 
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Selectivity appears to be a clear area to improve on.  There are limited examples 
of gadolinium and other lanthanides being used in asymmetric complexes to form 
enantioenriched products.223–225 For example, Shibasaki et al. reported several 
lanthanide-lithium binol complex catalysed reactions.224 Amongst them was a 
nitroaldol reaction (Scheme 261) with yields of 21-97%, syn:anti drs of between 
74:26 and 94:6 and ees for the syn diastereomer of 66-97%.224 The authors report 
that the catalyst complexes were highly tunable through the choice of lanthanide 
and may be a promising set of catalysts which which to start. 
 
Scheme 261: Chiral catalysed nitroaldol reaction 
More recently, the Yamamoto group published a method of aminolysing aromatic 
trans-2,3-epoxy sulfonamides with a gadolinium-N,N’-dioxide (Scheme 262).223 
This reaction was found to proceed well with a wide range of amines, seeing 
yields between 93-98% and ees of 88-98%. However, changes to the epoxide 
were far less tolerated, with yields reduced to 25% and ees reduced to 7% in 
some instances.223 
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Scheme 262: Enantioselective epoxide ring opening223 
Conditions such as these could be adapted to perform nitro-Mannich cyclisations. 
Alternatively, enantioenriched cyclisations in this manner have previously been 
performed within the group with the use of an external hydride source.210  
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3. Experimental 
3.1 General Experimental Details 
All non-aqueous reactions were carried out in oven-dried glassware under an 
inert atmosphere unless otherwise indicated. All reaction temperatures refer to 
the values of the external heating element and not that of the reaction mixture. 
Room temperature implies a temperature range of 20-25 °C. A temperature of 0 
°C was achieved using an ice-water bath whereas cryogenic conditions (-78 °C 
or -68 °C) were achieved using a dry ice and acetone or DCM bath respectively. 
All additions of reagent occurred as a single portion or fast unless otherwise 
stated. Column chromatography was carried out using BDH (40-60 µm) silica gel 
and analytical thin layer chromatography was carried out using Merck Keiselgel 
aluminium-backed plates coated with silica gel. Automatic column 
chromatography was carried on a Biotage® Isolera™ Spektra or CombiFlash® EZ 
Prep fitted with RediSep® or Biotage® SNAP Ultra cartridges. Components were 
visualised using ultra-violet light (254 nm) and a basic potassium permanganate 
dip. Removal of solvent in vacuo was achieved using Büchi rotary evaporators 
and either the house vacuum or a Büchi Vac® V-500 pump. Where a compound 
has been prepared using a specific literature procedure, this is referenced by the 
compound name. 
3.2 Purification of Solvents and Reagents 
All commercial chemicals and solvents were used as supplied unless otherwise 
stated. The dry solvents toluene and THF were obtained from a solvent tower, 
where degassed solvents were passed through two columns of activated alumina 
and a 7 micron filter under 4 bar pressure. Other anhydrous solvents were 
purchased bottled from the Aldrich chemical company and used as provided. 
Activation of 4 Å molecular sieves was achieved by heating under a high vacuum. 
3.3 Characterisation 
Melting points are uncorrected and were obtained using a Reichert Melting Point 
Apparatus. Infrared (IR) spectra were recorded on a Perkin Elmer spectrum 100 
FT-IR (ATR mode). 1H NMR spectra were recorded at 300 MHz on a Bruker 
Avance 300 spectrometer, at 400 MHz on a Bruker Avance 400 spectrometer, at 
500 MHz on a Bruker Avance 500 spectrometer, at 600 MHz on a Bruker Avance 
600 spectrometer or at 700 MHz on a Bruker Avance 700 spectrometer in the 
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stated solvent using the residual protic solvent CHCl3 (δ = 7.26 ppm, s) or DMSO 
(δ = 2.56 ppm, qn) as the internal standard. Chemical shifts are quoted in ppm 
using the following abbreviations: s, singlet d, doublet t, triplet q, quartet qn, 
quintet m, multiplet, br, broad or a combination of these. The coupling constants 
(J) are measured in Hertz. 13C NMR spectra were recorded at 125 MHz on a 
Bruker Avance 600 Spectrometer or at 175 MHz on a Bruker Avance 700 
Spectrometer in the stated solvent using the internal reference of CHCl3 (δ = 77.0 
ppm, t) or DMSO (δ = 39.52 ppm, sept) as the internal standard.226 Chemical 
shifts are reported to the nearest 0.1 ppm. Mass spectrometry data was collected 
on Thermo Finnigan Mat900xp (EI/CI) VG-70se (FAB) and Waters LCT Premier 
XE (ES) instruments. 
3.4 Experimental Procedures 
3.4.1 Synthesis of 2-Aminobenzaldehydes 
General Procedure A171 
A secondary amine (1.2 equivalents) was added to a suspension of potassium 
carbonate (1.2 equivalents) in a solution of a 2-fluoroaryl aldehyde (1 equivalent) 
and DMF (1 mL per mmol) at rt. The solution was heated to 120 °C for 18 h before 
cooling to rt. The reaction mixture was diluted with water (30 mL) and the mixture 
extracted with EtOAc (50 mL). The organic layer was then washed with sat. 
NaHCO3 solution (4 x 50 mL) and brine (50 mL) before being dried (MgSO4), 
filtered and the solvent removed in vacuo. The crude product was then purified 
via column chromatography to give the pure product.  
General Procedure B 
A 2-bromoaryl aldehyde (1 equivalent) was added to a suspension/solution of 
caesium carbonate (1.4 equivalents), Pd(OAc)2 (0.01 equivalents) and (±)BINAP 
(0.03 equivalents) in toluene (10 mL per mmol). The reaction mixture was stirred 
at rt for 5 min before a secondary amine (1.1 equivalents) was added and the 
resulting mixture was heated to 90 °C for 18 h. Following cooling to rt, the solvent 
was removed in vacuo and the crude product was purified via column 
chromatography. 
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2-(Pyrrolidin-1-yl)benzaldehyde 290171 
 
Prepared via general procedure A. Potassium carbonate (1.66 g, 12.0 mmol), 
DMF (10 mL), 2-fluorobenzaldehyde (1.08 mL, 10.0 mmol), pyrrolidine (1.02 mL, 
12.0 mmol). Purified via column chromatography (10% EtOAc in hexane) to give 
the product as a bright orange oil (1.52 g, 87%). 
1H NMR (400 MHz, CDCl3) δ 10.09 (1H, s, ArCHO), 7.71 (1H, dd, J = 7.8, 1.8 Hz, 
ArH), 7.38 (1H, ddd, J = 8.7, 7.0, 1.8 Hz, ArH), 6.86 – 6.75 (2H, m, ArH), 3.36 
(4H, ddd, J = 6.5, 4.2, 2.6 Hz, NCH2), 2.05 – 1.92 (4H, m, NCH2CH2). 
Data in agreement with literature values171 
2-(Piperidin-1-yl)benzaldehyde 453171 
 
Prepared via general procedure A. Potassium carbonate (835 mg, 6 mmol), DMF 
(5 mL), 2-fluorobenzaldehyde (0.54 mL, 5.0 mmol) and piperidine (0.60 mL, 6.0 
mmol). Purified via column chromatography (5% TBME in hexane) to give the 
product as a yellow oil (509 mg, 53%) 
1H NMR (400 MHz, CDCl3) δ 10.30 (1H, d, J = 0.6 Hz, ArCHO), 7.79 (1H, dd, J = 
7.7, 1.7 Hz, ArH), 7.50 (1H, ddd, J = 8.3, 7.3, 1.8 Hz, ArH), 7.12 – 7.03 (2H, m, 
ArH), 3.08 – 3.00 (4H, m, NCH2), 1.80 – 1.73 (4H, m, NCH2CH2), 1.66 – 1.58 (2H, 
m, NCH2CH2CH2). 
Data in agreement with literature values202 
2-(Azepan-1-yl)benzaldehyde 477  
 
                                                                                                            Oliver Ware 
163 
 
Prepared via general procedure A. Potassium carbonate (1.68 g, 12.2 mmol), 
DMF (10 mL), 2-fluorobenzaldehyde (1.10 mL, 10.4 mmol) and 
hexamethyleneimine (1.4 mL, 1.2 mmol). Purified via column chromatography 
(10% EtOAc in hexane) to give the product as a yellow oil (1.27 g, 62%) 
1H NMR (400 MHz, CDCl3) δ 10.21 (1H, s, CHO), 7.74 (1H,dd, J = 7.8, 1.8 Hz, 
ArH), 7.41 (1H, ddd, J = 8.6, 7.1, 1.8 Hz, ArH), 7.08 (1H, d, J = 8.4 Hz, ArH), 6.93 
(1H, t, J = 7.4 Hz, ArH), 3.44 – 3.36 (4H, m, NCH2), 1.86 – 1.76 (4H, m, 
NCH2CH2), 1.74 – 1.63 (4H, m, NCH2CH2CH2). 
Data in agreement with literature values227 
2-(Perhydroisoquinolin-2-yl)benzaldehyde 478 
 
Prepared via general procedure A. Potassium carbonate (1.65 g, 11.9 mmol), 
DMF (10 mL), 2-fluorobenzaldehyde (1.08 mL, 10.0 mmol) and 
perhydroisoquinoline (1.79 mL, 12.0 mmol). Purified via automatic column (0-
10% EtOAc in heptane) to give the product as a yellow oil as a mixture of 
diastereomers (2.10 g, 86%, d.r. 3:1) 
1H NMR (400 MHz, CDCl3) δ 10.35 (1H, s, CHO), 7.79 (1H, dd, J = 7.7, 1.6 Hz, 
ArH), 7.52 – 7.45 (1H, m, ArH), 7.14 – 7.03 (2H, m, ArH), 3.25 – 3.18 (1H, m), 
3.15 – 3.08 (1H, m), 2.96 (1H, d, J = 10.0 Hz), 2.94 – 2.85 (1H, m), 2.04 (1H, s), 
1.94 – 1.82 (2H, m), 1.66 (2H, td, J = 10.0, 4.1 Hz), 1.60 – 1.40 (7H, m), 1.29 (4H, 
dd, J = 15.1, 7.6 Hz). 
Data in agreement with literature values228 
2-Morpholinobenzaldehyde 479 
 
Prepared via general procedure A. Potassium carbonate (1.66 g, 12.0 mmol), 
DMF (10 mL), 2-fluorobenzaldehyde (1.08 mL, 10.0 mmol) and morpholine 
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(1.05 mL, 12.0 mmol). Purified via automatic column chromatography (2-20% 
EtOAc in heptane) to give the product as a yellow oil (1.34 g, 70%) 
1H NMR (400 MHz, CDCl3) δ 10.35 (1H, d, J = 0.5 Hz, CHO), 7.82 (1H, dd, J = 
7.7, 1.6 Hz, ArH), 7.55 (1H, ddd, J = 8.2, 7.3, 1.7 Hz, ArH), 7.20 – 7.08 (2H, m, 
ArH), 3.93 – 3.86 (4H, m, OCH2), 3.09 (4H, dd, J = 5.5, 3.8 Hz, NCH2). 
Data in agreement with literature values227 
2-Thiomorpholinobenzaldehyde 480 
 
Prepared via general procedure B. Caesium carbonate (915 mg, 2.81 mmol), 
Pd(OAc)2 (5 mg, 0.02 mmol), (±)BINAP (40 mg, 0.06 mmol), toluene (20 mL), 
2-bromobenzaldehyde (0.23 mL, 2.0 mmol), thiomorpholine (0.22 mL, 2.2 mmol). 
Purified via column chromatography (10% EtOAc in hexane) to give the product 
as a yellow oil (340 mg, 83%). 
1H NMR (500 MHz, CDCl3) δ 10.33 (1H, d, J = 0.5 Hz, CHO), 7.82 (1H, dd, J = 
7.7, 1.7 Hz, ArH), 7.54 (1H, ddd, J = 8.1, 7.3, 1.7 Hz, ArH), 7.15 (2H, m, ArH), 
3.38 – 3.33 (4H, m, NCH2), 2.88 – 2.83 (4H, m, SCH2). 
Data in agreement with literature values229 
2-(Benzyl(methyl)amino)benzaldehyde 468 
 
Prepared via general procedure A. Potassium carbonate (1.68 g, 12.2 mmol), 
DMF (10 mL), 2-fluorobenzaldehyde (1.01 mL, 9.59 mmol) and 
N-benzylmethylamine (1.51 mL, 11.7 mmol). Purified via automatic column (2-
20% EtOAc in heptane) to give the product as a yellow oil (1.67 g, 74%). 
1H NMR (400 MHz, CDCl3) δ 10.40 (1H, d, J = 0.5 Hz, CHO), 7.82 (1H, dd, J = 
7.7, 1.7 Hz, ArH), 7.48 (1H, ddd, J = 8.3, 7.2, 1.8 Hz, ArH), 7.35 – 7.30 (2H, m, 
ArH), 7.28 (3H, apparent triplet, J = 3.0 Hz, ArH), 7.12 – 7.04 (2H, m, ArH), 4.34 
(2H, s, NCH2Ar), 2.82 (3H, s, NCH3). 
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Data in agreement with literature values170 
2-((4-Methoxybenzyl)(methyl)amino)benzaldehyde 490 
 
Prepared via general procedure A. Potassium carbonate (832 mg, 6.02 mmol), 
DMF (5 mL), 2-fluorobenzaldehyde (0.54 mL, 5.0 mmol) and 4-methoxy-N-
methylbenzylamine (0.90 mL, 6.0 mmol). Purified via column chromatography 
(10% EtOAc in hexane) to give the product as a yellow oil (616 mg, 48%) 
1H NMR (700 MHz, CDCl3) δ 10.39 (1H, s, CHO), 7.82 (1H, dd, J = 7.7, 1.7 Hz, 
ArH), 7.47 (1H, ddd, J = 8.8, 7.3, 1.7 Hz, ArH), 7.16 (2H, d, J = 8.6 Hz, ArH), 7.07 
(2H, m, ArH), 6.85 (2H, d, J = 8.6 Hz, ArH), 4.26 (2H, s, NCH2), 3.80 (3H, s, 
OCH3), 2.79 (3H, s, NCH3). 
Data in agreement with literature values230 
2-((4-Chlorobenzyl)(methyl)amino)benzaldehyde 492 
 
Prepared via general procedure A. Potassium carbonate (835 mg, 6.04 mmol), 
DMF (5 mL), 2-fluorobenzaldehyde (0.54 mL, 5.0 mmol) and N-(4-chlorobenzyl)-
N-methylamine (0.80 mL, 6.0 mmol). Purified via column chromatography (10% 
EtOAc in hexane) to give the product as a yellow oil (277 mg, 21%). 
1H NMR (400 MHz, CDCl3) δ 10.37 (1H, s, CHO), 7.82 (1H,dd, J = 7.9, 1.7 Hz, 
ArH), 7.48 (1H, td, J = 8.0, 1.7 Hz, ArH), 7.32 – 7.27 (2H, m, ArH), 7.20 (2H, d, J 
= 8.5 Hz, ArH), 7.09 (2H, t, J = 7.8 Hz, ArH), 4.29 (2H, s, NCH2Ar), 2.80 (3H, s, 
NCH3). 
Data in agreement with literature values230 
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2-(Dibutylamino)benzaldehyde 494 
 
Prepared via general procedure A. Potassium carbonate (1.68 g, 12.2 mmol), 
DMF (10 mL), 2-fluorobenzaldehdye (1.10 mL, 10.4 mmol), dibutylamine (2.0 mL, 
12 mmol). Purified via column chromatography (0-2% EtOAc in hexane) to give 
the product as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ 10.33 (1H, d, J = 0.6 Hz, CHO), 7.80 (1H, dd, J = 
7.7, 1.7 Hz, ArH), 7.48 (1H, ddd, J = 8.3, 7.2, 1.8 Hz, ArH), 7.16 (1H, d, J = 8.2 
Hz, ArH), 7.06 (1H, t, J = 7.5 Hz, ArH), 3.18 – 3.07 (4H, t, J = 7.4 Hz, NCH2), 1.52 
– 1.41 (4H, m, NCH2CH2), 1.26 (4H, apparent sextet, J = 14.6, 7.3 Hz, 
NCH2CH2CH2), 0.86 (6H, t, J = 7.3 Hz, NCH2CH2CH2CH3). 
Data in agreement with literature values231 
5-Bromo-2-(pyrrolidin-1-yl)benzaldehyde 502 
 
Prepared via general procedure A. Potassium carbonate (1.69 g, 12.3 mmol), 
DMF (10 mL), 5-bromo-2-fluorobenzaldehyde (1.21 g, 5.96 mmol), pyrrolidine 
(1.0 mL, 12 mmol). Purified via automatic column chromatography (2 – 20% 
EtOAc in heptane) to give the product as an orange oil (530 mg, 35%). 
1H NMR (500 MHz, CDCl3) δ 10.02 (1H, s, CHO), 7.79 (1H, d, J = 2.5 Hz, ArH), 
7.42 (1H, dd, J = 9.0, 2.6 Hz, ArH), 6.72 (1H, d, J = 9.0 Hz, ArH), 3.38 – 3.31 (4H, 
m, NCH2), 2.03 – 1.97 (4H, m, NCH2CH2). 
Data in agreement with literature values232 
2-(Pyrrolidin-1-yl)nicotinaldehyde 504 
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Prepared via general procedure A. Potassium carbonate (1.67 g, 12.1 mmol), 
DMF (10 mL), 2-fluoro-3-pyridine carboxaldehyde (1.00 mL, 10.4 mmol) and 
pyrrolidine (1.10 mL, 13.2 mmol). Purified via automatic column chromatography 
(2 – 20% EtOAc in heptane) to give the product as a yellow oil (1.18 g, 67%). 
1H NMR (500 MHz, CDCl3) δ 10.02 (1H, s, CHO), 8.33 (1H, dd, J = 4.6, 1.9 Hz, 
ArH), 7.94 (1H, dd, J = 7.6, 2.0 Hz, ArH), 6.71 (1H, dd, J = 7.6, 4.6 Hz, ArH), 3.58 
– 3.50 (4H, m, NCH2), 2.01 – 1.95 (4H, m, NCH2CH2). 
Data in agreement with literature values134 
4,5-Dimethoxy-2-(pyrrolidin-1-yl)benzaldehyde 506 
 
Prepared via general procedure B. Caesium carbonate (911 mg, 2.80 mmol), 
Pd(OAc)2 (5 mg, 0.02 mmol), (±)BINAP (39 mg, 0.06 mmol). 
6-bromoveratraldehyde (493 mg, 2.02 mmol), toluene (20 mL), pyrrolidine 
(0.19 mL, 2.2 mmol). Purified via column chromatography (40% EtOAc in 
hexane) to give the product as a yellow crystalline solid (373 mg, 79%). 
1H NMR (600 MHz, CDCl3) δ 10.11 (1H, s, CHO), 7.30 (1H, s, ArH), 6.32 (1H, s, 
ArH), 3.94 (3H, s, OCH3), 3.87 (3H, s, OCH3), 3.44 (4H, t, J = 6.5 Hz, NCH2), 2.04 
– 1.96 (4H, m, NCH2CH2). m.p. 70 – 72 °C Lit. not reported 
Data in agreement with literature values233 
6-(Pyrrolidin-1-yl)piperonal 508 
 
Prepared via general procedure B. Caesium carbonate (915 mg, 2.80 mmol), 
Pd(OAc)2 (4 mg, 0.02 mmol), (±)BINAP (40 mg, 0.06 mmol), 6-bromopiperonal 
(460 mg, 2.02 mmol), toluene (20 mL), pyrrolidine (0.19 mL, 2.2 mmol. Purified 
via column chromatography (20% EtOAc in hexane) to give the product as a 
yellow crystalline solid (375 mg, 86%). 
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1H NMR (600 MHz, CDCl3) δ 10.01 (1H, s, CHO), 7.22 (1H, s, ArH), 6.44 (1H, s, 
ArH), 5.94 (2H, s, OCH2O), 3.40 – 3.35 (4H, m, NCH2), 2.02 – 1.96 (4H, m, 
NCH2CH2). 13C NMR (150 MHz, CDCl3) δ 188.1 (CHO), 153.7 (ArC), 150.6 (ArC) 
140.6 (ArC), 117.4 (ArC), 108.6 (ArC), 101.7 (OCH2O), 95.8 (ArC), 54.0 (NCH2), 
26.0 (NCH2CH2). IR (neat) 2969 C-H 2945 C-H 2865 C-H 1627 C=O 1604 C=C 
1493 cm-1 C=C. LRMS 220.1 (100) 221.1 (22). HRMS Expected: 220.0974 
Found: 220.0979 m.p. 71 – 73 °C 
3-(Pyrrolidin-1-yl)thiophene-2-carbaldehyde 510 
 
Prepared via general procedure B. Caesium carbonate (910 mg, 2.80 mmol), 
Pd(OAc)2 (10 mg, 0.02 mmol), (±)BINAP (39 mg, 0.06 mmol), 
3-bromothiophene-2-carboxaldehyde (0.22 mL, 2.0 mmol), toluene (20 mL) and 
pyrrolidine (0.20 mL, 2.2 mmol). The crude mixture was purified via column 
chromatograpy (40% EtOAc in hexane) to give the product as an off-white solid 
(275 mg, 76%). 
1H NMR (400 MHz, CDCl3) δ 9.87 (1H, d, J = 1.1 Hz, CHO), 7.52 (1H, dd, J = 5.5, 
1.1 Hz, ArH), 6.55 (1H, d, J = 5.5 Hz, ArH), 3.56 – 3.51 (4H, m, NCH2), 2.14 – 
2.01 (4H, m, NCH2CH2). m.p. 84-85 °C Lit. Not reported 
Data in agreement with literature values234 
2-(Diallylamino)benzaldehyde 519 
 
Prepared via general procedure A. Potassium carbonate (1.67 g, 12.1 mmol), 
DMF (10 mL), 2-fluorobenzaldehyde (1.08 mL, 10.0 mmol) and diallylamine (1.98 
mL, 16.0 mmol). Purified via automatic column (2-20% EtOAc in heptane) to give 
the product as a yellow oil (217 mg, 9%). 
1H NMR (400 MHz, CDCl3) δ 10.38 (1H, d, J = 0.4 Hz, CHO), 7.92 – 7.85 (1H, m, 
ArH), 7.80 (1H, dd, J = 7.7, 1.7 Hz, ArH), 7.61 (1H, dddd, J = 8.4, 7.3, 5.4, 1.9 
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Hz, ArH), 7.46 (1H, ddd, J = 8.3, 7.2, 1.8 Hz, ArH), 5.82 (2H, ddt, J = 16.2, 10.3, 
6.0 Hz, NCH2CHCH2), 5.22 (2H, dd, J = 16.2, 1.4 Hz, NCH2CHCH2), 5.18 (2H, 
dd, J = 10.3, 1.4 Hz, NCH2CHCH2) 3.79 (4H, dt, J = 5.9, 1.3 Hz, NCH2CHCH2). 
Data in agreement with literature values228 
2-(Allyl(methyl)amino)benzaldehyde 520 
 
Prepared via general procedure A. Potassium carbonate (830 mg, 6.01 mmol), 
DMF (5 mL), 2-fluorobenzaldehyde (0.54 mL, 5.0 mmol) and N-allylmethylamine 
(0.60 mL, 6.0 mmol). Purified via automatic column (2-20% EtOAc in heptane) to 
give the product as a yellow oil (236 mg, 27%). 
1H NMR (400 MHz, CDCl3) δ 10.27 (1H, s, CHO), 7.79 (1H, dd, J = 7.7, 1.7 Hz, 
ArH), 7.47 (1H, ddd, J = 8.8, 7.2, 1.8 Hz, ArH), 7.09 (1H, d, J = 8.2 Hz, ArH), 7.03 
(1H, t, J = 7.4 Hz, ArH), 5.91 (1H, ddt, J = 16.1, 10.2, 5.9 Hz, NCH2CHCH2), 5.28 
(1H, dd, J = 16.1, 1.5 Hz, NCH2CHCH2), 5.24 (1H, dd, J = 10.2, 1.5 Hz, 
NCH2CHCH2) 3.74 (2H, d, J = 5.9 Hz, NCH2CHCH2), 2.86 (3H, s, NCH2). 
Data in agreement with literature values228 
4,5-Dimethoxy-2-morpholinobenzaldehyde 543 
 
Prepared via general procedure B. Caesium carbonate (1.83 g, 5.62 mmol), 
Pd(OAc)2 (8 mg, 0.04 mmol), (±)BINAP (78 mg, 0.12 mmol), toluene (40 mL), 
6-bromoveratraldehyde (980 mg, 4.02 mmol), morpholine (0.38 mL, 4.4 mmol). 
Purified via column chromatography (40% EtOAc in hexane) to give the product 
as a yellow oil (273 mg, 27%). 
1H NMR (600 MHz, CDCl3) δ 10.34 (1H, s, CHO), 7.35 (1H, s, ArH), 6.65 (1H, s, 
ArH), 3.97 (3H, s, OCH3), 3.91 (3H, s, OCH3), 3.90 – 3.89 (4H, m, OCH2), 3.08 – 
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3.04 (4H, m, NCH2). LRMS 252.1 (100) 253.1 (18). HRMS Expected: 252.1236 
Found: 252.1242 
4,5-Dimethoxy-2-thiomorpholinobenzaldehyde 545 
 
Prepared via general procedure B.  Caesium carbonate (915 mg, 2.80 mmol), 
Pd(OAc)2 (5 mg, 0.02 mmol), (±)BINAP (44 mg, 0.07 mmol), toluene (20 mL), 
6-bromoveratraldehyde (491 mg, 2.00 mmol), thiomorpholine (0.22 mL, 2.2 
mmol). Purified via column chromatography (20% EtOAc in hexane) to give the 
product as a yellow oil (90 mg, 13%). 
1H NMR (700 MHz, CDCl3) δ 10.30 (1H, s, CHO), 7.33 (1H, s, ArH), 6.65 (1H, s, 
ArH), 3.95 (3H, s, OCH3), 3.90 (3H, s, OCH3), 3.32 – 3.28 (4H, m, NCH2), 2.87 – 
2.83 (4H, m, SCH2). 13C NMR (175 MHz, CDCl3) δ 190.0 (CHO), 155.0 (ArC), 
153.4 (ArC), 146.0 (ArC), 122.9 (ArC), 109.7 (ArC), 103.5 (ArC), 56.9 (NCH2), 
56.3 (OCH3), 56.2 (OCH3), 28.3 (SCH2). IR (neat): 2907 C-H 2828 C-H 1665 C=O 
1594 C=C 1503 C=C 1446 1406 cm-1. LRMS: 268.1 (100) 269.1 (15) HRMS 
Expected: 268.1007 Found: 268.1012 
4-(Pyrrolidin-1-yl)benzaldehyde 
 
Potassium carbonate (841 mg, 6 mmol) was suspended in DMF (5.0 mL). To this 
4-fluorobenzaldehyde (0.54 mL, 5 mmol) and pyrrolidine (0.51 mL, 6 mmol) were 
added and the mixture was heated to reflux for 18 h. Following cooling to rt, the 
reaction was diluted with water (30 mL) and the organics were extracted with 
EtOAc (50 mL). The organic layer was then washed with sat. NaHCO3 solution 
(4 x 50 mL) and brine (50 mL) before being dried (MgSO4), filtered and the solvent 
removed in vacuo. The crude product was then purified via column 
chromatography (33% EtOAc in hexane) to give the product as an orange 
crystalline solid (713 mg, 81%). 
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1H NMR (400 MHz, CDCl3) δ 9.71 (1H, s, CHO), 7.78 – 7.67 (2H, m, ArH), 6.57 
(2H, d, J = 8.9 Hz, ArH), 3.38 (4H, ddd, J = 6.6, 4.2, 2.6 Hz, NCH2CH2), 2.10 – 
1.97 (4H, m, NCH2CH2). 
Data in agreement with literature values235 
3.4.2 Synthesis of Nitroalkenes 
General Procedure C 
Into toluene (5.0 mL per mmol) an aldehyde (1 equivalent) was added. KF (0.19 
equivalents), Me2NH.HCl (1.5 equivalents) and MeNO2 (3.5 mL per mmol) were 
added and the solution heated to 90 °C for 18 h. The solvent was then removed 
in vacuo to give the crude product which was then purified directly via column 
chromatography. 
(E)-1-(2-(2-Nitrovinyl)phenyl)pyrrolidine 357 
 
Prepared via general procedure C. Toluene (33 mL), 2-(pyrrolidin-1-yl) 
benzaldehyde (1.22 g, 6.94 mmol), KF (113 mg, 1.94 mmol), dimethylamine 
hydrochloride (1.16 g, 14.2 mmol) and MeNO2 (27 mL). Purified via column 
chromatography (2% EtOAc in hexane) to give the product as a dark red solid 
(527 mg, 35%). 
1H NMR (400 MHz, CDCl3) δ 8.43 (1H, d, J = 13.4 Hz, ArCHCHNO2), 7.46 (1H, 
d, J = 13.4 Hz, ArCHCHNO2), 7.37 (1H, dd, J = 7.8, 1.6 Hz, ArH), 7.32 (1H, ddd, 
J = 8.6, 7.2, 1.6 Hz, ArH), 6.89 (1H, d, J = 8.4 Hz, ArH), 6.84 (1H, t, J = 7.5 Hz, 
ArH), 3.39 – 3.32 (4H, m, NCH2), 2.01 – 1.93 (4H, m, NCH2CH2). 
Data in agreement with literature values171 
 (E)-1-(2-(2-Nitrovinyl)phenyl)piperidine 454 
 
                                                                                                            Oliver Ware 
172 
 
Prepared via general procedure C. Toluene (12 mL), 2-piperidin-1-yl) 
benzaldehyde (470 mg, 2.50 mmol), KF (37 mg, 0.63 mmol), dimethylamine 
hydrochloride (407 mg, 5.00 mmol) and MeNO2 (9.0 mL). Purified via column 
chromatography (1% EtOAc in hexane) to give the product as a dark red oil 
(232 mg, 40%). 
1H NMR (400 MHz, CDCl3) δ 8.36 (1H, d, J = 13.8 Hz, ArCHCHNO2), 7.70 (1H, 
d, J = 13.8 Hz, ArCHCHNO2), 7.47 (1H, dd, J = 7.7, 1.6 Hz, ArH), 7.45 – 7.40 
(1H, m, ArH), 7.10 (1H, d, J = 8.2 Hz, ArH), 7.06 (1H, t, J = 7.5 Hz, ArH), 2.96 – 
2.85 (4H, m, NCH2), 1.82 – 1.72 (4H, m, NCH2CH2), 1.65 – 1.57 (2H, m, 
NCH2CH2CH2). 
Data in agreement with literature values171 
 (E)-1-(2-(2-Nitrovinyl)phenyl)azepane 472 
 
Prepared via general procedure C. Toluene (12 mL), 2-(azepan-1-yl) 
benzaldehyde (690 mg, 3.35 mmol), KF (41 mg, 0.64 mmol), dimethylamine 
hydrochloride (410 mg, 5.02 mmol) and MeNO2 (10 mL). Purified via column 
chromatography (2% EtOAc in hexane) to give the product as a dark red oil (477 
mg, 58%). 
1H NMR (400 MHz, CDCl3) δ 8.43 (1H, d, J = 13.7 Hz, CHCHNO2), 7.58 (1H, d, 
J = 13.7 Hz, CHNO2), 7.44 (1H, dd, J = 7.8, 1.6 Hz, ArH), 7.41 – 7.36 (1H, m, 
ArH), 7.15 (1H, dd, J = 8.3, 0.9 Hz, ArH), 7.00 (1H, m, ArH), 3.23 – 3.17 (4H, m, 
ring H), 1.83-1.73 (8H, m, ring H). 13C NMR (150 MHz, CDCl3) δ 156.6 (ArC), 
138.2 (CHCHNO2), 136.2 (CHNO2), 132.6 (ArC), 129.0 (ArC), 123.8 (ArC), 122.0 
(ArC), 120.8 (ArC), 56.8 (NCH2), 29.3 (NCH2CH2), 27.3 (NCH2CH2CH2). IR (neat) 
3098 C-H 2952 C-H 2912 C-H 2878 C-H 2831 C-H 1624 C=C 1596 C=C 1505 
cm-1 C=C. LRMS 247.1 (100) 248.1 (20). HRMS: Expected 247.1447 Found: 
247.1454 
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(E)-2-(2-(2-Nitrovinyl)phenyl)perhydroisoquinoline 473 
 
Prepared via general procedure C. Toluene (7.0 mL), 2-(perhydroisoquinolin-2-
yl)benzaldehyde (467 mg, 1.80 mmol), KF (23 mg, 0.36 mmol), dimethylamine 
hydrochloride (236 mg, 2.56 mmol) and MeNO2 (6.0 mL). Purified via automatic 
column chromatography (0-10% EtOAc in heptane) to give the product as a red 
oil in a mixture of diastereomers (254 mg, 47%, d.r. 3:1)  
1H NMR (400 MHz, CDCl3) δ 8.43 (1H, d, J = 13.8 Hz, CHCHNO2), 7.63 (1H, d, 
J = 13.8 Hz, CHNO2), 7.46 (1H, d, J = 7.7 Hz, ArH), 7.42 (1H, ddd, J = 9.9, 4.2, 
2.1 Hz, ArH), 7.11 (1H, d, J = 8.2 Hz, ArH), 7.05 (1H, t, J = 7.5 Hz, ArH), 3.12 
(1H, dd, J = 13.5, 11.3 Hz, NCH2), 2.99 (1H, dd, J = 11.3, 2.2 Hz, NCH2), 2.79 
(2H, ddd, J = 15.1, 9.6, 2.7 Hz, NCH2), 2.04 (2H, m), 1.85 (2H, m), 1.79 – 1.71 
(2H, m), 1.70 – 1.62 (2H, m), 1.46 (2H, m), 1.39 – 1.24 (2H, m). 
(E)-4-(2-(2-Nitrovinyl)phenyl)morpholine 474 
 
Prepared via general procedure C. Toluene (7.0 mL), 2-morpholino-
benzaldehyde (368 mg, 1.88 mmol), KF (23 mg, 0.36 mmol), dimethylamine 
hydrochloride (237 mg, 2.56 mmol) and MeNO2 (6.0 mL). Purified via automatic 
column chromatography (0-10% EtOAc in heptane) to give the product as an 
orange oil (186 mg, 38%).  
1H NMR (400 MHz, CDCl3) δ 8.40 (1H, d, J = 13.8 Hz, CHCHNO2), 7.67 (1H, d, 
J = 13.8 Hz, CHNO2), 7.53 – 7.44 (2H, m, ArH), 7.13 (2H, dd, J = 7.7, 6.3 Hz, 
ArH), 3.94 – 3.88 (4H, m, NCH2CH2), 3.00 – 2.96 (4H, m, NCH2). 
(E)-4-(2-(2-Nitrovinyl)phenyl)thiomorpholine 475 
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Prepared via general procedure C. Toluene (6.5 mL), 2-thiomorpholino-
benzaldehyde (340 mg, 1.64 mmol), KF (18 mg, 0.31 mmol), dimethylamine 
hydrochloride (202 mg, 2.46 mmol) and MeNO2 (5.7 mL). Purified via column 
chromatography (10% EtOAc in hexane) to give the product as a light red solid 
(260 mg, 63%). 
1H NMR (600 MHz, CDCl3) δ 8.39 (1H, d, J = 13.8 Hz, CHCHNO2), 7.64 (1H, d, 
J = 13.8 Hz, CHNO2), 7.51 (1H, d, J = 7.8 Hz, ArH), 7.49 – 7.45 (1H, m, ArH), 
7.16 – 7.12 (2H, m, ArH), 3.26 – 3.20 (4H, m, NCH2), 2.91 – 2.86 (4H, m, 
NCH2CH2) 13C NMR (150 MHz, CDCl3) δ 155.0 (ArC), 137.3 (CHCHNO2), 136.3 
(CHNO2), 133.0 (ArC), 128.9 (ArC), 124.9 (ArC), 124.0 (ArC), 120.8 (ArC), 55.7 
(NCH2), 28.40 (NCH2CH2). LRMS: 250.1 (30) 204.1 (49) 130.1 (100). HRMS: 
Expected: 250.07705 Found: 250.0771 
(E)-N-Benzyl-N-methyl-2-(2-nitrovinyl)aniline 468 
 
Prepared via general procedure C. Toluene (40 mL), 
2-(benzyl(methyl)amino)benzaldehyde (2.25 g, 10.0 mmol), KF (110 mg, 
1.90 mmol), dimethylamine hydrochloride (1.24 g, 15.0 mmol) and MeNO2 (35 
mL). Purified via column chromatography (2% EtOAc in hexane) to give the 
product as a bright red oil (761 mg, 28%).  
 1H NMR (400 MHz, CDCl3) δ 8.52 (1H, d, J = 13.8 Hz, CHCHNO2), 7.64 (1H, d, 
J = 13.8 Hz, CHNO2), 7.52 – 7.48 (1H, m, ArH), 7.45 – 7.39 (1H, m, ArH), 7.36 – 
7.30 (2H, m, ArH), 7.27 (3H, m, ArH), 7.16 – 7.12 (1H, m, ArH), 7.12 – 7.06 (1H, 
m, ArH), 4.13 (2H, s, NCH2Ar), 2.69 (3H, s, NCH3). IR (neat): 3099 C-H 3058 C-
H 3025 C-H 2945 C-H 1623 C=C 1593 C=C 1552 NO2 1507 cm-1 C=C. LRMS 
269.1 (100) 270.1 (20). HRMS Expected: 269.1290 Found: 269.1298 
(E)-N-(4-Methoxybenzyl)-N-methyl-2-(2-nitrovinyl)aniline 486 
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Prepared via general procedure C. Toluene (10 mL), 2-((4-
methoxybenzyl)(methyl)amino)benzaldehyde (616 mg, 2.40 mmol), KF (22 mg, 
0.46 mmol), dimethylamine hydrochloride (297 mg, 3.62 mmol) and MeNO2 (8.5 
mL). Purified via column chromatography (10% EtOAc in hexane) to give the 
product as a red oil (228 mg, 32%). 
1H NMR (600 MHz, CDCl3) δ 8.52 (1H, d, J = 13.8 Hz, CHCHNO2), 7.65 (1H, d, 
J = 13.8 Hz, ArCHNO2), 7.50 (1H, dd, J = 7.7, 1.4 Hz, ArH), 7.46 – 7.39 (1H, m, 
ArH), 7.19 – 7.15 (2H, m, ArH), 7.13 (1H, d, J = 8.2 Hz, ArH), 7.09 (1H, dd, J = 
11.4, 4.1 Hz, ArH), 6.88 – 6.84 (2H, m, ArH), 4.06 (2H, s, NCH2), 3.80 (3H, s, 
OCH3), 2.67 (3H, s, NCH3). 13C NMR (150 MHz, CDCl3) δ 159.1 (ArC), 154.4 
(ArC), 137.2 (CHCHNO2), 136.9 (CHNO2), 132.8 (ArC), 130.0 (ArC), 129.4 (ArC), 
129.3 (ArC), 124.8 (ArC), 123.3 (ArC), 121.2 (ArC), 113.9 (ArC), 61.7 (NCH2Ar), 
55.4 (OCH3), 41.6 (NCH3). IR (neat): 3097 C-H 3030 C-H 2950 C-H 2832 C-H 
2798 C-H 1623 C=C 1609 C=C 1594 C=C 1508 cm-1 C=C. LRMS 299.1 (100) 
300.1 (18). HRMS Expected: 299.13174 Found: 299.13181 
(E)-N-(4-Chlorobenzyl)-N-methyl-2-(2-nitrovinyl)aniline 487 
 
Prepared via general procedure C. Toluene (4.0 mL), 2-((4-
chlorobenzyl)(methyl)amino)benzaldehyde (261 mg, 1.00 mmol), KF (13 mg, 
0.20 mmol), dimethylamine hydrochloride (126 mg, 1.50 mmol) and MeNO2 (3.6 
mL). Purified via column chromatography (10% EtOAc in hexane) to give the 
product as a red oil (105 mg, 35%). 
 1H NMR (700 MHz, CDCl3) δ 8.50 (1H, d, J = 13.8 Hz, CHCHNO2), 7.64 (1H, d, 
J = 13.8 Hz, CHNO2), 7.51 (1H, d, J = 7.8 Hz, ArH), 7.42 (1H, t, J = 7.3 Hz, ArH), 
7.30 (2H, d, J = 8.3 Hz, ArH), 7.20 (2H, d, J = 8.2 Hz, ArH), 7.11 (2H, m, ArH), 
4.09 (2H, s, NCH2Ar), 2.68 (3H, s, NCH3). 13C NMR (175 MHz, CDCl3) δ 154.0 
(ArC), 137.1 (ArCHCHNO2), 136.8 (CHNO2), 135.8 (ArC), 133.5 (ArC) 132.8 
(ArC), 130.0 (ArC), 129.3 (ArC), 128.8 (ArC), 124.8 (ArC), 123.6 (ArC), 121.2 
(ArC), 61.4 (NCH2Ar), 42.1 (NCH3). IR (neat) 3102 C-H 3032 C-H 2879 C-H 2800 
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C-H  1625 C=C 1596 C=C 1553 NO2 1509 cm-1 C=C. LRMS 303.1 (100) 304.1 
(17) 305.1 (37). HRMS Expected: 303.0900 Found: 303.0908 
(E)-N,N-Dibenzyl-2-(2-nitrovinyl)aniline 
 
Prepared via general procedure C. Toluene, (5.0 mL), 2-dibenzylamino 
benzaldehyde (75 mg, 0.25 mmol), KF (3 mg, 0.06 mmol), dimethylamine 
hydrochloride (46 mg, 0.6 mmol) and MeNO2 (2.0 mL). Purified via column 
chromatography (0-2% EtOAc in hexane) to give the product as an orange oil 
(11 mg, 13%). 
1H NMR (400 MHz, CDCl3) δ 8.62 (1H, d, J = 13.8 Hz, ArCHCHNO2), 7.55 (1H, 
d, J = 13.8 Hz, ArCHCHNO2), 7.48 (1H, dd, J = 7.7, 1.4 Hz, ArH), 7.40 – 7.33 
(2H, m, ArH), 7.32 – 7.21 (6H, m, ArH), 7.21 – 7.15 (3H, m, ArH), 7.09 (2H, t, J = 
8.1 Hz, ArH), 4.15 (4H, s, ArCH2N). 13C NMR (150 MHz, CDCl3) δ 152.4 (ArC), 
137.2 (ArCHCHNO2), 136.9 (ArC), 136.7 (CHNO2), 132.4 (ArC), 129.0 (ArC), 
128.7 (ArC), 128.5 (ArC), 127.6 (ArC), 126.2 (ArC), 124.1 (ArC), 123.6 (ArC), 
58.5 ((ArCH2)2N). IR (neat): 2953 C-H 2927 C-H 2858 C-H 1623 C=C 1593 C=C 
1509 cm-1 C=C. LRMS 345.1 (100), 346.1 (20). HRMS Expected: 345.1063 
Found: 345.1605 
(E)-N,N-Dibutyl-2-(2-nitrovinyl)aniline 495 
 
Prepared via general procedure C. Toluene (12 mL), 2-dibutylamino 
benzaldehyde (700 mg, 3.00 mmol), KF (33 mg, 0.57 mmol), dimethylamine 
hydrochloride (376 mg, 4.50 mmol) and MeNO2 (11 mL). Purified via column 
chromatography (0-2% EtOAc in hexane) to give the product as an orange oil 
(398 mg, 48%). 
1H NMR (600 MHz, CDCl3) δ 8.41 (1H, d, J = 13.8 Hz, CHCHNO2), 7.65 (1H, d, 
J = 13.8 Hz, CHNO2), 7.49 (1H, dd, J = 7.8, 1.3 Hz, ArH), 7.43 – 7.40 (1H, m, 
ArH), 7.17 (1H, d, J = 8.2 Hz, ArH), 7.07 (1H, t, J = 7.7 Hz, ArH), 3.03 – 2.99 (4H, 
m, NCH2), 1.44 (4H, tt, J = 7.7, 6.5 Hz, NCH2CH2), 1.30 – 1.22 (4H, m, 
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NCH2CH2CH2), 0.86 (6H, t, J = 7.4 Hz, NCH2CH2CH2CH3). 13C NMR (150 MHz, 
CDCl3) δ 153.4 (ArC), 137.4 (CHCHNO2), 136.7 (CHNO2), 132.26 (ArC), 129.3 
(ArC), 126.1 (ArC), 123.1 (ArC), 122.5 (ArC), 54.5 (NCH2), 29.6 (NCH2CH2), 20.5 
(NCH2CH2CH2), 14.0 (NCH2CH2CH2CH3). LRMS 277.1 (100), 251.1 (76). HRMS 
Expected: 277.1916 Found: 277.1921 
(E)-1-(4-Bromo-2-(2-nitrovinyl)phenyl)pyrrolidine 496 
 
Prepared via general procedure C. Toluene (8.0 mL), 5-Bromo-2-(pyrrolidin-1-
yl)benzaldehyde (530 mg, 2.09 mmol), KF (23 mg, 0.40 mmol), dimethylamine 
hydrochloride (255 mg, 3.13 mmol) and MeNO2 (6.5 mL). Purified via automatic 
column chromatography to give a red solid (242 mg, 39%). 
1H NMR (600 MHz, CDCl3) δ 8.33 (1H, d, J = 13.4 Hz, CHCHNO2), 7.46 (1H, d, 
J = 2.4 Hz, ArH), 7.42 (1H, d, J = 13.4 Hz, ArCHNO2), 7.37 (1H, dd, J = 8.9, 2.4 
Hz, ArH), 6.75 (1H, d, J = 9.0 Hz, ArH), 3.35 (4H, m, NCH2), 2.01 – 1.96 (4H, m, 
NCH2CH2). 13C NMR (150 MHz, CDCl3) δ 150.1 (ArC), 138.3 (ArCHCHNO2), 
135.4 (ArC), 135.0 (ArC), 131.8 (CHNO2), 119.9 (ArC), 117.4 (ArC), 110.9 (ArC), 
52.9 (NCH2), 25.8 (NCH2CH2). IR (neat) 3112 C-H 2987 C-H 2950 C-H 2922 C-H 
2851 C-H 1607 C=C 1588 C=C 1551 NO2 1530 cm-1. LRMS: 297.0 (100), 299.0 
(97). HRMS Expected: 297.0239 Found: 297.0248 m.p. 88-89 °C 
(E)-3-(2-Nitrovinyl)-2-(pyrrolidin-1-yl)pyridine 497 
 
Prepared via general procedure C. Toluene (12 mL), 2-(pyrrolidin-1-yl)-
nicotinaldehyde (584mg, 3.35 mmol), KF (41 mg, 0.68 mmol), dimethylamine 
hydrochloride (412 mg, 5.02 mmol) and MeNO2 (10 mL). Purified via column 
chromatography (20% EtOAc in hexane) to give the product as a bright red solid 
(282 mg, 30%). 
1H NMR (600 MHz, CDCl3) δ 8.36 (1H, d, J = 13.3 Hz, CHCHNO2), 8.25 (1H, dd, 
J = 4.6, 1.8 Hz, ArH), 7.59 (1H, dd, J = 7.6, 1.6 Hz, ArH), 7.37 (1H, d, J = 13.3 
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Hz, CHNO2), 6.68 (1H, dd, J = 7.6, 4.7 Hz, ArH), 3.65 – 3.60 (4H, m, NCH2), 1.99 
– 1.94 (4H, m, NCH2CH2). 13C NMR (150 MHz, CDCl3) δ 158.4 (ArC), 151.3 
(ArC), 138.8 (ArCCHCHNO2), 138.0 (ArC), 135.1 (CHNO2), 113.5 (ArC), 110.6 
(ArC), 51.3 (NCH2CH2), 25.9 (NCH2CH2). IR (neat) 3176 C-H 3104 C-H 2983 C-H 
2958 C-H 2876 C-H 2859 C-H 1683 C=C 1607 C=C 1586 C=C 1545 cm-1 NO2. 
LRMS 279.1 (100). HRMS Expected: 220.1086 Found: 220.1112 m.p. 64-66 °C 
 (E)-1-(4,5-Dimethoxy-2-(2-nitrovinyl)phenyl)pyrrolidine 498 
 
Prepared via general procedure C. Toluene (6.0 mL), 4,5-dimethoxy-2-
(pyrrolidin-1-yl)benzaldehyde (353 mg, 1.50 mmol), KF (17 mg, 0.29 mmol), 
dimethylamine hydrochloride (185 mg, 2.27 mmol) and MeNO2 (5.0 mL). Purified 
via column chromatography (20% EtOAc in hexane) to give the product as a dark 
purple solid (259 mg, 62%). 
1H NMR (600 MHz, CDCl3) δ 8.45 (1H, d, J = 13.3 Hz, CHCHNO2), 7.45 (1H, d, 
J = 13.2 Hz, CHNO2), 6.83 (1H, s, ArH), 6.45 (1H, s, ArH), 3.93 (3H, s, OCH3), 
3.86 (3H, s, OCH3), 3.36 – 3.33 (4H, m, NCH2), 2.04 – 1.96 (4H, m, NCH2CH2). 
13C NMR (150 MHz, CDCl3) δ 153.9 (ArC), 148.5 (ArC), 143.3 (ArC), 138.8 
(CHCHNO2), 132.4 (CHNO2), 111.1 (ArC), 110.7 (ArC), 99.9 (ArC), 56.4 (OCH3), 
56.0 (OCH3), 53.6 (NCH2), 25.6 (NCH2CH2). IR (neat): 3118 C-H 2964 C-H 2918 
C-H 2862 C-H 2848 C-H 2826 C-H 1625 C=C 1584 C=C 1569 C=C 1546 NO2 
1517 cm-1 C=C. LCMS 279.1 (100) 280.1 (18). HRMS Expected: 279.1345 Found 
279.1347 m.p. 136-138 °C 
(E)-1-(6-(2-Nitrovinyl)benzo[d][1,3]dioxol-5-yl)pyrrolidine 499 
 
Prepared via general procedure C. Toluene (6.0 mL), 6-(pyrrolidin-1-yl) piperonal 
(334 mg, 1.53 mmol), KF (19 mg, 0.31 mmol), dimethylamine hydrochloride (186 
mg, 2.28 mmol) and MeNO2 (5.0 mL). Purified via column chromatography (10% 
EtOAc in hexane) to give the produce as a red solid (140 mg, 36%). 
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1H NMR (600 MHz, CDCl3) δ 8.41 (1H, d, J = 13.3 Hz, CHCHNO2), 7.40 (1H, d, 
J = 13.3 Hz, CHNO2), 6.84 (1H, s, ArH), 6.55 (1H, s, ArH), 5.96 (2H, s, OCH2O), 
3.27 (4H, m, NCH2), 2.00 – 1.95 (4H, m, NCH2CH2).  13C NMR (150 MHz, CDCl3) 
δ 152.5 (ArC), 150.1 (ArC), 142.1 (ArC), 138.7 (CHCHNO2), 132.8 (CHNO2), 
112.8 (ArC), 106.9 (ArC), 101.8 (OCH2O), 98.1 (ArC), 53.9 (NCH2), 25.5 
(NCH2CH2). IR (neat) 3128 C-H 2950 C-H 2917 C-H 2835 C-H 2678 C-H 1596 
C=C 1502 cm-1 C=C. LCMS 236.1 (50) 264.1 (10) 277.1 (100). HRMS Expected: 
263.1032 Found: 263.1040 m.p. 91-93 °C 
(E)-1-(2-(2-Nitrovinyl)thiophen-3-yl)pyrrolidine 500 
 
Prepared via general procedure C. Toluene (4.0 mL), 3-(pyrrolidin-1-
yl)thiophene-2-carbaldehyde (170 mg, 0.94 mmol), KF (12 mg, 0.19 mmol), 
diemethylamine hydrochloride (122 mg, 1.50 mmol), and MeNO2 (3.5 mL). 
Purified via column chromatography to give the product as a yellow solid (69 mg, 
31%). 
1H NMR (600 MHz, CDCl3) δ 8.56 (1H, dd, J = 12.2, 1.0 Hz, CHCHNO2), 7.37 
(1H, dd, J = 5.7, 1.1 Hz, ArH), 7.22 (1H, d, J = 12.2 Hz, ArCHNO2), 6.56 (1H, d, 
J = 5.7 Hz, ArH), 3.65 – 3.61 (4H, m, NCH2), 2.12 – 2.05 (4H, m, NCH2CH2). 
13C NMR (150 MHz, CDCl3) δ 154.0 (ArC), 135.0 (ArCHCHNO2), 132.5 (ArC), 
127.6 (CHNO2), 119.9 (ArC), 105.3 (ArC), 52.2 (NCH2), 25.8 (NCH2CH2). IR 
(neat) 3087 C-H 2959 C-H 2922 C-H 2852 C-H 1534 cm-1 NO2. LRMS 225 (100). 
HRMS Expected: 225.0698 Found: 225.0115 m.p. 157-159 °C 
(E)-4-(4,5-Dimethoxy-2-(2-nitrovinyl)phenyl)morpholine 541 
 
Prepared via general procedure C. Toluene (4.0 mL), 4,5-dimethoxy-2-
morpholinobenzaldehyde (251 mg, 1.00 mmol), KF (13 mg, 0.2 mmol), 
dimethylamine hydrochloride (128 mg, 1.57 mmol) and MeNO2 (3.5 mL). Purified 
via column chromatography to give the product as a dark red solid (118 mg, 40%). 
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1H NMR (600 MHz, CDCl3) δ 8.45 (1H, d, J = 13.7 Hz, CHCHNO2), 7.63 (1H, d, 
J = 13.7 Hz, CHNO2), 6.94 (1H, s, ArH), 6.69 (1H, s, ArH), 3.95 (3H, s, OCH3), 
3.93 – 3.91 (4H, m, NCH2CH2), 3.90 (3H, s, OCH3), 2.97 – 2.93 (4H, m, NCH2). 
IR (neat) 3106 C-H 2930 C-H 2908 C-H 2829 C-H 1618 C=C 1596 C=C 1564 NO2 
1506 cm-1 C=C. LRMS 295.1 (100). HRMS Expected: 295.1294 Found: 295.1282 
m.p. 116-118 °C 
(E)-4-(4,5-Dimethoxy-2-(2-nitrovinyl)phenyl)thiomorpholine 542 
 
Prepared via general procedure C. Toluene (2.0 mL), 4,5-dimethoxy-2-
thiomorpholinobenzaldehyde (80 mg, 0.30 mmol), KF (4 mg, 0.08 mmol), 
diemethylamine hydrochloride (40 mg, 0.45 mmol), and MeNO2 (1.0 mL). Purified 
via column chromatography to give the product as a red solid (62 mg, 67%). 
1H NMR (600 MHz, CDCl3) δ 8.43 (1H, d, J = 13.7 Hz, CHCHNO2), 7.60 (1H, d, 
J = 13.7 Hz, CHNO2), 6.93 (1H, s, ArH), 6.68 (1H, s, ArH), 3.94 (3H, s, OCH3), 
3.90 (3H, s, OCH3), 3.21 – 3.15 (3H, m, NCH2), 2.87 (3H, apparent singlet, 
NCH2CH2) IR (neat) 3109 C-H 2955 C-H 2913 C-H 2890 C-H 2850 C-H 2825 C-
H 1618 C=C 1596 C=C 1562 NO2 1507 cm-1 C=C. LRMS 311.1 (100) 312.1 (15). 
HRMS: Expected: 310.1066 Found: 311.1243 m.p. 103-104 °C 
(E)-1-(Benzyloxy)-2-(2-nitrovinyl)benzene 465 
 
A suspension of K2CO3 (303 mg, 2.20 mmol) in EtOH (5.0 mL) was prepared and 
to this was added salicyl aldehyde (0.24 mL, 2.3 mmol) and benzyl bromide 
(0.3 mL, 2.5 mg). The resulting mixture was heated to reflux for 18 h before being 
cooled to rt and the solvent was then removed in vacuo. The resulting residue 
was taken up in EtOAc (25 mL) and washed with water (25 mL), sat. NaHCO3 
solution (3 x 25 mL) and brine (25 mL) before drying (MgSO4), filtering and the 
solvent removed in vacuo to give the benzylated aldehyde as a crude product 
that was used directly. 
                                                                                                            Oliver Ware 
181 
 
To AcOH (5.0 mL) was added 2-(benzyloxy)benzaldehyde (415 mg, 1.96 mmol), 
ammonium acetate (161 mg, 2.09 mmol) and MeNO2 (1.10 mL, 20 mmol). The 
resulting mixture was heated to 80 ºC for 162 h before being cooled to rt. The 
reaction mixture was diluted in EtOAc (50 mL) and washed with sat. NaHCO3 
solution (4 x 50 mL) and brine (50 mL) before being dried (MgSO4), filtered and 
the solvent removed in vacuo. The crude material was purified via column 
chromatography to give the product as a yellow crystalline solid (187 mg, 42% 
over two steps). 
1H NMR (400 MHz, CDCl3) δ 8.19 (1H, d, J = 13.6 Hz, CHCHNO2), 7.85 (1H, d, 
J = 13.6 Hz, CHNO2), 7.48 (1H, dd, J = 7.9, 1.7 Hz, ArH), 7.46 – 7.34 (6H, m, 
ArH), 7.06 – 7.00 (2H, m, ArH), 5.22 (2H, s, OCH2Ph). m.p. 70-72 °C Lit. 71-
73 °C236 
Data in agreement with literature values215 
 (E)-1-(4-(2-Nitrovinyl)phenyl)pyrrolidine 
 
Prepared via general procedure C. Toluene (14 mL), 4-(pyrrolidin-1-
yl)benzaldehyde (502 mg, 2.85 mmol), Me2NH.HCl (481 mg, 5.90 mmol), KF 
(47 mg, 0.81 mmol) and MeNO2 (12 mL). Purified via column chromatography 
(20% EtOAc in hexane) to give the product as a red crystalline solid (315 mg, 
51%). 
1H NMR (600 MHz, CDCl3) δ 7.98 (1H, d, J = 13.4 Hz, CHCHNO2), 7.50 (1H, d, 
J = 13.3 Hz, ArCHNO2), 7.44 – 7.39 (2H, m, ArH), 6.58 – 6.53 (2H, m, ArH), 3.41 
– 3.35 (4H, m, NCH2), 2.10 – 2.02 (4H, m, NCH2CH2). 13C NMR (150 MHz, CDCl3) 
δ 150.7 (ArC), 140.8 (ArCCHCHNO2), 131.8 (ArC), 131.6 (CHNO2), 116.9 (ArC), 
112.2 (ArC), 47.8 (NCH2CH2), 25.5 (NCH2CH2). IR (neat): 3103 C-H 2972 C-H 
2952 C-H 2853 C-H 1591 C=C 1531 cm-1 NO2. LRMS (CI) 219.1 (100). HRMS: 
Expected: 219.1128 Found: 219.1128 m.p. 136-138 ºC  
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(E)-1-Fluoro-2-(2-nitrovinyl)benzene 
 
To toluene (1 mL) was added 2-fluorobenzaldehyde (0.11 mL, 1.0 mmol), MeNO2 
(0.32 mL, 5.9 mmol), iron (III) chloride (17 mg, 0.10 mmol) and piperidine (9.8 µL, 
0.10 mmol) before the mixture was heated to 100 ºC for 18 h. Following cooling 
to rt the solvent was removed in vacuo and the resulting residue was purified via 
column chromatography (5% EtOAc in hexane) to give the product as an off-white 
crystalline solid (137 mg, 82%). 
1H NMR (300 MHz, CDCl3) δ 8.06 (1H, d, J = 13.8 Hz, CHCHNO2), 7.74 (1H, d, 
J = 13.8 Hz, CHNO2), 7.57 – 7.44 (2H, m, ArH), 7.29 – 7.13 (2H, m, ArH). m.p. 
52-54 °C Lit. 56 °C217 
Data in agreement with literature217 
(E)-1-(2-Nitrovinyl)-2-propoxybenzene 521 
 
Ammonium acetate (778 mg, 10.1 mmol) and 2-propoxybenzaldehyde (824 mg, 
5.01 mmol) were dissolved in AcOH (12.4 mL). MeNO2 (2.8 mL, 50 mmol) was 
added and heated to 80 °C for 36 h. The reaction was cooled then neutralised 
with NaHCO3 (sat. solution). The organics were extracted with EtOAc (3 x 25 mL), 
combined, washed with sat. NaHCO3 solution (3 x 75 mL), dried (MgSO4), filtered 
and the solvent was removed in vacuo. The crude residue was purified via column 
chromatography (10% EtOAc in hexane) to give the product as a yellow 
crystalline solid (793 mg, 77%). 
1H NMR (300 MHz, CDCl3) δ 8.15 (1H, d, J = 13.6 Hz, CHCHNO2), 7.92 (1H, d, 
J = 13.6 Hz, CHNO2), 7.44 (2H, t, J = 7.7 Hz, ArH), 6.99 (2H, m, ArH), 4.07 (2H, 
t, J = 6.5 Hz, OCH2), 1.93 (2H, tq, J = 7.4, 6.7 Hz, OCH2CH2), 1.10 (3H, t, J = 7.4 
Hz, OCH2CH2CH3) 
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3.4.3 Synthesis of Cyclised Products 
General Procedure D 
Nitroalkene (1 equivalent) and Gd(OTf)3 (0.3 equivalents) were heated in toluene 
(10.0 mL per mmol) to 100 °C until the reaction reached completion (18 h unless 
otherwise stated). The toluene was then removed in vacuo and the resultant 
residue purified via column chromatography to give the cyclised product. 
(3aS*,4R*)-4-Nitro-1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinoline 358a 
 
To HFIP (4 mL) was added (E)-1-(2-(2-nitrovinyl)phenyl)pyrrolidine (60 mg, 0.27 
mmol). The solution was heated to 58 °C for 4 h then cooled to rt and the solvent  
removed in vacuo to give a crude residue which was purified via column 
chromatography (2% EtOAc in hexane) to give the product as a yellow crystalline 
solid (54 mg, 90%). 
1H NMR (400 MHz, CDCl3) δ 7.15 (1H, t, J = 7.7 Hz, ArH), 7.05 (1H, d, J = 7.4 
Hz, ArH), 6.66 (1H, td, J = 7.4, 1.0 Hz, ArH), 6.50 (1H, d, J = 8.1 Hz, ArH), 4.46 
(1H, ddd, J = 11.9, 9.7, 4.8 Hz, CHNO2), 3.83 – 3.73 (1H, m, (NO2)CHCHN), 3.53 
– 3.41 (2H, m, NCH2/ArCH2), 3.34 – 3.20 (2H, m, NCH2/ArCH2), 2.24 (1H, ddd, J 
= 12.2, 7.1, 2.0 Hz, (NO2)CHCHCH2), 2.17 – 2.09 (1H, m, (NO2)CHCHCH2), 2.05 
– 1.95 (1H, m, NCH2CH2), 1.82 – 1.71 (1H, m, NCH2CH2). m.p. 94-95 °C Lit. not 
reported 
Data in agreement with literature values171 
(4aS*,5R*)-5-Nitro-2,3,4,4a,5,6-hexahydro-1H-pyrido[1,2-a]quinoline 456a 
 
To HFIP (4.0 mL) was added (E)-1-(2-(2-nitrovinyl)phenyl)piperidine (92 mg, 0.40 
mmol). The solution was heated to 58 °C for 18 h then cooled to rt and the solvent 
was removed in vacuo to give a crude residue which was purified via column 
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chromatography (2% EtOAc in hexane) to give the product as a waxy yellow solid 
(53 mg, 58%). 
1H NMR (600 MHz, CDCl3) δ 7.18 – 7.15 (1H, td, J = 8.3, 0.8 Hz, ArH), 7.05 (1H, 
d, J = 7.3 Hz, ArH), 6.84 (1H, d, J = 8.3 Hz, ArH), 6.76 (1H, td, J = 7.4, 0.8 Hz, 
ArH), 4.70 (1H, ddd, J = 7.7, 6.2, 5.1 Hz, CHNO2), 3.95 – 3.89 (1H, m, NCH2), 
3.54 (1H, ddd, J = 10.8, 6.2, 2.5 Hz, NCHCHNO2), 3.44 (1H, dd, J = 15.5, 7.8 Hz, 
ArCH2), 3.16 (1H, dd, J = 15.5, 5.0 Hz, ArCH2), 2.83 (1H, td, J = 12.6, 2.9 Hz, 
NCH2), 1.95 – 1.88 (1H, m, ring H), 1.80 – 1.72 (1H, m, NCH2CH2), 1.69 – 1.44 
(4H, m, ring H) 13C NMR (150 MHz, CDCl3) δ 145.3 (ArC), 129.2 (ArC), 128.3 
(ArC), 120.0 (ArC), 118.8 (ArC), 113.1 (ArC), 86.4 (CHNO2), 59.0 (NCH), 48.1 
(NCH2), 31.5 (ArCH2), 30.1 (NCHCH2), 24.5 (NCH2CH2), 24.1 (NCH2CH2CH2) IR 
(neat): 2938 C-H 2850 C-H 1597 C=C 1576 C=C 1540 cm-1 NO2. LRMS: 233.1 
(100) 234.1 (15). HRMS: Expected: 233.1290 Found: 233.1305 
(6R*,6aS*)-6-Nitro-5,6,6a,7,8,9,10,11-octahydroazepino[1,2-a]quinoline 
527a 
 
(6R*,6aR*)-6-Nitro-5,6,6a,7,8,9,10,11-octahydroazepino[1,2-a]quinolone 
527b 
 
Prepared via general procedure D. Toluene (4.0 mL), (E)-1-(2-(2-
nitrovinyl)phenyl)azepane (90 mg, 0.40 mmol), Gd(OTf)3 (74 mg, 0.12 mmol). 
Purified via column chromatography (5% EtOAc in hexane) to give the product 
as a yellow oil (60 mg, 67%, dr 2:1). 
527a 1H NMR (600 MHz, CDCl3) δ 7.10 (1H, t, J = 7.8 Hz, ArH), 7.06 (1H, d, J = 
7.4 Hz, ArH), 6.66 (1H, t, J = 7.3 Hz, ArH), 6.60 (1H, d, J = 8.3 Hz, ArH), 4.69 – 
4.67 (1H, m, CHNO2), 4.12 (1H, ddd, J = 7.6, 6.4, 3.1 Hz, NCHCHNO2), 3.85 (1H, 
ddd, J = 15.3, 5.9, 2.9 Hz, NCH2), 3.54 (1H, d, J = 17.8 Hz, ArCH2), 3.21 (1H, dd, 
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J = 17.8, 5.4 Hz, ArCH2), 3.11 (1H, ddd, J = 15.6, 10.6, 5.3 Hz, NCH2), 2.11 – 
2.03 (1H, m, NCH2CH2), 1.87 – 1.82 (1H, m, NCHCH2), 1.72 – 1.59 (4H, m, ring 
protons), 1.58 – 1.50 (1H, m, NCHCH2), 1.48 – 1.40 (1H, m, NCH2CH2CH2). 13C 
NMR (150 MHz, CDCl3) δ 143.0 (ArC), 129.2 (ArC), 128.0 (ArC), 116.5 (ArC), 
116.0 (ArC), 111.0 (ArC), 81.9 (CHNO2), 60.6 (NCHCHNO2), 49.4 (NCH2), 33.5 
(NCHCH2), 27.4 (NCH2CH2), 27.2 (ArCH2), 26.1 (NCHCH2CH2), 25.9 
(NCH2CH2CH2). IR (neat): 3025 C-H 2923 C-H 2858 C-H 1602 C=C 1578 C=C 
1540 NO2 1499 cm-1 C=C. LRMS (ES+) 247.1 (100) 248.1 (18). HRMS Expected 
247.1447 Found 247.1461 
527b 1H NMR (600 MHz, CDCl3) δ 7.12 (1H, t, J = 7.7 Hz, ArH), 7.08 (1H, t, J = 
6.8 Hz, ArH), 6.67 (1H, td, J = 7.4, 0.7 Hz, ArH), 6.62 (1H, d, J = 8.3 Hz, ArH), 
4.90 (1H, ddd, J = 12.4, 5.7, 4.3 Hz, CHNO2), 4.08 (1H, dt, J = 8.5, 4.3 Hz, NCH), 
3.92 (1H, ddd, J = 15.1, 6.1, 3.1 Hz, NCH2), 3.53 (1H, dd, J = 16.2, 12.4 Hz, 
ArCH2), 3.27 – 3.16 (2H, m, NCH2, ArCH2), 2.15 – 2.06 (1H, m, ring H), 1.72 – 
1.47 (6H, m, ring H), 1.43 – 1.33 (1H, m, ring H) 13C NMR (150 MHz, CDCl3) δ 
142.9 (ArC), 129.9 (ArC), 128.3 (ArC), 116.6 (ArC), 116.1 (ArC), 110.8 (ArC), 
81.1 (CHNO2), 60.0 (NCH), 49.9 (ArC), 28.7 (ring C), 27.0 (ring C), 26.7 (ring C), 
26.2 (ring C), 25.6 (ring C) IR (neat): 3021 C-H 2930 C-H 2903 C-H 2855 C-H 
1600 C=C 1574 C=C 1530 NO2 1494 cm-1 C=C. LRMS: 247.1 (100) 248.1 (18). 
HRMS Expected 247.1447 Found 247.1461 
5-Nitro-1,2,4,4a,5,6-hexahydro-[1,4]thiazino[4,3-a]quinoline 531 
 
Prepared via general procedure D with a reaction time of 7 d. Toluene (4.0 mL), 
(E)-4-(2-(2-nitrovinyl)phenyl)thiomorpholine (100 mg, 0.4 mmol), Gd(OTf)3 (72 
mg, 0.12 mmol). Purified via column chromatography (10% EtOAc in hexane) to 
give the product as a yellow waxy solid (9 mg, 9%). 
1H NMR (600 MHz, CDCl3) δ 7.17 (1H, td, J = 8.3, 1.5 Hz, ArH), 7.09 (1H, d, J = 
7.2 Hz, ArH), 6.80 (1H, td, J = 7.4, 0.8 Hz, ArH), 6.76 (1H, d, J = 8.3 Hz, ArH), 
4.67 (1H, q, J = 5.0 Hz, CHNO2), 4.34 (1H, dddd, J = 11.0, 4.4, 2.0, 1.1 Hz, NCH), 
4.29 (1H dt, J = 14.5, 2.8 Hz, NCH2), 3.48 – 3.42 (2H, m, ArCH2, NCH2), 3.15 
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(1H, dd, J = 16.6, 5.2 Hz, ArCH2), 3.03 (1H, ddd, J = 13.5, 12.2, 2.7 Hz, 
NCH2CH2), 2.80 (1H, dd, J = 13.0, 11.0 Hz, NCHCH2), 2.39 (1H, d, J = 13.0 Hz, 
NCHCH2), 2.31 (1H, ddd, J = 13.4, 4.0, 2.5 Hz, NCH2CH2) 13C NMR (150 MHz, 
CDCl3) δ 142.9 (ArC), 129.4 (ArC), 128.5 (ArC), 119.6 (ArC), 119.1 (ArC), 113.5 
(ArC), 83.9 (CHNO2), 60.5 (NCH), 50.1 (ArCH2), 28.8 (NCH2), 28.2 (NCHCH2), 
23.4 (NCH2CH2). LRMS: 251.1 (100) 252.1 (21) 253.1 (18) 254.1 (10). HRMS: 
Expected: 251.0854 Found 251.0858 
(2S*,3R*)-1-Methyl-3-nitro-2-phenyl-1,2,3,4-tetrahydroquinoline 469a 
 
(2R*,3R*)-1-Methyl-3-nitro-2-phenyl-1,2,3,4-tetrahydroquinoline 469b 
  
Prepared via general procedure D. Toluene (4.0 mL), (E)-N-benzyl-N-methyl-2-
(2-nitrovinyl)aniline (109 mg, 0.41 mmol), Gd(OTf)3 (74 mg, 0.12 mmol). Purified 
via column chromatography (10% EtOAc in hexane) to give the product as a 
yellow solid (73 mg, 67%, dr 3:1). 
469a 1H NMR (500 MHz, CDCl3) δ 7.36 – 7.28 (3H, m, ArH), 7.23 – 7.18 (3H, m, 
ArH), 7.03 (1H, d, J = 7.3 Hz, ArH), 6.72 (2H, m, ArH), 5.19 (1H, apparent singlet, 
NCHAr), 4.84 (1H, apparent dd, J = 7.8, 3.9 Hz, CHNO2), 3.42 (1H, ddd, J = 16.8, 
3.7, 1.4 Hz, ArCH2), 3.01 (1H, dd, J = 16.8, 4.4 Hz, ArCH2) 13C NMR (175 MHz, 
CDCl3) δ 144.4 (ArC), 139.5 (ArC), 129.3 (ArC), 129.0 (ArC), 128.5 (ArC), 128.4 
(ArC), 126.6 (ArC), 117.3 (ArC), 110.6 (ArC), 83.8 (CHNO2), 64.8 (CHAr), 37.8 
(NCH3), 27.6 (ArCH2) IR (neat): 3060 C-H 3026 C-H 2895 C-H 2827 C-H 1601 
C=C 1576 C=C 1546 NO2 1497 cm-1 C=C. LRMS: 269.1 (100) 270.1 (17). HRMS: 
Expected: 269.1290 Found: 269.1986 m.p. 93-94 °C 
469b 1H NMR (500 MHz, CDCl3) δ 7.32 – 7.20 (5H, m, ArH), 7.08 (1H, d, J = 7.4 
Hz, ArH), 7.01 (2H, dt, J = 3.7, 2.1 Hz, ArH), 6.75 (1H, td, J = 7.4, 0.9 Hz, ArH), 
6.69 (1H, d, J = 8.2 Hz, ArH), 5.16 (1H, dd, J = 9.3, 4.6 Hz, CHAr), 5.15 – 5.12 
(1H, m, CHNO2), 3.33 – 3.25 (1H, m, ArCH2), 3.14 – 3.08 (1H, m, ArCH2), 1.55 
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(3H, s, NCH3). 13C NMR (125 MHz, CDCl3) δ 144.3 (ArC), 135.7 (ArC), 129.3 
(ArC), 128.5 (ArC), 128.5 (ArC), 128.3 (ArC), 127.1 (ArC), 116.8 (ArC), 116.3 
(ArC), 109.8 (ArC), 81.5 (CHNO2), 64.5 (NCHAr), 37.6 (NCH3), 26.4 
(ArCCH2CHNO2). IR (neat): 3025 C-H 2895 C-H 2833 C-H 1602 C=C 1577 C=C 
1542 NO2 1499 cm-1 C=C. LRMS: 269.1 (100) 270.1 (17). HRMS: Expected: 
269.1290 Found 269.1298 
(2S*,3R*)-2-(4-Methoxyphenyl)-1-methyl-3-nitro-1,2,3,4-tetrahydroquinoline 
533a 
 
Prepared via general procedure D. Toluene (4.0 mL), (E)-N-(4-methoxybenzyl)-
N-methyl-2-(2-nitrovinyl)aniline (114 mg, 0.38 mmol), Gd(OTf)3 (72 mg, 0.12 
mmol). Purified via column chromatography (10% EtOAc in hexane) to give the 
product as an orange waxy solid with inseparable diastereomers (96 mg, 84%, 
d.r. 10:1). 
1H NMR (600 MHz, CDCl3) δ 7.20 – 7.16 (1H, m, ArH), 7.07 – 7.03 (2H, m, ArH), 
6.87 – 6.84 (2H, m, ArH), 6.82 (1H, d, J = 7.6 Hz, ArH), 6.72 (1H, d, J = 8.3 Hz, 
ArH), 6.68 (1H, td, J = 7.5, 1.0 Hz, ArH), 4.90 (1H, td, J = 6.6, 3.4 Hz, CHNO2), 
4.80 (1H, d, J = 6.6 Hz, NCHAr), 3.79 (3H, s, OCH3), 3.77 (1H, ddd, J = 11.9, 6.7, 
1.1 Hz, ArCH2), 3.58 (1H, dd, J = 12.0, 3.4 Hz, ArCH2), 2.99 (3H, s, NCH3). 
13C NMR (150 MHz, CDCl3) δ 159.0 (ArC), 145.3 (ArC), 133.6 (ArC), 130.4 (ArC), 
130.1 (ArC), 128.3 (ArC), 121.7 (ArC), 118.1 (ArC), 114.4 (ArC), 111.7 (ArC), 
85.8 (CHNO2), 55.4 (OCH3), 51.2 (ArCH2), 46.4 (NCHAr), 39.3 (NCH3). IR (neat) 
2927 C-H 2833 C-H 1603 C=C 1575 C=C 1508 cm-1 C=C. LRMS: 269.1 (100) 
270.1 (18). HRMS: Expected: 269.1290 Found: 269.1294 
 1-Butyl-3-nitro-2-propyl-1,2,3,4-tetrahydroquinoline 536 
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Prepared via general procedure D. Toluene (3.0 mL), (E)-N,N-dibutyl-2-(2-
nitrovinyl)aniline (83 mg, 0.3 mmol), Gd(OTf)3 (53 mg, 0.09 mmol). Purified via 
column chromatography (0-2% EtOAc in hexane) to give the product as a yellow 
oil (82 mg, 74%). 
1H NMR (600 MHz, CDCl3) δ 7.10 (1H, t, J = 7.8 Hz, ArH), 7.07 (1H, d, J = 7.3 
Hz, ArH), 6.68 (1H, td, J = 7.4, 0.8 Hz, ArH), 6.58 (1H, d, J = 8.3 Hz, ArH), 4.75 
(1H, m, C), 4.04 (1H, m, NCH), 3.52 (1H, d, J = 18.1 Hz, ArCH2), 3.43 (1H, ddd, 
J = 14.6, 9.7, 5.0 Hz, NCH2), 3.12 (1H, dd, J = 18.1, 5.6 Hz, ArCH2), 2.99 (1H, 
ddd, J = 14.7, 9.8, 6.4 Hz, NCH2), 1.60 (2H, ddd, J = 10.2, 6.8, 2.7 Hz, NCHCH2), 
1.55 – 1.34 (4H, m, alkyl H), 1.33 – 1.25 (2H, m, alkyl H), 0.97 (3H,  td, J = 7.2, 
2.6 Hz, CH3), 0.93 (3H, t, J = 7.4 Hz, CH3). 13C NMR (150 MHz, CDCl3) δ 142.5 
(ArC), 129.2 (ArC), 127.7 (ArC), 117.0 (ArC), 116.7 (ArC), 111.9 (ArC), 81.1 
(CHNO2), 60.8 (NCH), 50.9 (NCH2), 34.4 (CH2), 29.8 (CH2), 26.2 (Ar CH2), 20.2 
(CH2), 19.4 (CH2), 14.2 (CH3), 14.1 (CH3). IR (neat) 3036 C-H 2954 C-H 2928 
C-H 2868 C-H 1601 C=C 1575 C=C 1544 NO2 1498 cm-1 C=C. LRMS: 277 (100) 
278 (20). HRMS Expected: 277.19160 Found: 277.19169 
(3aS*,4R*)-7-Bromo-4-nitro-1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinolone 
537a 
 
(3aR*,4R*)-7-Bromo-4-nitro-1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinolone 
537b 
 
Prepared via general procedure D. Toluene (4.0 mL), (E)-1-(4-bromo-2-(2-
nitrovinyl)phenyl)pyrrolidine (118 mg, 0.4 mmol), Gd(OTf)3 (74 mg, 0.12 mmol). 
Purified via column chromatography (5% EtOAc in hexane) to give the product 
as an orange crystalline solid (50 mg, 42%, dr 9:1). 
537a 1H NMR (600 MHz, CDCl3) δ 7.22 (1H, dd, J = 8.6, 1.9 Hz, ArH), 7.16 (1H, 
s, ArH), 6.36 (1H, d, J = 8.6 Hz, ArH), 4.42 (1H, ddd, J = 12.0, 9.7, 4.7 Hz, 
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CHNO2), 3.76 (1H, td, J = 9.6, 5.5 Hz, NCHCHNO2), 3.47 – 3.41 (2H, m, 
NCH2/ArCH2), 3.27 – 3.21 (m, 2H, NCH2/ArCH2), 2.25 (1H, ddd, J = 12.3, 6.9, 1.4 
Hz, (NO2)CHCHCH2), 2.16 (1H, ddd, J = 12.8, 9.7, 7.5 Hz, (NO2)CHCHCH2), 2.06 
– 1.96 (1H, m, NCH2CH2), 1.77 (1H, tdd, J = 11.9, 9.5, 7.8 Hz, NCH2CH2). 13C 
NMR (150 MHz, CDCl3) δ 142.1 (ArC), 131.4 (ArC), 131.1 (ArC), 119.4 (ArC), 
112.7 (ArC), 108.2 (ArC), 83.9 (CHNO2), 60.4 (NCH), 47.8 (NCH2), 33.4 (ArCH2), 
30.8 (NCH2CH2), 23.5 (NCHCH2). IR (neat) 2971 C-H 2946 C-H 2856 C-H 1595 
C=C 1532 NO2 1495 cm-1 C=C. LRMS (ES+) 297 (100) 299 (90). HRMS 
Expected 297.0239 Found 297.0236 m.p. 138 °C (dec.) 
537b 1H NMR (600 MHz, CDCl3) δ 7.21 (dt, J = 11.1, 5.6 Hz, 1H, ArH), 7.16 – 
7.14 (m, 1H, ArH), 6.40 (d, J = 8.6 Hz, 1H, ArH), 5.11 (dt, J = 5.1, 2.7 Hz, 1H, 
CHNO2), 3.74 (ddd, J = 9.2, 6.3, 2.7 Hz, 1H, NCH), 3.39 (td, J = 8.8, 3.4 Hz, 1H, 
NCH2), 3.33 – 3.26 (m, 3H, NCH2, ArCH2), 2.22 (dtd, J = 9.5, 6.9, 2.8 Hz, 1H, 
NCHCH2), 2.10 – 2.03 (m, 1H, NCH2CH2), 2.03 – 1.95 (m, 1H, NCH2CH2), 1.86 
– 1.78 (m, 1H, NCHCH2) 13C NMR (150 MHz, CDCl3) δ 142.8 (ArC), 131.1 (ArC), 
130.5 (ArC), 118.7 (ArC), 112.9 (ArC), 108.5 (ArC), 78.7 (CHNO2), 58.5 (NCH), 
47.3 (ArC), 31.6 (NCH2), 28.4 (NCHCH2), 23.1 (NCH2CH2). IR (neat) 2970 C-H 
2946 C-H 2855 C-H 1594 C=C 1532 NO2 1495 cm-1 C=C. LRMS: 297.0 (85) 
298.0 (100). HRMS: Expected: 297.0239 Found: 297.0248 m.p. 137 °C (dec.) 
(3aS*,4R*)-7,8-Dimethoxy-4-nitro-1,2,3,3a,4,5-hexahydropyrrolo[1,2-
a]quinoline 539a 
 
Prepared via general procedure D. Toluene (4.0 mL), (E)-1-(4,5-dimethoxy-2-(2-
nitrovinyl)phenyl)pyrrolidine (111 mg, 0.4 mmol), Gd(OTf)3 (73 mg, 0.12 mmol). 
Purified via column chromatography (20% EtOAc in hexane) to give the product 
as an orange crystalline solid (69 mg, 62%). 
1H NMR (600 MHz, CDCl3) δ 6.63 (1H, s, ArH), 6.14 (1H, s, ArH), 4.45 (1H, ddd, 
J = 11.8, 9.8, 4.9 Hz, CHNO2), 3.87 (3H, s, OCH3), 3.81 (3H, s, OCH3), 3.72 (1H, 
td, J = 9.2, 5.7 Hz, NCH), 3.47 (1H, td, J = 8.6, 3.0 Hz, NCH2), 3.42 (1H, ddd, J = 
14.9, 11.9, 0.7 Hz, ArCH2), 3.29 (1H, dd, J = 16.0, 8.4 Hz, NCH2), 3.20 (1H, dd, 
J = 15.0, 4.9 Hz, ArCH2), 2.25 – 2.20 (1H, m, NCHCH2), 2.16 – 2.09 (1H, m, 
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NCH2CH2), 2.06 – 1.96 (1H, m, NCH2CH2), 1.82 – 1.75 (1H, m, NCHCH2). 13C 
NMR (150 MHz, CDCl3) δ 149.4 (ArC), 140.9 (ArC), 138.0 (ArC), 113.7 (ArC), 
108.5 (ArC), 97.3 (ArC), 84.8 (CHNO2), 60.4 (NCH), 57.0 (OCH3), 56.1 (OCH3), 
48.5 (NCH2), 33.3 (ArCH2), 30.6 (NCHCH2), 23.5 (NCH2CH2). IR (neat): 2989 
C-H 2938 C-H 2919 C-H 2878 C-H 1618 C=C 1592 C=C 1535 NO2 1521 cm-1 
C=C. LRMS: 279.1 (100) 278.1 (60). HRMS: Expected: 279.1345 Found: 
279.1345 m.p. 163-164 °C 
(3aS*,4R*)-4-Nitro-1,2,3,3a,4,5-hexahydro-[1,3]dioxolo[4,5-g]pyrrolo[1,2-
a]quinolone 540b 
 
Prepared via general procedure D. Toluene (4.0 mL), (E)-1-(6-(2-
nitrovinyl)benzo[d][1,3]dioxol-5-yl)pyrrolidine (100 mg, 0.38 mmol), Gd(OTf)3 
(72 mg, 0.12 mmol). Purified via column chromatography (10% EtOAc in hexane) 
to give the product as a yellow crystalline solid (72 mg, 72%). 
1H NMR (600 MHz, CDCl3) δ 6.57 (1H,  s, ArH), 6.16 (1H, s, ArH), 5.85 (2H, dd, 
J = 3.3, 1.3 Hz, OCH2O), 4.43 (1H, ddd, J = 11.8, 9.7, 4.9 Hz, CHNO2), 3.70 (1H, 
td, J = 9.3, 5.7 Hz, NCHCHNO2), 3.43-3.38 (2H, m, ArCH2CHNO2/NCH2), 3.24 
(1H, dd, J = 16.1, 8.5 Hz, NCH2), 3.17 (1H, dd, J = 15.1, 4.9 Hz, ArCH2), 2.24 – 
2.18 (1H, m, NCHCH2), 2.14 – 2.08 (1H, m, NCH2CH2), 2.03 – 1.94 (1H, m, 
NCH2CH2), 1.77 (1H, tt, J = 11.1, 8.4 Hz, NCHCH2). 13C NMR (150 MHz,CDCl3) 
δ 147.7 (ArC), 139.0 (ArC), 138.7 (ArC), 109.0 (ArC), 109.0 (ArC), 100.8 
(OCH2O), 94.4 (ArC), 84.7 (CHNO2), 60.4 (NCHCHNO2), 48.7 (NCH2), 33.8 
(ArCH2), 30.6 (NCHCH2), 23.4 (NCH2CH2). IR (neat) 2981 C-H 2942 C-H 2895 
C-H 2870 C-H C-H 2836 C-H 2782 C-H 1625 C=C 1614 C=C 1540 NO2 1502 
cm-1 C=C. LRMS 263.1 (100). HRMS Expected: 263.1032 Found: 263.1029 m.p. 
166-168 °C 
5-nitro-4,5,5a,6,7,8-hexahydrothieno[3,2-e]indolizine 547 
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Prepared via general procedure D. Toluene (1.5 mL), (E)-1-(2-(2-
nitrovinyl)thiophen-3-yl)pyrrolidine (36 mg, 0.15 mmol), Gd(OTf)3 (27 mg, 
0.05 mol). Purified via column chromatography (10% EtOAc in hexane) to give 
the product as a white waxy solid (9 mg, 25%). 
1H NMR (700 MHz, CDCl3) δ 7.64 (1H, d, J = 5.6 Hz, ArH), 6.72 (1H, d, J = 5.6 
Hz, ArH), 4.52 – 4.48 (ddd, J = 10.6, 6.0, 3.2 Hz, CHNO2), 4.46 (1H, dd, J = 10.2, 
7.0 Hz, NCH), 3.96 (1H, d, J = 15.7 Hz, ArCH2), 3.60 – 3.55 (1H, m, NCH2), 3.35 
– 3.25 (1H, m, NCH2), 3.21 (1H, dd, J = 15.7, 3.5 Hz, ArCH2), 2.12 (1H, dt, J = 
12.5, 6.4 Hz, NCHCH2), 2.06 (1H, dt, J = 9.7, 4.3 Hz, NCH2CH2), 2.03 – 1.98 (1H, 
m, NCH2CH2), 1.78 (1H, dd, J = 12.2, 5.7 Hz, NCHCH2) 13C NMR too faint to 
analyse. IR (neat): 3324 C-H 3295 C-H 2912 C-H 2865 C-H 1715 C=C 1669 C=C 
1602 C=C 1547 NO2 1506 cm-1 C=C. LRMS 225.1 (100). HRMS Expected: 
225.0692 Found: 225.0701 
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3.4.4 Synthesis of Other Materials 
L-Menthol-PMB ether 383179  
 
L-Menthol (251 mg, 1.60 mmol) was dissolved in THF (5.0 mL) and cooled to 0 
°C. Sodium hydride 60% in mineral oil (131 mg, 3.35) was added portionwise. 
This suspension was stirred for 10 min, then 4-methoxybenzyl chloride (288 mg, 
1.83 mmol) was added and the mixture refluxed overnight. The reaction was 
quenched with water (10 mL) and the organics were extracted with EtOAc (3 x 
10 mL), dried (MgSO4), and the solvent removed in vacuo. This crude material 
was purified via column chromatography (5% EtOAc in hexanes) to give the 
product as a colourless oil (312 mg, 71%) 
1H NMR (600 MHz, CDCl3) δ 7.27 (2H, d, J = 8.7 Hz, OCH2CArH), 6.87 (2H, d, J 
= 8.7 Hz, MeOCArH), 4.59 (1H, d, J = 11.1 Hz, OCH2Ar), 4.34 (1H, d, J = 11.1 
Hz, OCH2Ar), 3.81 (3H, s, OCH3), 3.15 (1H, td, J = 10.6, 4.1 Hz, OCHCH2), 2.28 
(1H, heptd, J = 7.0, 2.8 Hz, CH(CH3)2), 2.19 (1H, ddd, J = 12.1, 5.5, 3.8 Hz, 
CHCH(CH3)2), 1.69 – 1.59 (2H, m), 1.41 – 1.31 (1H, m), 1.27 (1H, ddt, J = 13.3, 
10.4, 3.1 Hz), 1.01 – 0.81 (9H, m), 0.70 (3H, d, J = 6.9 Hz, CHCH3). 
 Data in agreement with literature values179 
p-Methoxybenzyl bromide237 
 
p-Methoxybenzyl alcohol (0.44 mL, 3.6 mmol) was dissolved in Et2O (10 mL) and 
was cooled to 0 °C. PBr3 (4.3 mL, 1.8 mmol) was added and the mixture stirred 
at 0 °C for 3 h. The reaction was then quenched by the careful dropwise addition 
to ice water saturated with NaHCO3. The organic layer was separated and 
washed with sat. NaHCO3 solution (3 x 10 mL). The solvent was then removed 
in vacuo to give the product as a clear oil/white solid (562 mg, 77%). 
1H NMR (600 MHz, CDCl3) δ 7.33 (2H, d, J = 8.6 Hz, ArHCH2Br), 6.87 (2H, d, J 
= 8.7 Hz, ArHCOCH3), 4.51 (2H, s, ArCH2Br), 3.81 (3H, s, ArOCH3). 
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Data in agreement with literature values238 
p-Methoxy(ethoxymethyl)benzene 390 
 
Ethanol (0.38 mL, 6.4 mmol) was mixed with THF (10 mL) and cooled to 0 °C. 
Sodium hydride 60% in mineral oil (254 mg, 13.0 mmol) was added portionwise 
at 0 °C and was left to stir for 20 min. To this, 4-methoxybenzyl bromide (465 mg, 
2.31 mmol) was added and the mixture stirred at 0 °C for 30 min before being 
warmed to room temperature and being left overnight. After overnight stirring at 
room temperature, the reaction was heated to 70 °C and left overnight to ensure 
conversion. The reaction was then quenched with water (20 mL), then the 
organics were extracted with DCM (3 x 20 mL). The organic washings were 
combined and the solvent removed in vacuo to give a crude product which was 
then purified via column chromatography (5% EtOAc in hexanes) to give the 
product as a yellow oil (120 mg, 23%). 
1H NMR (600 MHz, CDCl3) δ 7.28 (2H, d, J = 8.6 Hz, ArHCCH2OEt), 6.89 (2H, d, 
J = 8.6 Hz, ArHCOMe), 4.44 (2H, s, ArCH2OEt), 3.81 (3H, s, ArOCH3), 3.52 (2H, 
q, J = 7.0 Hz, OCH2CH3), 1.24 (3H, t, J = 7.0 Hz, OCH2CH3). 
Data in agreement with literature values239 
p-Methoxy(methoxymethyl)benzene 389 
 
p-Methoxybenzyl alcohol (0.48 mL, 4.0 mmol) was dissolved in THF (20 mL), 
then sodium hydride 60% in mineral oil (320 mg, 16.0 mmol) was added and the 
resulting suspension stirred for 30 min. To this, iodomethane (1.0 mL, 16 mmol) 
was added and the mixture heated to 45 °C and stirred overnight. The reaction 
was then quenched with water (40 mL), then the organics were extracted with 
DCM (3 x 20 mL). The combined organic washings were dried (MgSO4) and the 
solvent removed in vacuo to give the pure product as a yellow oil (578 mg, 95%). 
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1H NMR (500 MHz, CDCl3) δ 7.26 (2H, d, J = 10.0 Hz, ArHCCH2OMe), 6.88 (2H, 
d, J= 10.0, ArHCOMe), 4.39 (2H, s, ArCH2OMe), 3.81 (3H, s, ArOCH3), 3.36 (3H, 
s, ArCH2OCH3). 
Data in agreement with literature values240 
1-((Benzyloxy)methyl)-4-methoxybenzene 399 
 
Benzyl alcohol (0.1 mL, 1.0 mmol) was dissolved in THF (2.0 mL), then sodium 
hydride 60% in mineral oil (156 mg, 3.90 mmol) and tetrabutyl ammonium iodide 
(cat.) were added and the mixture was stirred for 10 min. To this p-methoxybenzyl 
chloride (0.14 mL, 1.0 mmol) was added and the reaction stirred at rt for 72 h. 
The reaction was then quenched with water (10 mL) and extracted with 
dichloroethane (2 x 10 mL). The organic washings were combined, dried (MgSO4) 
and the solvent removed in vacuo to give the pure product as a yellow oil (189 
mg, 79%). 
1H NMR (300 MHz, CDCl3) δ 7.39 – 7.27 (7H, m, ArH), 6.89 (2H, d, J = 8.7 Hz, 
ArHCOMe), 4.53 (2H, s, ArCH2OCH2OPMB), 4.50 (2H, s, ArCH2CH2Ph), 3.81 
(3H, s, OCH3). 
Data in agreement with literature values241 
1,3,5-Trimethoxy-2-(4-methoxybenzyl)benzene 394 
 
p-Methoxy(methoxymethyl)benzene (308 mg, 2.02 mmol) was added to 
dihloromethane (6.0 mL) and cooled to -78 °C. To this BF3.OEt2 (0.60 mL, 4.8 
mmol) was added and the resulting solution was stirred for 10 min. PIFA (870 
mg, 2.02 mmol) was added and after 30 min 1,3,5-trimethoxybenzene (1.02 g, 
6.06 mmol) was added. The reaction mixture was then allowed to slowly warm to 
room temperature and was stirred overnight. This solution was quenched with 
sodium thiosulfate solution (10 mL, sat.), the organics were extracted with DCM 
(3 x 10 mL) and the solvent was removed in vacuo to give the crude product. This 
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was then purified via column chromatography (20% Et2O in hexane) to give 1,3,5-
trimethoxy-2-(4-methoxybenzyl)benzene as the major product (356 mg, 61%). 
1H NMR (600 MHz, CDCl3) δ 7.24 – 7.21 (2H, m, CH2CCHCH), 6.83 – 6.80 (2H, 
m, MeOCCHCH), 6.20 (2H, s, MeOCCHCOMe), 3.94 (2H, s, ArCH2Ar), 3.84 (3H, 
s, ArOCH3), 3.83 (6H, s, ArOCH3), 3.79 (3H, s, ArOCH3). 
Data in agreement with literature values242 
Diethyl homophthalate 413183  
 
Homophthalic acid (5.03 g, 27.9 mmol) was dissolved in a mixture of ethanol 
(23 mL) and toluene (12 mL) and stirred in a flask fitted with a Dean-Stark 
apparatus in air. To this sulphuric acid (1.5ml, conc.) was added and the solution 
was heated to 115 °C for 72 h. The reaction was cooled to room temperature, 
quenched with sodium hydrogen carbonate solution (5%, 60 mL) and extracted 
with toluene (3 x 20 mL). The organic layers were dried (MgSO4) and the solvent 
removed in vacuo to give the desired product as a yellow oil (6.14 g, 93%). 
1H NMR (600 MHz, CDCl3) δ 7.97 (1H, d, J = 7.6 Hz, ArHCCO2Et), 7.40 (1H, t, J 
= 7.4 Hz, ArHCCH2), 7.29 (1H, t, J = 7.5 Hz, ArHCHCCO2Et), 7.19 (1H, d, J = 7.4 
Hz, ArHCHCCH2), 4.33 (2H, q, J = 7.1 Hz, CH2OC(O)Ar), 4.16 (2H, q, J = 7.1 Hz, 
CH2OC(O)CH2), 4.01 (2H, s, ArCH2CO2Et), 1.37 (3H, t, J = 7.1 Hz, 
CH3CH2OC(O)Ar), 1.25 (3H, t, J = 7.1 Hz, CH3CH2OC(O)CH2).  
Data in agreement with literature values243 
3-Hydroxyisochroman 414184  
 
Diethyl homophthalate (4.975g, 21.15 mmol) was dissolved in toluene (250 mL) 
and cooled to -78 °C. DIBAL-H (1M in hexanes, 65.6 mL, 65.6 mmol) was added 
dropwise and then the reaction mixture was stirred at -78 °C for 2 h.  The reaction 
mixture was quenched with sodium potassium tartrate solution (100 mL, sat.) and 
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the organics extracted. The aqueous layer was washed with EtOAc (3 x 150 mL) 
and the combined organics dried (MgSO4), filtered and concentrated in vacuo to 
give the product as an off-white crystalline solid (2.80 g, 89%). 
1H NMR (500 MHz, CDCl3) δ 7.21 – 7.17 (2H, m, ArH), 7.15 – 7.11 (1H, m, ArH), 
7.05 – 7.01 (1H, m, ArH), 5.38 (1H, dd, J = 5.2, 3.8 Hz, OCHCH2), 4.98 (1H, d, J 
= 14.8 Hz, ArCH2O), 4.80 (1H, d, J = 14.8 Hz, ArCH2O), 3.09 (1H, dd, J = 16.3, 
3.7 Hz, ArCH2CH), 2.88 (1H, d, J = 5.0 Hz, OH), 2.84 (1H, dd, J = 16.2, 5.2 Hz, 
ArCH2CH). m.p. 70 – 72 °C Lit. 71 – 71.5 °C184 
Data in agreement with literature values244 
Isochroman-3-yl acetate 421 
 
3-Hydroxyisochroman (160 mg, 1.06 mmol) was dissolved in pyridine (4.0 mL). 
Acetic anhydride (0.1 mL, 1 mmol) was added, turning the solution from 
colourless to yellow before being stirred for 12 d. The reaction mixture was then 
quenched with saturated copper sulfate solution (50 mL) and EtOAc (50 mL) 
added. The organic layer was washed with saturated copper sulfate solution (3 x 
50 mL) then saturated sodium bicarbonate solution (3 x 50 mL). The organic layer 
was then dried (MgSO4), filtered, and the solvent removed in vacuo to give a 
brown oil. The crude product was purified via column chromatography (10% 
EtOAc in hexanes) to give the product as an orange oil (88 mg, 45%). 
1H NMR (600 MHz, CDCl3) δ 7.25 – 7.20 (2H, m, ArH), 7.16 – 7.13 (1H, m, ArH), 
7.07 – 7.04 (1H, m, ArH), 6.36 (1H, dd, J = 4.4, 3.2 Hz, CHOAc), 4.93 (1H, d, J = 
14.6 Hz, ArCH2O), 4.82 (1H, d, J = 14.6 Hz, ArCH2O), 3.20 (1H, dd, J = 16.7, 4.4 
Hz, ArCH2CH), 2.88 (1H, dd, J = 16.7, 3.2 Hz, ArCH2CH), 2.08 (3H, s, 
OC(O)CH3). 13C NMR (150 MHz, CDCl3) δ 170.2 (OC(O)CH3), 133.4 (ArC), 130.0 
(ArC), 128.9 (ArCH), 127.1 (ArCH), 126.6 (ArCH), 124.2 (ArCH), 91.4 (CHOAc), 
63.4 (ArCH2O), 32.1 (ArCH2C), 21.3 (OC(O)CH3). LRMS (CI) 210.1 (67), 150.1 
(100), 132.0 (20). HRMS Expected 210.11247 Found 210.11239 
Isochromene 265188 
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3-Hydroxyisochroman (4.00 g, 26.6 mmol) and KHSO4 (503 mg, 3.69 mmol) were 
distilled at 100 °C, 40 mbar with a Vigreux condenser. The organic distillate was 
taken up in ether (40 mL), decanted, then dried (MgSO4). This solution was then 
filtered and concentrated in vacuo to give the product as an orange oil that 
solidified to orange crystals upon swirling (2.66 g, 74%). 
1H NMR (300 MHz, CDCl3) δ 7.22 – 7.11 (2H, m, ArH), 7.01 – 6.93 (2H, m, ArH), 
6.58 (1H, d, J = 5.7 Hz, OCHCH), 5.81 (1H, d, J = 5.7 Hz, OCHCHCAr), 5.06 (2H, 
s, CH2OCH). m.p. 20-22 °C Lit. not reported. 
Data in agreement with literature values183 
2-[(Trimethylsilyl)ethynyl]benzaldehyde 416186 
 
2-Bromobenzaldehyde (500 mg, 2.70 mmol), triphenylphosphine (11 mg, 0.04 
mmol), and palladium diacetate (6 mg, 0.03 mmol) were dissolved in triethylamine 
(25 mL, dried over 4Å MS) and stirred. TMS-acetylene (406 mg, 4.05 mmol) was 
added, then the reaction mixture was heated to 80 °C and stirred for 6 h. The 
reaction was allowed to cool to rt and additional triethylamine was added until a 
suspension formed which was filtered off. The filtrate was collected, combined 
with water (50 mL) and then washed with DCM (3 x 50 mL). The combined 
organics dried (MgSO4), filtered, concentrated in vacuo and purified via column 
chromatography (1% EtOAc in hexanes) to give the product as a yellow oil which 
formed an orange waxy solid upon cooling to -4 °C (340 mg, 52%). 
1H NMR (600 MHz, CDCl3) δ 10.56 (1H, s, ArCHO), 7.91 (1H, dd, J = 7.9, 0.8 Hz, 
CHCCHO), 7.57 (1H, dd, J = 7.7, 1.1 Hz, CHCCCTMS), 7.54 (1H, td, J = 7.4, 1.3 
Hz, CHCHCCCTMS), 7.45 – 7.42 (1H, m, CHCHCHO), 0.28 (9H, s, Si(CH3)3). 
Data in agreement with literature values186 
2-Ethynylbenzaldehyde 417186  
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2-[(Trimethylsilyl)ethynyl]benzaldehyde (243 mg, 1.20 mmol) and KF (154 mg, 
2.65 mmol) were dissolved in DMF (1.2 mL) and stirred for 3 h. The product was 
then poured into water (40 mL) and extracted with DCM (3 x 10 mL). The 
combined organics were dried (MgSO4) and the solvent removed in vacuo. This 
crude product was then purified via column chromatography (20% EtOAc in 
hexanes) to give the desired product as a white solid (60 mg, 38%) 
1H NMR (300 MHz, CDCl3) δ 10.54 (1H, s, CHO), 7.96 – 7.91 (1H, m, CHCCHO), 
7.65 – 7.60 (1H, m, CHCCCH), 7.57 (1H, td, J = 7.4, 1.5 Hz, CHCHCCCH), 7.52 
– 7.45 (1H, m, CHCHCCHO), 3.46 (1H, s, CCH). m.p. 62 – 64 °C Lit. 62 – 65 
°C245 
Data in agreement with literature values186 
2-Ethynylbenzyl alcohol 418186  
 
2-[((Trimethylsilyl))phenyl]methanol (204 mg, 1 mmol) was dissolved in methanol 
(4.0 mL) and K2CO3 (17 mg, 0.10 mmol) was added. The resulting mixture was 
stirred at rt for 3 h. The reaction was then quenched with water and extracted with 
EtOAc, the organic layers were combined, dried (MgSO4) and the solvent 
removed in vacuo to give the product as a solid (98 mg, 74% over two steps). 
 1H NMR (600 MHz, CDCl3) δ 7.52 (1H, dd, J = 7.6, 1.1 Hz, ArH), 7.46 (1H, ddd, 
J = 7.7, 1.3, 0.6 Hz, ArH), 7.38 (1H, td, J = 7.7, 1.3 Hz, ArH), 7.29 – 7.25 (4H, m, 
ArH), 4.85 (2H, s, ArCH2OH), 3.35 (1H, s, ArCCH). 
Data in agreement with literature values186 
3-(2,4,6-Trimethoxyphenyl)isochroman 423 
 
Isochromene (34 mg, 0.25 mmol), 1,3,5-trimethoxybenzene (52 mg, 0.30 mmol), 
CuBr2 (2 mg, 0.01 mmol), ZnBr2 (3 mg, 0.01 mmol) were dissolved in MeCN (5 
mL) and cooled to -10 °C. To this DDQ (58 mg, 0.25 mmol) was added and the 
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reaction allowed to warm to room temperature overnight. The solvent was then 
removed in vacuo, then the crude mixture was twice purified via column 
chromatography (10% EtOAc in hexane) then (30% EtOAc in hexane) to give the 
product as an off-white solid (12 mg, 16%) 
1H NMR (600 MHz, CDCl3) δ 7.19 – 7.15 (2H, m, CHAr), 7.14 – 7.10 (1H, m, 
CHAr), 7.06 – 7.03 (1H, m, CHAr), 6.17 (2H, s, MeOCCHCOMe), 5.33 (1H, dd, J 
= 11.6, 3.4 Hz, OCHCAr), 4.98 (2H, s, CArCH2O), 3.83 (3H, s, CArOCH3), 3.82 
(1H, dd, J = 16.2, 11.6 Hz, ArCH2CHAr), 3.80 (6H, s, ArOCH3), 2.62 (1H, dd, J = 
16.2, 3.4 Hz, CArCH2CHAr). 13C NMR (150 MHz, CDCl3) δ 161.1 (ArCOMe), 
159.9 (ArCOMe), 135.5 (ArCCH2CH), 135.3 (ArCCH2O), 128.9 (ArC), 126.2 
(ArC), 125.8 (ArC), 124.5 (ArC), 109.8 (ArCCH), 91.2 (ArCCOMe), 69.7 
(OCHCH2), 69.4 (OCH2), 56.0 (CHCCOCH3), 55.4 (ArOCH3), 31.7 (ArCH2CH). 
IR (neat): 3004 C-H 2938 C-H 2908 C-H 2836 C-H 1600 C=C 1583 C=C 1494 
cm-1 C=C.  LRMS (EI) 300.12 (32), 195.06 (56), 104.03 (100). HRMS Expected: 
300.1356 Found 300.1355 m.p. 112 – 114 °C 
1-Allyl-isochromene 266130  
 
Isochromene (129 mg, 1.0 mmol) was dissolved in DCM (10 mL). 4Å molecular 
sieves (250 mg) and LiClO4 (162 mg, 1.50 mmol) were added then the solution 
was cooled to – 40 °C and stirred for 5 min. DDQ (299 mg, 1.32 mmol) was added 
and the solution stirred for 10 mins. Allyltributylstannane (0.60 mL, 1.9 mmol) was 
added and the solution allowed to warm to rt over 1.5 h. The reaction was then 
quenched with sat. NaHCO3 solution (30 mL) and the organics extracted with 
DCM (3 x 20 mL). The combined organics were dried (MgSO4), filtered and the 
solvent removed in vacuo. This crude product was purified via column 
chromatography (1% EtOAc in hexanes) to give the 1-allyl-isochromene as a 
clear oil (30 mg, 17%). 
1H NMR (500 MHz, CDCl3) δ 7.19 (1H, td, J = 7.4, 1.2 Hz, ArCH), 7.14 (1H, td, J 
= 7.5, 1.2 Hz, ArCH), 6.98 – 6.94 (2H, m, ArCH), 6.49 (1H, d, J = 5.7 Hz, OCHCH), 
5.90 (1H, ddt, J = 17.2, 10.3, 7.0 Hz, CH2CHCH2), 5.75 (1H, d, J = 5.7 Hz, 
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ArCHCHO), 5.15 – 5.10 (2H, m, CH2CHCH2), 5.06 (1H, s, ArCHO), 2.84 – 2.75 
(1H, m, ArCHCH2CHCH2), 2.55 – 2.48 (1H, m, ArCHCH2CHCH2). 
Data in agreement with literature values130 
2-Phenyl-1,2,3,4-tetrahydroisoquinoline 73189  
 
(±)BINAP (32 mg, 5 mol%) was dissolved in toluene (3.0 mL) and stirred. To this 
bromobenzene (0.12 mL, 1.0 mmol), 1,2,3,4-tetrahydroisoquinoline (0.16 mL, 1.2 
mmol), tBuOK (170 mg, 1.50 mmol) and Pd(OAc)2 (11 mg, 5 mol%) were added. 
The reaction mixture was then heated to 100 °C for 18 h, turning dark red. The 
crude mixture was cooled, concentrated in vacuo and purified via column 
chromatography (10% EtOAc in hexane) to give the product as a brown oil (74 
mg, 35%) 
1H NMR (500 MHz, CDCl3) δ 7.33 (2H, td, J = 7.7, 1.3 Hz, CHAr), 7.21 (4H, qd, 
J = 6.4, 3.1 Hz, CHAr), 7.03 (2H, d, J = 8.5 Hz, CHAr), 6.87 (1H, td, J = 7.3, 0.7 
Hz, CHAr), 4.45 (2H, s, ArCH2N), 3.60 (2H, t, J = 5.8 Hz, ArCH2CH2N), 3.03 (2H, 
t, J = 5.8 Hz, ArCH2CH2N). 
Data in agreement with literature values53 
2-(But-3-en-1-yl)-1,2,3,4-tetrahydroisoquinoline 430 
 
Potassium carbonate (338 mg, 2.45 mmol) and potassium iodide (84 mg, 0.2 
mmol) were suspended in MeCN (6.0 mL) and stirred. To this, 1,2,3,4-
tetrahydroisoquinoline (0.25 mL, 2.0 mmol) and 4-bromo-1-butene (0.4 mL, 4.0 
mmol) were added. The reaction mixture was heated to 80 °C for 18 h, turning 
brown. The reaction mixture was quenched with sat. NaHCO3 solution (10 mL) 
and the organics extracted with EtOAc (3 x 10 mL). These organic fractions were 
combined, dried (MgSO4), filtered then the solvent removed in vacuo to give the 
product as a brown oil (305 mg, 81%). 
1H NMR (600 MHz, CDCl3) δ 7.15 – 7.08 (3H, m, ArH), 7.02 (1H, dd, J = 7.9, 5.7 
Hz, ArH), 5.87 (1H, ddt, J = 17.0, 10.2, 6.7 Hz, CH2CHCH2), 5.11 (1H, dq, J = 
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17.1, 1.6 Hz, CH2CHCH2), 5.03 (1H, ddt, J = 10.2, 2.1, 1.2 Hz, CH2CHCH2), 3.66 
(2H, s, ArCH2N), 2.92 (2H, t, J = 5.9 Hz, ArCH2CH2), 2.76 (2H, t, J = 6.0 Hz, 
ArCH2CH2N), 2.63 – 2.59 (2H, m, NCH2CH2CHCH2), 2.38 (2H, dt, J = 7.6, 6.8 
Hz, NCH2CH2CHCH2). 13C NMR (150 MHz, CDCl3) δ 136.7 (CH2CHCH2), 134.9 
(ArC), 134.4 (ArC), 128.8 (ArCH), 126.7 (ArCH), 126.2 (ArCH), 125.7 (ArCH), 
115.8 (CH2CHCH2), 57.9 (ArCCH2N), 56.2 (ArCCH2CH2N), 51.0 
(NCH2CH2CHCH2), 31.9 (ArCCH2CH2N), 29.2 (NCH2CH2CHCH2). IR (neat): 
3064 C-H 3020 C-H 2917 C-H 2799 C-H 2762 C-H 1640 C=C 1497 cm-1 C=C. 
LRMS (EI) 189.15 (10), 188.14 (100). HRMS Expected 188.1439 Found 
188.1440  
2-(But-3-en-1-yl)-3,4-dihydroisoquinolin-1-one 434 
 
Into a mixture of MeCN (3.5 mL) and water (0.5 mL) 2-(but-3-en-1-yl)-1,2,3,4-
tetrahydroisoquinoline (94 mg, 0.50 mmol) was added. RuCl3 hydrate (cat.) was 
added and the mixture stirred for 5 min. Sodium periodate (214 mg, 1.00 mmol) 
was added portionwise and stirring was continued at rt for 18 h. The reaction was 
then quenched with sat. sodium bisulfate solution (5.0 mL), diluted with EtOAc 
(10 mL). The organics were then washed with sat. sodium bisulfate solution (3 x 
15 mL), dried (MgSO4), filtered and the solvent removed in vacuo. The crude 
residue was purified via column chromatography (25% EtOAc in hexane) to give 
the product as a brown oil (41 mg, 41%). 
1H NMR (600 MHz, CDCl3) δ 8.08 (1H, dd, J = 7.7, 1.0 Hz, ArH), 7.41 (1H, td, J 
= 7.4, 1.4 Hz, ArH), 7.34 (1H, t, J = 7.3 Hz, ArH), 7.17 (1H, d, J = 7.5 Hz, ArH), 
5.86 (1H, ddt, J = 17.1, 10.2, 6.9 Hz, NCH2CH2CHCH2), 5.11 (1H, ddd, J = 17.1, 
3.2, 1.5 Hz, NCH2CH2CHCH2), 5.07 – 5.01  (1H, m, NCH2CH2CHCH2), 3.65 (2H, 
t, J = 7.1 Hz, NCH2CH2CHCH2), 3.58 – 3.55 (2H, t, J = 6.6 Hz, ArCH2CH2N), 2.98 
(2H, t, J = 6.6 Hz, ArCH2CH2N), 2.41 (2H, q, J = 7.0 Hz, NCH2CH2CHCH2). LRMS 
(CI) 203.1 (15), 202.1 (100). HRMS Expected: 202.1226 Found 202.1227 
2-Allyl-1,2,3,4-tetrahydroisoquinoline 435 
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Potassium carbonate (341 mg, 2.47 mmol) was suspended in MeCN (6.0 mL) 
and stirred. To this 1,2,3,4-tetrahydroisoquinoline (0.25 mL, 2.0 mmol) was 
added and the mixture stirred for 30 min prior to the addition of allyl bromide (18 
mL, 2.0 mmol). This reaction mixture was then stirred at rt for 18 h. The reaction 
was then quenched with water (10 mL) and the organics extracted with EtOAc (3 
x 10 mL). The organic fractions were combined, dried (MgSO4), filtered and the 
solvent removed in vacuo to give the desired product as a yellow oil (152 mg, 
43%). 
1H NMR (400 MHz, CDCl3) δ 7.15 – 7.06 (3H, m, ArH), 7.05 – 6.99 (1H, m, ArH), 
5.96 (1H, ddt, J = 16.7, 10.1, 6.5 Hz, NCH2CHCH2), 5.26 (1H, ddt, J = 17.1, 3.3, 
1.5 Hz, NCH2CHCH2), 5.20 (1H, ddt, J = 10.1, 2.1, 1.1 Hz, NCH2CHCH2), 3.63 
(2H, s, ArCH2N), 3.18 (2H, dt, J = 6.5, 1.3 Hz, NCH2CHCH2), 2.92 (2H, t, J = 5.9 
Hz, ArCH2CH2N), 2.74 (2H, t, J = 6.0 Hz, ArCH2CH2N). 
Data in agreement with literature values246 
2-(3,3-Diethoxypropyl)-1,2,3,4-tetrahydroisoquinoline 442 
 
Potassium carbonate (321 mg, 2.32 mmol) was suspended in MeCN (25 mL) and 
1,2,3,4-tetrahydroisoquinoline (0.25 mL, 2.0 mmol) was added. 3-
chloropropionaldehyde diethyl acetal (0.33 mL, 2.0 mmol) was added and the 
reaction heated to reflux for 48 h.  The reaction mixture was then cooled to rt and 
filtered through a silica plug (EtOAc) and the solvent removed in vacuo to give 
the product as a yellow oil (355 mg, 67%). 
1H NMR (600 MHz, CDCl3) δ 7.27 (1H, m, ArH), 7.15 – 7.08 (2H, m, ArH), 7.02 
(1H, d, J = 6.3 Hz, ArH), 4.63 (1H, t, J = 5.7 Hz, NCH2CH2CH(OEt)2), 3.71 – 3.64 
(2H, m, OCH2CH3), 3.64 (2H, s, ArCH2N), 3.56 – 3.49 (2H, m, OCH2CH3), 2.90 
(2H, t, J = 5.9 Hz, ArCH2CH2N), 2.74 (2H, t, J = 5.9 Hz, ArCH2CH2N), 2.62 – 2.57 
(2H, m, NCH2CH2CH(OEt)2), 1.92 (2H, dt, J = 18.2, 9.0 Hz, NCH2CH2CH(OEt)2) 
1.25 – 1.19 (6H, m, OCH2CH3). 13C NMR (150 MHz, CDCl3) δ 135.0 (ArC), 134.5 
(ArC), 128.8 (ArC), 126.7 (ArC), 126.2 (ArC), 125.7 (ArC), 101.7 
(NCH2CH2CH2(OEt)2), 61.4 (OCH2CH3), 56.3 (ArCH2N), 54.0 (ArCH2CH2N), 51.2 
(ArCH2CH2N), 31.6 (NCH2CH2CH(OEt)2), 29.3 (NCH2CH2CH(OEt)2), 15.5 
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(OCH2CH3). IR (neat) 3019 C-H 2969 C-H 2926 C-H 2894 C-H 2804 C-H 1697 
1606 C=C 1579 C=C 1495 cm-1 C=C. LRMS (ES+) 264.2 (100), 265.2 (20). 
HRMS Expected: 264.1964 Found: 264.1959 
4-Benzyloxybut-1-ene 447 
 
NaH (60% in mineral oil, 107 mg, 2.80 mmol) was suspended in THF and 
3-buten-1-ol (0.19 mL, 2.2 mmol) was added dropwise and the mixture stirred for 
5 min. Benzyl bromide (0.25 mL, 2.0 mmol) was then added and the reaction was 
stirred at rt for 18 h. The reaction was then quenched with water (10 mL) and the 
organics extracted with EtOAc (3 x 10 mL). The organics were combined, dried 
(MgSO4), filtered and the solvent removed in vacuo to give the pure product as a 
yellow oil (336 mg, 99%). 
1H NMR (300 MHz, CDCl3) δ 7.39 – 7.24 (5H, m, ArH), 5.85 (1H, ddt, J = 16.9, 
10.1, 6.7 Hz, OCH2CH2CHCH2), 5.16 – 5.01 (2H, m, OCH2CH2CHCH2), 4.53 (2H, 
s, ArCH2O), 3.53 (2H, t, J = 6.8 Hz, OCH2CH2CHCH2), 2.38 (2H, q, J = 6.7 Hz, 
OCH2CH2CHCH2). 
Data in agreement with literature values247 
3-(Benzyloxy)propan-1-ol 450 
 
Benzyl bromide (2.10 mL, 17.9 mmol) was dissolved in THF (30 mL) and cooled 
to 0 °C. TBAI (1.32 g, 3.58 mmol) was added and stirred, followed by 1,3-propane 
diol (3.87 mL, 53.5 mmol) and NaH (0.76 g, 19 mmol). This mixture was stirred 
at 0 °C for 15 min then allowed to warm to rt and stirred overnight. The reaction 
was then quenched with sat. NH4Cl solution (50 mL) and extracted with EtOAc (4 
x 50 mL). The organics were collected, dried (MgSO4), filtered and the solvent 
removed in vacuo to give the crude product which was purified via column 
chromatography (30% hexane in EtOAc) to give the product as a yellow oil (589 
mg, 20%). 
1H NMR (400 MHz, CDCl3) δ 7.39 – 7.27 (5H, m, ArH), 4.53 (2H, s, ArCH2O), 
3.88 – 3.74 (2H, m, OCH2CH2CH2OH), 3.67 (2H, t, J = 5.8 Hz, 
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ArCH2OCH2CH2CH2OH), 2.29 (1H, s, OH), 1.91 – 1.84 (2H, m, 
OCH2CH2CH2OH). 
Data in agreement with literature values248 
N,N-Dibenzyl-2-bromoaniline 
 
Potassium carbonate (2.77g, 20.0 mmol) and o-bromoaniline (678 mg, 3.94 
mmol) were added to DMF (8.0 mL). Benzyl bromide (1.9 mL, 16 mmol) was then 
added and the mixture heated to 120 °C for 48 h. The reaction was then cooled 
to 0°C and quenched with diethylamine (1.05 mL). The crude product was then 
extracted with Et2O (4 x 20 mL) and the combined organic extracts washed with 
brine (4 x 50 mL). The organics were then dried (MgSO4), filtered and the solvent 
removed in vacuo to give the crude product which was purified via column 
chromatography (3% EtOAc in hexane) to give the product as a pale yellow oil 
(915 mg, 65%) 
1H NMR (400 MHz, CDCl3) δ 7.59 (1H, dd, J = 7.9, 1.5 Hz, ArH), 7.35 – 7.18 
(10H, m, ArH), 7.12 (1H, ddd, J = 8.0, 7.3, 1.5 Hz, ArH), 6.92 (1H, dt, J = 3.5, 1.7 
Hz, ArH), 6.91 – 6.85 (1H, m, ArH), 4.18 (4H, s, ArCH2N). 
Data in agreement with literature values249 
2-(Dibenzylamino)benzaldehyde 
 
THF (10 mL) was cooled to -78 °C and n-BuLi in hexanes (1.6 mL, 2.25 mmol) 
was added. To this N,N-dibenzyl-2-bromoaniline (609 mg, 1.73 mmol) in THF (10 
mL) was added dropwise and stirred for 5 min at -78 °C. DMF (0.80 mL, 35 mmol) 
was added dropwise and the reaction stirred 5 min before being quenched with 
sat. NaHCO3 solution (25 mL) before warming to rt. The organics were then 
extracted in DCM (3 x 25 mL) and combined before being dried (MgSO4), filtered 
and the solvent removed in vacuo to give the crude product which was purified 
via column chromatography to give the product as a clear oil (177 mg, 34%). 
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1H NMR (400 MHz, CDCl3) δ 10.54 (1H, d, J = 0.5 Hz, ArCHO), 7.82 (1H, dd, J = 
7.7, 1.7 Hz, ArH), 7.44 (1H, ddd, J = 8.2, 7.3, 1.8 Hz, ArH), 7.32 – 7.22 (7H, m, 
ArH), 7.20 – 7.14 (3H, m, ArH), 7.11 (1H, t, J = 7.5 Hz, ArH), 7.04 (1H, d, J = 8.2 
Hz, ArH), 4.27 (4H, s, ArCH2N). 
Data in agreement with literature values142 
2-Propoxybenzaldehyde 524250 
 
Potassium carbonate (1.40 g, 10.1 mmol) was suspended in DMF (10 mL) and 
salicyl aldehyde (0.85 mL, 8.0 mmol) was added. Bromopropane (2.0 mL, 
excess) was added and the mixture was heated to 80 °C for 18 h before being 
cooled to rt. The reaction was diluted with sat. NaHCO3 solution (40 mL), then 
the organics were extracted with EtOAc (40 mL). The organic extract was washed 
with sat. NaHCO3 solution (3 x 40 mL) then brine (40 mL). The organics were 
then dried (MgSO4), filtered and the solvent was removed in vacuo to give the 
product as a faintly orange oil without further purification (1.173 g, 89%) 
1H NMR (400 MHz, CDCl3) δ 10.53 (1H, d, J = 0.8 Hz, CHO), 7.83 (1H, dd, J = 
7.7, 1.8 Hz, ArH), 7.53 (1H, ddd, J = 8.5, 7.3, 1.8 Hz, ArH), 7.03 – 6.95 (2H, m, 
ArH), 4.04 (2H, t, J = 6.4 Hz, OCH2), 1.93 – 1.83 (2H, m, OCH2CH2), 1.08 (3H, t, 
J = 7.4 Hz, OCH2CH2CH3). 
Data in agreement with literature values250 
2-Bromo-5-methoxybenzaldehyde  
 
To m-anisaldehyde (0.73 mL, 6.0 mmol) in AcOH (15 mL) was added bromine 
(0.36 mL, 6.6 mmol). The resultant mixture was covered and stirred for 24 h at rt 
before being poured into ice water (100 mL) and stirred for 18 h. This formed a 
precipitate which was filtered off to isolate the product as an off-white solid (1.11 
g, 86%). 
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1H NMR (400 MHz, CDCl3) δ 10.31 (1H, s, CHO), 7.52 (1H, d, J = 8.8 Hz, ArH), 
7.41 (1H, d, J = 3.2 Hz, ArH), 7.03 (1H, dd, J = 8.8, 3.2 Hz, ArH), 3.84 (3H, s, 
OCH3). m.p. 73-74 °C Lit. 73-75 °C251 
Data in agreement with literature values252 
2,2,2-Trifluoro-N-((anti)-1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinolin-4-
yl)acetamide 550 
 
To EtOAc (5.0 mL) and EtOH (5.0 mL) was added 358a (75 mg, 0.34 mmol). The 
mixture was cooled to 0 °C and HCl (6 M, 1.2 mL) was added dropwise. Zinc dust 
(223 mg) was added and the mixture was stirred for 30 min, turning from yellow 
to colourless. The reaction mixture was then quenched (NaHCO3 sat. solution), 
which caused the formation of a white precipitate. The precipitate was filtered 
through a short pad of Celite and washed with EtOAc (30 mL).  The aqueous 
layer was separated and extracted with EtOAc (30 mL) and combined organic 
layers were dried (MgSO4) and concentrated to give the crude amine as a 
colourless oil which was used directly. 
The crude amine was dissolved in DCM (7.0 mL) and cooled to -78 °C. DIPEA 
(0.18 mL, 1.0 mmol) and TFAA (0.14 mL, 1.0 mmol) were added and the mixture 
was stirred 10 min then warmed to rt. The reaction mixture was diluted with water 
(7.0 mL), then the organics were extracted in DCM (2 x 15 mL). The combined 
organic layers were dried (MgSO4), filtered and the solvent was removed in 
vacuo. The resultant crude material was purified via column chromatography 
(30% EtOAc in hexane) to give the product as an off-white waxy solid (45 mg, 
46%). 
1H NMR (700 MHz, CDCl3) δ 7.11 (1H, t, J = 7.6 Hz, ArH), 6.99 (1H, d, J = 7.4 
Hz, ArH), 6.61 (1H, t, J = 7.3 Hz, ArH), 6.44 (1H, d, J = 8.1 Hz, ArH), 6.12 (1H, s, 
NH), 4.08 (1H, ddd, J = 11.9, 9.7, 5.1 Hz, CHNCOCF3), 3.40 (1H, td, J = 8.9, 2.1 
Hz, NCH2), 3.34 (1H, td, J = 9.9, 5.3 Hz, NCH), 3.29 (1H, dd, J = 16.4, 8.8 Hz, 
NCH2), 3.08 (1H, dd, J = 15.2, 4.9 Hz, ArCH2), 2.84 (1H, dd, J = 15.1, 11.9 Hz, 
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ArCH2), 2.18 – 2.08 (2H, m, NCHCH2, NCH2CH2), 1.92 (1H, dtd, J = 15.6, 12.2, 
8.9 Hz, NCH2CH2), 1.75 (1H, ddd, J = 21.5, 11.7, 7.4 Hz, NCHCH2) 13C NMR 
(175 MHz, CDCl3) δ 143.8 (ArC), 129.0 (ArC), 128.2 (ArC), 118.6 (ArC), 116.2 
(ArC), 110.8 (ArC), 62.2 (NCH), 49.6 (CHNCOCF3), 47.6 (NCH2), 34.9 (ArCH2), 
31.2 (NCHCH2), 23.6 (NCH2CH2). IR (neat) 3220 C-H 3066 C-H 2927 C-H 2844 
C-H 1710 C=O 1602 C=C 1555 C=C 1502 cm-1 C=C LRMS: 281.1 (10), 269.1 
(20), 268.1 (100). HRMS: Expected: 281.0902 Found 281.0911 
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4. Appendices 
4.1 Computational modelling for 
1-methyl-3-nitro-2-phenyl-1,2,3,4-tetrahydroquinoline arrangements in 
space 
Isomer Designation Calc Energy Relative Energy (Hartree) 
 
Quinoline1 -879.19455451 0.00017632 
 
Quinoline2 -879.19473083 0 
 
Quinoline3 -879.18771543 0.00701540 
Energies calculated using B3LYP/6-31G*. Relative energies relative to lowest 
energy isomer. Quinoline4 is least stable. It is the only one with Ph equatorial. 
Energies are in Hartrees, 1 Hartree = 27.2114 eV. 
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Quinoline1    Quinoline2 
 
Quinoline3 
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4.2 Crystal structure for (3aS*,4R*)-7,8-dimethoxy-4-nitro-1,2,3,3a,4,5-
hexahydropyrrolo[1,2-a]quinoline 539a as an example of the spatial 
arrangement of a 6,6,5 ring system. 
 
Table 14: Crystallographic data and structure refinement 
Empirical formula C14H18N2O4 
Formula weight 278.3 
Temperature/K 293(2) 
Crystal system Monoclinic 
Space group P21/n 
a/Å 11.0509(2) 
b/Å 9.3888(2) 
c/Å 12.9912(3) 
α/° 90 
β/° 97.989(2) 
γ/° 90 
Volume/Å3 1334.82(5) 
Z 4 
ρcalcg/cm3 1.385 
μ/mm-1 0.849 
F(000) 592.0 
Crystal size/mm3 0.056 × 0.110 × 0.160 
Radiation CuKα (λ = 1.54184) 
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2Θ range for data collection/° 9.856 to 133.146 
Index ranges -13 ≤ h ≤ 13, -11 ≤ k ≤ 10, -15 ≤ l ≤ 15 
Reflections collected 18135 
Independent reflections 2354 [Rint = 0.0302, Rsigma = 0.0146] 
Data/restraints/parameters 2354/0/197 
Goodness-of-fit on F2 1.063 
Final R indexes [I>=2σ (I)] R1 = 0.0429, wR2 = 0.1118 
Final R indexes [all data] R1 = 0.0459, wR2 = 0.1144 
Largest diff. peak/hole / e Å-3 0.34/-0.23 
Empirical formula C14H18N2O4 
Formula weight 278.3 
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(48)  Condie, A. G.; González-Gómez, J. C.; Stephenson, C. R. J. J. Am. Chem. 
Soc. 2010, 132, 1464. 
(49)  Freeman, D. B.; Furst, L.; Condie, A. G.; Stephenson, C. R. J. Org. Lett. 
2012, 14, 94. 
(50)  Rueping, M.; Zhu, S.; Koenigs, R. M. Chem. Commun. 2011, 47, 12709. 
(51)  Rueping, M.; Vila, C.; Koenigs, R. M.; Poscharny, K.; Fabry, D. C. Chem. 
Commun. 2011, 47, 2360. 
(52)  Zhao, G.; Yang, C.; Guo, L.; Sun, H.; Chen, C.; Xia, W. Chem. Commun. 
2012, 48, 2337. 
(53)  Franz, J. F.; Kraus, W. B.; Zeitler, K. Chem. Commun. 2015, 51, 8280. 
(54)  Huo, C.; Wu, M.; Chen, F.; Jia, X.; Yuan, Y.; Xie, H. Chem. Commun. 2015, 
51, 4708. 
(55)  DeBoef, B.; Pastine, S. J.; Sames, D. J. Am. Chem. Soc. 2004, 126, 6556. 
                                                                                                            Oliver Ware 
215 
 
(56)  Yi, C. S.; Yun, S. Y.; Guzei, I. A. Organometallics 2004, 23, 5392. 
(57)  Ishii, Y.; Chatani, N.; Kakiuchi, F.; Murai, S. Organometallics 1997, 16, 
3615. 
(58)  Ishii, Y.; Chatani, N.; Kakiuchi, F.; Murai, S. Tetrahedron Lett. 1997, 38, 
7565. 
(59)  Chatani, N.; Asaumi, T.; Yorimitsu, S.; Ikeda, T.; Kakiuchi, F.; Murai, S. J. 
Am. Chem. Soc. 2001, 123, 10935. 
(60)  Tsuchikama, K.; Kasagawa, M.; Endo, K.; Shibata, T. Org. Lett. 2009, 11, 
1821. 
(61)  Pan, S.; Endo, K.; Shibata, T. Org. Lett. 2011, 13, 4692. 
(62)  Jun, C.-H. Chem. Commun. 1998, 13, 1405. 
(63)  Kawamorita, S.; Miyazaki, T.; Iwai, T.; Ohmiya, H.; Sawamura, M. J. Am. 
Chem. Soc. 2012, 134, 12924. 
(64)  Davies, H. M. L.; Hansen, T.; Hopper, D. W.; Panaro, S. A. J. Am. Chem. 
Soc. 1999, 121 6509. 
(65)  Davies, H. M. L.; Venkataramani, C.; Hansen, T.; Hopper, D. W. J. Am. 
Chem. Soc. 2003, 125, 6462. 
(66)  Davies, H. M. L.; Manning, J. R. Nature, 2008, 24, 417. 
(67)  McMills, M. C.; Humes, R. J.; Pavlyuk, O. M. Tetrahedron Lett. 2012, 53, 
849. 
(68)  Clarke, L. A.; Ring, A.; Ford, A.; Sinha, A. S.; Lawrence, S. E.; Maguire, A. 
R. Org. Biomol. Chem. 2014, 12, 7612. 
(69)  Flynn, C. J.; Elcoate, C. J.; Lawrence, S. E.; Maguire, A. R. J. Am. Chem. 
Soc. 2010, 132, 1184. 
(70)  Slattery, C. N.; Maguire, A. R. Org. Biomol. Chem. 2011, 9, 667. 
(71)  Slattery, C. N.; Clarke, L. A.; O’Neill, S.; Ring, A.; Ford, A.; Maguire, A. R. 
Synlett, 2011, 23, 765. 
(72)  Slattery, C. N.; Clarke, L. A.; Ford, A.; Maguire, A. R. Tetrahedron 2013, 
69, 1297. 
                                                                                                            Oliver Ware 
216 
 
(73)  Slattery, C. N.; Maguire, A. R. Tetrahedron Lett. 2013, 54, 2799. 
(74)  LaZerte, J. D.; Koshar, R. J. J. Am. Chem. Soc. 1955, 77, 910. 
(75)  Muramatsu, H.; Moriguchi, S.; Inukai, K. J. Org. Chem. 1966, 31, 1306. 
(76)  Muramatsu, H.; Inukai, K.; Ueda, T. Bull. Chem. Soc. Jpn. 1967, 40, 903. 
(77)  Gong, J.; Fuchs, P. L. J. Am. Chem. Soc. 1996, 118, 4486. 
(78)  Xiang, J.; Fuchs, P. L. J. Am. Chem. Soc. 1996, 118, 11986. 
(79)  Hirano, K.; Sakaguchi, S.; Ishii, Y. Tetrahedron Lett. 2002, 43, 3617. 
(80)  Yoshimitsu, T.; Arano, Y.; Nagaoka, H. J. Org. Chem. 2003, 68, 625. 
(81)  Yoshimitsu, T.; Makino, T.; Nagaoka, H. J. Org. Chem. 2003, 68, 7548. 
(82)  Yamamoto, Y.; Yamada, K.; Tomioka, K. Tetrahedron Lett. 2004, 45, 795. 
(83)  Yamada, K; Yamamoto, Y.; Tomioka, K. Org. Lett. 2003, 5, 1797. 
(84)  Clerici, A.; Cannella, R.; Pastori, N.; Panzeri, W.; Porta, O. Tetrahedron 
2006, 62, 5986. 
(85)  Sølvhøj, A.; Ahlburg, A.; Madsen, R. Chem. Eur. J. 2015, 21, 16272. 
(86)  Adams, J.; Poupart, M.-A.; Grenier, L.; Schaller, C.; Ouimet, N.; Frenette, 
R. Tetrahedron Lett. 1989, 30, 1749. 
(87)  Wang, P.; Adams, J. J. Am. Chem. Soc. 1994, 116, 3296. 
(88)  Davies, H. M. L.; Hansen, T. J. Am. Chem. Soc. 1997, 119, 9075. 
(89)  Davies, H. M. L.; Antoulinakis, E. G.; Hansen, T. Org. Lett. 1999, 1, 383. 
(90)  Davies, H. M. L.; Stafford, D. G.; Hansen, T. Org. Lett. 1999, 1, 233. 
(91)  Davies, H. M. .; Stafford, D. G.; Hansen, T.; Churchill, M. R.; Keil, K. M. 
Tetrahedron Lett. 2000, 41, 2035. 
(92)  Davies, H. M. L.; Grazini, M. V. A.; Aouad, E. Org. Lett. 2001, 3, 1475. 
(93)  Saito, H.; Oishi, H.; Kitagaki, S.; Nakamura, S.; Anada, M.; Hashimoto, S. 
Org. Lett. 2002, 4, 3887. 
(94)  Reddy, R. P.; Lee, G. H.; Davies, H. M. L. Org. Lett. 2006, 8, 3437. 
                                                                                                            Oliver Ware 
217 
 
(95)  Shen, Z.; Dong, V. M. Angew. Chem. Int. Ed. 2009, 48, 784. 
(96)  Davies, H. M. L.; Yang, J.; Nikolai, J. J. Organomet. Chem. 2005, 690, 
6111. 
(97)  Davies, H. M. L.; Hedley, S. J.; Bohall, B. R. J. Org. Chem. 2005, 70, 10737. 
(98)  Diaz-Requejo, M. M.; Belderrain, T. R.; Nicasio, M. C.; Trofimenko, S.; 
Perez, P. J. J. Am. Chem. Soc. 2002, 124, 896. 
(99)  Fraile, J. M.; García, J. I.; Mayoral, J. A.; Roldán, M. Org. Lett. 2007, 9, 
731. 
(100)  Shi, L.; Tu, Y. Q.; Wang, M.; Zhang, F. M.; Fan, C. A.; Zhao, Y. M.; Xia, W. 
J. J. Am. Chem. Soc. 2005, 127, 10836. 
(101)  Jiang, Y. J.; Tu, Y. Q.; Zhang, E.; Zhang, S. Y.; Cao, K.; Shia, L. Adv. Synth. 
Catal. 2008, 350, 552. 
(102)  Zhang, S. Y.; Tu, Y. Q.; Fan, C. A.; Zhang, F. M.; Shi, L. Angew. Chem. Int. 
Ed. 2009, 48, 8761. 
(103)  Kamitanaka, T.; Hikida, T.; Hayashi, S.; Kishida, N.; Matsuda, T.; Harada, 
T. Tetrahedron Lett. 2007, 48, 8460. 
(104)  Yoshida, J. I.; Suga, S.; Suzuki, S.; Kinomura, N.; Yamamoto, A.; Fujiwara, 
K. J. Am. Chem. Soc. 1999, 121, 9546. 
(105)  Andreades, S.; Zahnow, E. W. J. Am. Chem. Soc. 1969, 91, 4181. 
(106)  Chiba, T.; Takata, Y. J. Org. Chem. 1977, 42, 2973. 
(107)  Chen, C. K.; Hortmann, A. G.; Marzabadi, M. R. J. Am. Chem. Soc. 1988, 
110, 4829. 
(108)  Murahashi, S.; Komiya, N.; Terai, H.; Nakae, T. J. Am. Chem. Soc. 2003, 
125, 15312. 
(109)  Yeung, C. S.; Dong, V. M. Chem. Rev. 2011, 111, 1215. 
(110)  Li, Z.; Li, C. J. J. Am. Chem. Soc. 2004, 126, 11810. 
(111)  Li, Z.; MacLeod, P. D.; Li, C. J. Tetrahedron Asymmetry 2006, 17, 590. 
(112)  Zhao, L.; Li, C. J. Angew. Chem. Int. Ed. 2008, 47, 7075. 
                                                                                                            Oliver Ware 
218 
 
(113)  Li, Z.; Li, C. J. J. Am. Chem. Soc. 2005, 127, 6968. 
(114)  Yang, F.; Li, J.; Xie, J.; Huang, Z. Z. Org. Lett. 2010, 12, 5214. 
(115)  Ohta, M.; Quick, M. P.; Yamaguchi, J.; Wünsch, B.; Itami, K. Chem.Asian 
J. 2009, 4, 1416. 
(116)  Tsuchimoto, T.; Ozawa, Y.; Negoro, R.; Shirakawa, E.; Kawakami, Y. 
Angew. Chem. Int. Ed. 2004, 43, 4231. 
(117)  Li, Z.; Li, C. J. J. Am. Chem. Soc. 2005, 127, 3672. 
(118)  Li, Z.; Li, C. J. Eur. J. Org. Chem. 2005, 2005, 3173. 
(119)  Baslé, O.; Li, C.-J. Green Chem. 2007, 9, 1047. 
(120)  Sud, A.; Sureshkumar, D.; Klussmann, M. Chem. Commun. 2009, 22, 
3169. 
(121)  Zhang, J.; Tiwari, B.; Xing, C.; Chen, X.; Chi, Y. R. Angew. Chem. Int. Ed. 
2012, 51, 3649. 
(122)  Xu, Y.; Lebeau, E.; Gillard, J.; Attardo, G. Tetrahedron Lett. 1993, 34, 3841. 
(123)  Xu, Y.-C.; Lebeau, E.; Attardo, G.; Myers, P. L.; Gillard, J. W. J. Org. Chem. 
1994, 59, 4868. 
(124)  Katritzky, A. R.; Voronkov, M. V; Pastor, A.; Tatham, D. Heterocycles 1999, 
51, 1877. 
(125)  Zhang, Y.; Li, C.-J. Angew. Chem. Int. Ed. 2006, 45, 1949. 
(126)  Zhang, Y.; Li, C.-J. J. Am. Chem. Soc. 2006, 128, 4242. 
(127)  Liu, L.; Floreancig, P. E.; Pennsyl, V. Org. Lett. 2010, 12, 17. 
(128)  Chen, W.; Xie, Z.; Zheng, H.; Lou, H.; Liu, L. Org. Lett. 2014, 16, 5988. 
(129)  Murahashi, S.-I.; Komiya, N.; Terai, H. Angew. Chem. Int. Ed. 2005, 44, 
6931. 
(130)  Clausen, D. J.; Floreancig, P. E. J. Org. Chem. 2012, 77, 6574. 
(131)  Pinnow, J. Ber. Dtsch. Chem. Ges. 1895, 28, 3039. 
(132)  Meth-Cohn, O.; Suschitzky, H. Adv. Heterocycl. Chem. 1972, 14, 211. 
                                                                                                            Oliver Ware 
219 
 
(133)  Meth-Cohn, O. In Adv. Heterocycl. Chem. 1996, 65, 1. 
(134)  Mahoney, S. J.; Fillion, E. Chem. Eur. J. 2012, 18, 68. 
(135)  Pastine, S. J.; McQuaid, K. M.; Sames, D. J. Am. Chem. Soc. 2005, 127, 
12180. 
(136)  Burns, N. Z.; Baran, P. S.; Hoffmann, R. W. Angew. Chem. Int. Ed. 2009, 
48, 2854. 
(137)  Verboom, W.; Hamzink, M. R. J.; Reinhoudt, D. N.; Visser, R. Tetrahedron 
Lett. 1984, 25, 4309. 
(138)  Heathcock, C. H.; Hansen, M. M.; Ruggeri, R. B.; Kath, J. C. J. Org. Chem. 
1992, 57, 2544. 
(139)  Heathcock, C. H. Proc. Natl. Acad. Sci. 1996, 93, 25. 
(140)  Barluenga, J.; Fañanás-Mastral, M.; Aznar, F.; Valdés, C. Angew. Chem. 
Int. Ed. 2008, 47, 6594. 
(141)  Ruble, J. C.; Hurd, A. R.; Johnson, T. A.; Sherry, D. A.; Barbachyn, M. R.; 
Toogood, P. L.; Bundy, G. L.; Graber, D. R.; Kamilar, G. M. J. Am. Chem. 
Soc. 2009, 131, 3991. 
(142)  Zhang, C.; Murarka, S.; Seidel, D. J. Org. Chem. 2009, 74, 419. 
(143)  Mori, K.; Ohshima, Y.; Ehara, K.; Akiyama, T. Chem. Lett. 2009, 38, 524. 
(144)  Haibach, M. C.; Seidel, D. Angew. Chem. Int. Ed. 2014, 53, 20. 
(145)  Murarka, S.; Zhang, C.; Konieczynska, M. D.; Seidel, D. Org. Lett. 2009, 
11, 129. 
(146)  Han, Y. Y.; Han, W. Y.; Hou, X.; Zhang, X. M.; Yuan, W. C. Org. Lett. 2012, 
14, 4054. 
(147)  Jurberg, I. D.; Peng, B.; Wöstefeld, E.; Wasserloos, M.; Maulide, N. Angew. 
Chem. Int. Ed. 2012, 51, 1950. 
(148)  Zhou, G.; Zhang, J. Chem. Commun. 2010, 46, 6593. 
(149)  Wang, Y.; Chi, Y.; Zhang, W. X.; Xi, Z. J. Am. Chem. Soc. 2012, 134, 2926. 
(150)  Atkinson, R. S. J. Chem. Soc. D Chem. Commun. 1969, 13, 735a. 
                                                                                                            Oliver Ware 
220 
 
(151)  Atkinson, R. S.; Green, R. H. J. Chem. Soc. Perkin Trans. 1 1974, 3, 394. 
(152)  Schulz, J. G. D.; Onopchenko, A. J. Org. Chem. 1978, 43, 339. 
(153)  Yoshimatsu, M.; Hatae, N.; Shimizu, H.; Kataoka, T. Chem. Lett. 1993, 22, 
1491. 
(154)  Pastine, S. J.; Sames, D. Org. Lett. 2005, 7, 5429. 
(155)  McQuaid, K. M.; Long, J. Z.; Sames, D. Org. Lett. 2009, 11, 2972. 
(156)  Mori, K.; Kawasaki, T.; Sueoka, S.; Akiyama, T. Org. Lett. 2010, 12, 1732. 
(157)  McQuaid, K. M.; Sames, D. J. Am. Chem. Soc. 2009, 131, 402. 
(158)  Vadola, P. A.; Sames, D. J. Am. Chem. Soc. 2009, 131, 16525. 
(159)  Jiao, Z.-W.; Zhang, S.-Y.; He, C.; Tu, Y.-Q.; Wang, S.-H.; Zhang, F.-M.; 
Zhang, Y.-Q.; Li, H. Angew. Chem. Int. Ed. 2012, 51, 8811. 
(160)  Wölfling, J.; Frank, É.; Schneider, G.; Tietze, L. F. Eur. J. Org. Chem. 1999, 
1999, 3013. 
(161)  Mahoney, S. J.; Moon, D. T.; Hollinger, J.; Fillion, E. Tetrahedron Lett. 
2009, 50, 4706. 
(162)  Mori, K.; Sueoka, S.; Akiyama, T. J. Am. Chem. Soc. 2011, 133, 2424. 
(163)  Mori, K.; Kawasaki, T.; Akiyama, T. Org. Lett. 2012, 14, 1436. 
(164)  Boudou, M.; Enders, D. J. Org. Chem. 2005, 70, 9486. 
(165)  Vadola, P. a; Carrera, I.; Sames, D. J. Org. Chem. 2012, 77, 6689. 
(166)  Gwynn, D. E.; Skillern, L. Chem. Commun. 1968, 9, 490. 
(167)  Chou, D. T. H.; Huang, X.; Batchelor, R. J.; Einstein, F. W. B.; Bennet, A. 
J. J. Org. Chem. 1998, 63, 575. 
(168)  Alajarin, M.; Marin-Luna, M.; Vidala, A. Adv. Synth. Catal. 2011, 353, 557. 
(169)  Mori, K.; Kurihara, K.; Akiyama, T. Chem. Commun. 2014, 50, 3729. 
(170)  Briones, J. F.; Basarab, G. S. Chem. Commun. 2016, 52, 8541. 
(171)  Rabong, C.; Hametner, C.; Mereiter, K.; Kartsev, V. G.; Jordis, U. 
Heterocycles 2007, 75, 799. 
                                                                                                            Oliver Ware 
221 
 
(172)  Ghobrial, M.; Schnürch, M.; Mihovilovic, M. D. J. Org. Chem. 2011, 76, 
8781. 
(173)  Zhdankin, V. V. Arkivoc 2009, 1. 
(174)  Dess, D. B.; Martin, J. C. J. Am. Chem. Soc. 1991, 113, 7277. 
(175)  Meyer, S. D.; Schreiber, S. L. J. Org. Chem. 1994, 59, 7549. 
(176)  Patzelt, H.; Woggon, W.-D. Helv. Chim. Acta 1992, 75, 523. 
(177)  Havare, N.; Plattner, D. A. Org. Lett. 2012, 14, 5078. 
(178)  Dohi, T.; Ito, M.; Morimoto, K.; Iwata, M.; Kita, Y. Angew. Chem. Int. Ed. 
2008, 47, 1301. 
(179)  Tucker, J. W.; Narayanam, J. M. R.; Shah, P. S.; Stephenson, C. R. J. 
Chem. Commun. 2011, 47, 5040. 
(180)  Surendra, K.; Srilakshmi Krishnaveni, N.; Arjun Reddy, M.; Nageswar, Y. 
V. D.; Rama Rao, K. J. Org. Chem. 2003, 68, 2058. 
(181)  Bartlett, S. L.; Beaudry, C. M. J. Org. Chem. 2011, 76, 9852. 
(182)  Yadav, J. S.; Reddy, B. V. S.; Basak, A. K.; Venkat Narsaiah, A. 
Tetrahedron 2004, 60, 2131. 
(183)  Cottet, F.; Cottier, L.; Descotes, G. Synthesis 1987, 5, 497. 
(184)  Kraiss, G.; Povarny, M.; Scheiber, P.; Nador, K. Tetrahedron Lett. 1973, 
23, 2359. 
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